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Abstract and Key Words 
This thesis describes three separate research projects within the broad topic of 
synthetic organic chemistry. The synthesis of alkyl-substituted siloles and their reactivity 
in Diels–Alder chemistry is reported. Furthermore, the cleavage of the bicyclic adducts 
by Tamao–Fleming oxidation has been achieved which reveals a highly substituted 
cyclohexene-1,4-diol structure.  
The second chapter describes the cycloaddition chemistry of alkoxy-activated 
cyclobutane dicarboxylates with aldehydes, nitrones and nitrosoarenes. The cycloaddition 
occurs, in the case of aldehydes, with uniformly high diastereoselectivity to afford 
tetrahydropyrans in good to excellent yield. When nitrones were used as the dipolarophile 
the cycloaddition occurs in a rather unselective manner though the formed oxazepanes 
undergo equilibration to yield single diastereomers in most cases. The cycloaddition with 
nitrosoarenes, however, proved an exception as the regioselectivity of the reaction was 
dependant both on the nitrosoarenes and the catalyst employed. 
Lastly, progress towards the synthesis of grandilodine A is reported. Several 
routes were developed in attempts to form the central 8-membered ring; however, 
successful ring closure has eluded this study.  
 
Key Words: Diels–Alder, Dipolar Cycloaddition, Donor-Acceptor Cyclobutane, 
Grandilodine A, Methodology, Natural Product, Nitrone, Nitrosoarene, Total Synthesis, 
Tamao–Fleming Oxidation. 
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Preface 
The field of synthetic organic chemistry is a rich source of unsolved problems. It 
continually challenges and inspires practitioners to create innovative solutions, discover 
new processes, and apply these methods to the synthesis of complex target molecules. 
Furthermore, it provides us with pleasing challenges to test our understanding of 
fundamental principles and rewards our endeavors richly upon success. To this end, I 
have worked towards expanding our understanding of several fundamental concepts 
described within this thesis. Enclosed within are three projects which may seem, at first, 
to be disparate. However, the broad nature of synthetic organic chemistry encompasses 
all of these subjects. The synthetic methodologies of the first two chapters create 
intriguing new molecules which may possess biological activity, or can be used as 
platforms for the installation of further complexity. The last chapter explores the de novo 
synthesis of a complex natural product and, while the process does not use any of the 
methods developed in the first two chapters, serves as a lesson of current challenges in 
synthetic organic chemistry that still need to be addressed and possibly as a stimulus for 
further methodology development. 
The first chapter demonstrates that siloles may engage productively in Diels–
Alder chemistry with exceptionally high levels of stereocontrol. I have also displayed the 
value of the corresponding adducts in context by oxidatively cleaving the silicon-carbon 
bonds; creating the complex cyclohexene-1,4-diol core of the eudesmanolide natural 
products. 
The second chapter of this thesis describes the investigation of donor-acceptor 
strained ring systems. I, along with coworkers, was able to show that alkoxy-activated 
 
 
xix 
 
cyclobutane dicarboxylates could successfully undergo annulation events with two and 
three atom dipoles to form a variety of unique bicyclic hetereocycles. These new 
compounds have striking molecular architecture and may find application as novel 
scaffolds for biological studies. 
Lastly, I directed efforts towards the total synthesis of the recently disclosed 
natural product grandilodine A. I explored multiple routes towards the total synthesis of 
grandilodine A, yet was continually stymied by unanticipated intricacies that revealed 
themselves through my studies. Despite the incomplete nature of the work, many lessons 
were learned that may assist in the successful synthesis in the future. 
Though these projects appear to be quite disparate in scope and nature, they serve 
as a reminder of the wide breadth of the field of synthetic organic chemistry. I hope the 
reader will find the body of work as stimulation for further studies, or as a valuable 
resource of relevant background information. 
-Andrew C. Stevens 
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Chapter 1.  Diels–Alder Chemistry of Siloles and their Transformation into 
Cyclohex-2-ene-1,4-diols. 
This chapter describes the synthesis of siloles with substitution patterns that are 
continuative toward natural product synthesis and their reactivity in Diels–Alder 
chemistry. The cleavage of the resulting bicyclic adducts reported reveals a highly 
functionalized cyclohexene-diol core. Relevant background information of silicon’s role 
in organic synthesis is included. A portion of this work has been published in Organic 
Letters.1 Portions of text and schemes have been reprinted in part with permission from 
Stevens, A. C.; Pagenkopf, B. L. Org. Lett. 2010, 12, 3658–3661. Copyright © 2010 
American Chemical Society. 
 
1.1 Introduction: Silicon in Organic Synthesis 
Silicon is the second most abundant element in our planet’s crust, after oxygen.2 
The unique reactivity of silicon has promoted its extensive use in organic chemistry over 
the past several decades.3 Much of the chemistry associated with silicon is due to the 
strength of the silicon-carbon, silicon-oxygen, and silicon-fluorine bonds (290 kJ/mol, 
368 kJ/mol and 582 kJ/mol respectively).4 The silicon-carbon and silicon-oxygen bonds 
are strong enough to survive most organic transformations, but can be readily cleaved 
under mild conditions which has led to the extensive use of silicon-based protecting 
groups.5 In addition, the ability of silicon to stabilize positive charges ß to the functional 
group has facilitated important carbon-carbon bond forming reactions such as the 
Hosomi–Sakurai6 and Mukaiyama aldol7 reactions. More recently, silicon has found use 
2 
 
 
 
as an activating group for cross-coupling chemistry where organosilicon reagents act as 
nucleophilic donors (i.e., the Hiyama coupling).8 This reaction allows toxic, expensive 
and reactive organo-metallic reagents such as organozinc and organotin species to be 
replaced with benign organosilicon reagents. Though initial findings required fluoride 
sources to activate the silicon for cross-coupling, extensive investigations have found that 
mild bases can be used as an alternative when the organosilane is appropriately 
substituted.9  
Silicon has also found use as a Lewis acid in a plethora of transformations when 
weakly coordinating anions are present (e.g, TMSOTf).10 Recent reports from the 
Leighton group have described the use of strain-release from silacycles which has 
resulted in a new class of allylation reagents (1-1) which act as both an allylation source 
and a Lewis acid (Figure 1.1).11,12 These reagents are important as allylations are one of 
the most used reactions for the generation of new stereocenters and append a vital 
synthetic handle for further chemical transformations. They have proven to be a viable 
alternative to the commonly used Brown allylation, as the Leighton allylation reagents 
are readily available from commodity chemicals (and are now commercially available), 
are stable solids that can be stored for extended periods of time, have good 
enantioselectivity and the products are easily separated from the reaction byproducts. 
This is in contrast to the Brown allylation reagents which must be prepared fresh (a time-
intensive procedure), are exceedingly moisture sensitive and require extensive work-up 
conditions to remove the by-products from the reaction products. Additionally, 
derivatives of the silacycle have been synthesized and applied as the first enantioselective 
3 
 
 
 
silicon Lewis acids for a number of transformations including but not limited to Diels–
Alder,13 Mannich,14 and Pictet–Spengler15 reactions. 
 
 
Figure 1.1. Enantioselective Silicon Based Lewis Acid Catalysts 
 
The use of silicon as a lynchpin for novel strategies in synthetic chemistry has 
also seen intense investigation. Application of the disparity between carbon-silicon and 
carbon-oxygen bond strength allows for the Brook rearrangement (1-7 to 1-8 or 1-11 to 
1-12), where a carbon-silicon bond is cleaved and an oxygen-silicon bond is formed, 
creating a carbanion. Typically this carbanion is protolytically quenched; however, 
tandem reactions involving the Brook rearrangement have recently been explored, most 
notably by Smith and Takeda (Scheme 1.1). This strategy has been dubbed anionic relay 
chemistry and is capable of engaging a diverse array of reaction partners for rapid and 
efficient generation of libraries of compounds.16  
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Scheme 1.1. Type I and Type II Anion Relay Chemistry 
 
The widespread use of silicon as a protecting group has led to investigation of 
silicon as a temporary tether or as a template, strategies explored both by Leighton and 
Kozmin. Leighton has demonstrated this concept through a tandem 
silylformylation/allylsilation sequence.17 Treatment of diallylsilyl ether (1-14) with 
Rh(acac) under carbon monoxide atmosphere followed by Tamao–Fleming oxidation 
afforded 1,3,5-triol 1-15 with high diastereoselectivity (Scheme 1.2). Extension of this 
methodology to pendant alkynes allowed for an alternative stereochemical outcome.18 In 
both cases the proposed stereochemical model implicates allyl transfer through activation 
of the aldehyde (installed via silylformylation) in an intramolecular fashion and 
intramolecular allyl transfer.  
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Scheme 1.2. Tandem Silylformylation/Allylation of Pendant Alkenes and Alkynes 
 
 
Kozmin has also developed chemistry whereby he uses silicon as a templating 
reagent, allowing for an asymmetric rearrangement to occur.19 meso-Silacyclopentene 
oxide 1-20 was treated with a chiral amine base (1-25) to afford chiral allyl alcohol 1-21 
(Scheme 1.3). Subsequent hydroxyl-directed epoxidation and epoxide opening allowed 
for the synthesis of highly substituted silacyclopentane 1-23. Cleavage of the silicon-
carbon bonds (once again via Fleming–Tamao oxidation) revealed the polyol structure, 
available with complete control over the stereochemical outcome at each stereogenic 
center. Importantly, the chiral amine base was found to be capable of acting in a catalytic 
fashion, allowing for application in large-scale reactions such as those required for total 
synthesis. Subsequently, this methodology was applied in the enantioselective synthesis 
of pinolidoxin.20  
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Scheme 1.3. Enantioselective Rearrangement of Silacyclopenteneoxide and Application 
for Total Synthesis 
 
 
Though there has been significant exploration of silacycles in organic chemistry, 
there remain many opportunities that have not yet been realized. One such area of 
potential utility is that of siloles, which have previously been extensively investigated for 
their intriguing optoelectronic properties.21 It is readily apparent that siloles may undergo 
Diels–Alder cycloadditions, as cyclopentadiene is a well explored diene for Diels–Alder 
chemistry. It was somewhat surprising that there have only been few reports of Diels–
Alder chemistry of siloles, very limited in scope, and the adducts obtained have only had 
rudimentary explorations as to their potential usefulness.22 At the onset of this work, it 
was believed that the bicyclic adduct of a silole Diels–Alder reaction could undergo 
silicon-carbon bond cleavage to form a highly functionalized cyclohex-2-ene-1,4-diol 
(Scheme 1.4). The structural features contained in 1-28 could facilitate rapid access to a 
diverse range of compounds, potentially leading to the synthesis of natural products such 
as the eudesmanolides.23 
  
7 
 
 
 
Scheme 1.4. Cyclohex-2-ene-1,4-diols from Siloles and Potential Applications 
 
 
1.2 Results and Discussion 
1.2.1 Synthesis of a C-Unsubstituted Silole 
The initial target of study was 1,1-diphenylsilole (1-30) as the limited hindrance 
about the carbon ring would increase the likelihood of a successful Diels–Alder reaction24 
and the aromatic substituents on the silicon would enable the subsequent oxidative 
cleavage of the silicon-carbon bond (Scheme 1.5).25 The majority of research regarding 
siloles has involved development for electrochemical purposes26 resulting in synthetic 
strategies that are only suitable for siloles bearing aromatic substituents about the carbon 
ring.27 Rapid preparation of siloles absent of an aromatic substituent has been reported 
using flash vacuum pyrolysis,28 a process our lab was ill-equipped to perform. 
Additionally, this method has only been demonstrated successfully with siloles bearing 
small alkyl substituents on the silicon atom, which would prove ineffective for 
subsequent Tamao–Fleming oxidation and as such, an alternative synthesis was explored. 
It was believed that a direct oxidation or an oxidation-elimination sequence could provide 
an expedient route to access silole 1-30 from commercially available 
dichlorodiphenylsilane (Scheme 1.5).  
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Scheme 1.5. Proposed Synthetic Route to a C-unsubstituted Silole 
 
 
Synthetic efforts began with formation of dihydrosilole 1-19 (Scheme 1.6). The 
material was readily available through either a two-step process by reaction of 
dichlorodiphenylsilane with allylmagnesium bromide and subsequent RCM29 or in a one-
step reductive cyclization of dichlorodiphenylsilane with Rieke magnesium and 1,3-
butadiene.30 The single step process was preferred due to shorter reaction times and the 
potential to access tri- and tetrasubstituted olefins which would be problematic to form 
via RCM.31 
Scheme 1.6. Synthesis of Silacyclopentene 1-19 
Ph2SiCl2
MgBr
Ph2Si
1-33 (0.75 mol %)
76%
Ph2Si
77%
Mg*, 1,3-butadiene, THF
58%
Grubbs II catalyst
Ru
Ph
N N
PCy3
Cl
Cl
MesMes
1-191-31
1-33
 
 
Unfortunately, direct oxidation of 1-19 with DDQ, MnO2, Pd/C, and SeO2 failed 
to deliver the silole, thus a stepwise dihydroxylation/elimination reaction sequence was 
explored (Scheme 1.7). Dihydrosilole 1-19 was dihydroxylated with OsO4 and 
K2Fe(CN)6 and the diol was converted to a bis-mesylate. Unfortunately, base promoted 
elimination of the bis-mesylate (1-34) failed under a variety of reaction conditions.
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Scheme 1.7. Oxidation-Elimination of Dihydrosilole 1-19 
 
 
As a double elimination was not possible, elimination of an allylic alcohol was 
investigated. Through a sequence similar to that employed by Kozmin,19 allylic alcohol 
1-21 was obtained through epoxidation of dihydrosilole 1-19 and epoxide rearrangement 
with LDA (Scheme 1.8). Unfortunately, derivatives of compound 1-21 were highly 
susceptible to silicon-carbon bond cleavage, as installation of relatively stable leaving 
groups (sulfonates) resulted in elimination in situ to form silanol 1-35. This process also 
occurred even when mild elimination protocols of Burgess32 or Grieco33 were employed. 
Scheme 1.8. Elimination via Allylic Alcohol 
 
 
Faced with difficulties in the formation of a C-unsubstituted silole, research was 
directed towards the more stable C-substituted siloles (i.e, 1-40, Scheme 1.9).34 
Additionally, since tertiary alcohols are more readily eliminated from dihydrosiloles than 
are secondary alcohols, milder reaction conditions were expected to be applicable.34 
1.2.2 Synthesis of 1,1-Diphenyl-3-methylsilole 
The same three-step protocol was used to prepare tertiary alcohol 1-38 (Scheme 
1.9). Reductive cyclization between dichlorodiphenylsilane, isoprene and Rieke 
magnesium formed dihydrosilole 1-36, which was epoxidized with mCPBA. 
Rearrangement of epoxide 1-37 with LDA occurred with complete regioselectivity to 
10 
 
 
 
afford tertiary alcohol 1-38. Dehydration of tertiary alcohol 1-38 was achieved through 
formation of the phenyl carbamate followed by thermolysis; however, only the dimeric 
product 1-41 was obtained and the monomeric silole 1-40 was not observed. Lower-
temperature eliminations were examined via mesylates or tosylates but in situ elimination 
occurred and only the dimeric product was obtained.  
Scheme 1.9. Preparation of an Alkyl Silole Dimer 
 
 
 Introduction of maleic anhydride as a dienophile during thermolysis of tertiary 
carbamate 1-39 was successful in trapping the silole and Diels–Alder adduct 1-42 was 
obtained in 83% yield (Scheme 1.10). Unfortunately, this interception strategy could not 
be extended to other dienophiles. Attempts to crack the silole dimer (1-41) and trap it 
with maleic anhydride were also unsuccessful and only slow decomposition of the dimer 
was observed even under prolonged times at high temperature (refluxing xylenes). 
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Scheme 1.10. Trapping of 1,1-Diphenyl-3-methylsilole with Maleic Anhydride 
 
 
1.2.3 Synthesis of 3,4-Dimethyl-1,1-diphenylsilole 
Buoyed by the successful formation of the Diels–Alder adduct, yet frustrated by 
the inability to isolate the monomeric silole, attention was turned towards synthesis of a 
C-disubstituted silole in hopes of isolating a monomeric compound whose reactivity 
could be fully explored. To this end, the same 3-step protocol used previously was 
applied to synthesize tertiary alcohol 1-45 (Scheme 1.11).  
Scheme 1.11. Synthesis of 3,4-Dimethyl-1,1,-diphenylsilole (1-47) 
 
 
Reductive cyclization of 2,3-dimethylbutadiene with diphenyldichlorosilane 
afforded dihydrosilole 1-43. Epoxidation and subsequent rearrangement afforded allylic 
alcohol 1-45 in good yield, producing only the endo-alkene. Subsequent conversion of 
the allylic alcohol to carbamate 1-46 occurred readily and in high yield. Upon heating 1-
46 in toluene thermal elimination occurred to produce 3,4-dimethylsilole 1-47 without 
formation of the dimer and only trace amounts of exo-elimination products (<5%). Single 
step eliminations of allylic alcohol 1-45 to form the silole through a mesylate or tosylate 
12 
 
 
 
were found to be unsatisfactory due to substantial (25%) formation of the exo isomer 
which could not be separated from the silole. Investigation into the propensity of the 
silole to dimerize found that 3,4-dimethyl-1,1-diphenylsilole (1-47) was very resilient, as 
dimerization was not observed even over extended periods of time at elevated 
temperatures.  
1.2.4 Diels–Alder Reactions of Siloles 
1.2.4.1 Thermal Diels–Alder Reaction 
Having secured a reliable route to a monomeric silole, the breadth of the thermal 
Diels–Alder cycloaddition was investigated (Table 1.1). Cycloadditions with highly 
reactive dienophiles, such as maleic anhydride or maleimide (entries 1 and 2), were 
complete after 16 h at room temperature while less reactive dienophiles, such as 
fumarates and quinones (entries 3 - 5), required elevated temperatures to undergo 
cyclization. Trisubstituted dienophiles (entries 6 and 7) or those bearing only a single 
activating group (entries 8 - 10) did not react and only starting material was observed. 
Acetylenic species (entry 11) did not undergo the reaction, and hetero-Diels–Alder 
reactions did not occur (entry 12). 
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Table 1.1. Thermal Diels–Alder Reaction 
 
entry dienophile product, yield entry dienophile product, yield 
1a 
 
 
7 
 
n.r.c 
2a 
 
 
8 
 
n.r.c 
3b 
 
 
9  n.r.
c 
4 
 
 
10 
 
n.r.c 
5 
 
 
11 
 
n.r.c 
6 
 
 
n.r.c 12 
 
n.r.c 
a PhMe, 22 °C, 16 h. b PhMe, reflux, 16 h. c Silole starting material recovered. 
 
The reaction of benzyne with 3,4-dimethylsilole was also investigated (Scheme 
1.12). Benzyne was generated through four different methods; however, each case failed 
to provide the desired cycloadduct. Control tests were performed and, in the presence of 
cyclopentadiene, the expected cycloadducts were formed. 
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Scheme 1.12. Investigation of Benzyne Reactivity with Siloles 
 
 
Due to the sluggish nature of these silole Diels–Alder reactions and the somewhat 
limited scope, methods for accelerating the reaction were investigated. 
1.2.4.2 Lewis Acid Mediated and High Pressure Diels–Alder Reactions 
Two known methods for the enhancement of Diels–Alder reaction, Lewis acid 
activation and high pressure conditions, were explored.35 Though both accelerate Diels–
Alder reactions, they do so through different mechanisms. 
The Diels–Alder reaction is a 4π + 2π pericyclic reaction that forms two new σ-
bonds at the expense of two π-bonds. The net result is a new 6-membered ring that forms 
in a strongly exergonic process (ΔHǂ ~ 16 to 18 kcal • mol-1 and ΔSǂ ~ - 30 to - 40 cal •  
K-1 • mol-1). The reaction occurs due to overlap between the HOMO of a diene and the 
LUMO of a dienophile (or vice-versa in the case of inverse demand Diels–Alder 
reactions) (Figure 1.2). The selectivity observed in Diels–Alder chemistry has, for many 
years, been attributed to secondary orbital overlap between the diene and the electron 
withdrawing groups on the dienophile. More recently, this rationale has fallen out of 
favor as calculations have shown that the atoms presumed to engage in secondary orbital 
interactions are situated relatively far (2.8 Å) apart in the transition state structures.36 The 
currently prevailing view is that a combination of steric interactions, solvent effects and 
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electrostatic forces can successfully explain the typically high level of endo selectivity 
found in Diels–Alder reactions.36 
EWG
HOMOdiene
LUMOdienophile
endo
EWG
HOMOdiene
LUMOdienophile
exoEDG
EWG
LUMO
HOMO
Diels-Alder Frontier
Molecular Orbitals endo and exo selectivity
 
Figure 1.2. Frontier Molecular Orbitals of Diels–Alder Reactions and Endo/Exo 
Selectivity 
 
Lewis acids serve as catalysts in Diels–Alder chemistry where they increase not 
only the speed of the reaction, but also the selectivity. This process occurs through 
coordination of the Lewis acid to the dienophile, lowering the energy of the LUMO and 
causing better overlap between the diene and the dienophile resulting in an increased rate 
of reaction.  
After screening several Lewis acids, it was found that diethylaluminium chloride 
mediated the reaction between the siloles and dienophiles, though one full equivalent of 
Lewis acid was required to promote full conversion of the starting material (Table 1.2). 
Lewis acidic conditions allowed for dienophiles bearing a single activating group (e.g., 
acrylates, methyl vinyl ketone, entries 3 - 6) to react at ambient temperature and reduced 
reaction times (from 16 h to 2 h). Despite the increased rate of reaction of singly-
activated dienophiles, the Diels–Alder reaction was found to be quite limited as 
disubstituted alkenes (entries 1, 7 - 10) did not undergo the cycloaddition unless both 
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substituents on the dienophile were activating groups. Additionally, compounds prone to 
polymerization (entry 2) could not be accessed as they were found to undergo 
polymerization faster than the desired Diels–Alder reaction. Due to these limitations, 
additional modes of Diels–Alder enhancement were investigated. 
Table 1.2. Lewis Acid Mediated Diels–Alder Reaction 
 
entry dienophile product, yield entry dienophile product, yield 
1 
 
7 
 
n.r. 
2 
 
polymer 8 
 
n.r. 
3 
 
9 
 
n.r. 
4 
 
10 
 
n.r. 
5 
 
11 
 
n.r. 
6 
 
   
 
High pressure has also been explored for its effect on Diels–Alder chemistry. 
Diels–Alder reactions have large negative volumes of activation,37 and as such high 
pressures accelerate the rate of reaction without necessitating high temperatures.38 High 
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pressure reactions facilitated access to the same cycloadducts available using Lewis acid 
catalysis (Table 1.3); however, compounds which were previously found to readily 
polymerize preferentially underwent Diels–Alder cycloaddition (entry 4). Once again, 
disubstituted olefins were found to be beyond the scope of the reaction unless both of the 
substituents were activating groups (entries 1, 5 - 9) and trisubstituted olefins were found 
to be unreactive, even if two of the substituents were activating groups (entries 10 and 
11). 
Table 1.3. High Pressure Diels–Alder Reaction 
 
entry dienophile product, yield entry dienophile product, yield 
1 
 
7 
 
n.r. 
2 
 
8 
 
n.r. 
3 
 
9 
 
n.r. 
4 
 
10 
 
n.r. 
5 
 
11 
 
n.r. 
6 
 
n.r    
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1.2.5 Synthesis of Alternative Silole Substitution Patterns 
 Having successfully discovered complementary reaction conditions for the Diels–
Alder reaction with siloles, more interesting substrates with greater potential utility in 
natural product synthesis were prepared.  
Cyclohexyl-fused silole 1-62 was prepared from cyclohexanone according to the 
route outlined in Scheme 1.13. Mannich reaction between cyclohexanone, dimethylamine 
and formaldehyde followed by Wittig olefination and Hoffmann elimination afforded the 
requisite diene (1-57). Reductive cyclization with Rieke magnesium and 
dichlorodiphenylsilane produced dihydrosilole 1-58. Epoxidation with mCPBA, 
rearrangement with LDA and elimination via carbamate thermolysis yielded silole 1-62. 
Scheme 1.13. Synthesis of a Cyclohexyl-Fused Silole 
Ph2Si
O Me2NH-HCl,
HCOH, HCl(aq)
O
NMe2 NMe2
Ph3PMeBr
THF, KOtBu
71%
MeI, Et2O
95%
NMe3
Ag2O, H2O
93%
Mg*, Ph2SiCl2
THF, 93%
Ph2Si
mCPBA
CH2Cl2, 92%
Ph2Si O
Ph2Si
OH
LDA, THF
70%
PhNCO,
tin(ethylhexanoate)2
Et2O, 93%
PhMe, reflux
94%
Ph2Si
OCONHPh
1-541-53 1-55
1-581-57
1-60
1-56
1-59
1-62
1-61
70% I
 
 
A previously reported C-unsubstituted silole was also synthesized;22c however it 
bore the very large mesityl groups about the silicon atom to prevent the previously 
described dimerization (see Scheme 1.9) and silicon-carbon bond cleavage (see Scheme 
1.8). Lithiation of mesityl bromide and treatment with tetrachlorosilane afforded 
dichlorodimesitylsilane (Scheme 1.14). Reductive cyclization with 1,3-butadiene and 
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Rieke magnesium afforded dihydrosilole 1-64. Epoxidation and epoxide rearrangement 
formed allylic alcohol 1-66. The previous synthesis of silole 1-67 used a Chugaev 
elimination to form the silole; however, a very low yield was reported (23-36%). It was 
found that the Burgess reagent proved vastly superior, affording silole 1-67 in 72% yield.  
Scheme 1.14. Synthesis of a C-unsubstituted Silole 
 
 
With siloles 1-62 and 1-67 in hand, the Diels–Alder reaction was explored using 
the previously developed conditions (Table 1.4). Cyclohexyl-fused silole 1-62 was found 
to undergo the cycloaddition with maleic anhydride, methyl fumarate, methylacrolein, 
and methylvinyl ketone (entries 1 - 4) in yields comparable to those found with silole 1-
47. Likewise, C-unsubstitued silole 1-67 formed the desired cycloadducts with 
methacrolein, methyl vinyl ketone, and benzoquinone (entries 5 - 7); however, there was 
a noticeable increase in reaction times due to increased steric bulk of the mesityl 
groups.39 
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Table 1.4. Additional Substituted Silole Substrates 
 
entry dienophile product, yield entry dienophile product, yield  
1a 
 
 
5c 
 
  
2b 
 
6b 
 
 
 
3b 
 
 
7d 
 
  
4b 
 
 
 
 
a PhMe, 22 °C, 16 h. b PhMe, Et2AlCl, 2 h. c PhMe, Et2AlCl, 24 h. d CH2Cl2, 160 000 psi.  
 
The relative stereochemistry of the Diels–Alder adducts was determined through 
NMR by observing nOe interactions between the methine proton α to the electron-
withdrawing group and the aryl protons (Figure 1.3). Furthermore, the typically 
diagnostic chemical shift difference between the axial and equatorial positions of all-
carbon [2.2.1] bicyclic systems suggests that the exo products were never formed in a 
quantity sufficient to be detected by NMR spectroscopy.40  
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Figure 1.3. Key nOe Interaction for Structural Determination 
 
1.2.6 Tamao–Fleming Oxidation 
The 7-silabicyclo[2.2.1]hept-2-ene framework displays several functional groups 
that evoke opportunities for synthetic manipulation (Scheme 1.15). To illustrate this 
point, oxidation of the carbon-silicon bond by the Tamao–Fleming reaction successfully 
converted representative silole Diels–Alder adducts 1-48f, 1-48g, and 1-69c 
diastereoselectively to their respective cis-diols in 44-50% isolated yield.  
Scheme 1.15. Tamao–Fleming Oxidation of the Diels–Alder Adducts 
 
 
1.3 Concluding Remarks 
In summary, the reactivity of siloles in Diels–Alder chemistry has been explored. 
Various promoters, including elevated temperatures, Lewis acids, and high pressures 
were necessary to expand the reaction scope with less active dienophiles and in all cases 
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complete endo selectivity was observed. Furthermore, the resulting bicyclic adducts were 
successfully cleaved to reveal highly substituted cyclohex-2-ene-1,4-diols. Future 
research will focus on accessing alternate substitution patterns about the silole ring and 
application of the 1,4-diol species in natural product synthesis. 
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1.4 Experimental  
The following section contains experimental procedures and characterization data 
for the compounds prepared in Chapter 1. 
1.4.1 General Experimental Details 
All reactions were run under an argon atmosphere unless otherwise indicated. 
Flasks were oven dried and cooled in a dessicator prior to use unless water was used in 
the reaction. Solvents and reagents were purified by standard methods.41 
Dichloromethane, diethyl ether, THF, and toluene were purified by passing the solvents 
through activated alumina columns.  All other chemicals were of reagent quality and used 
as obtained from commercial sources unless otherwise noted. The progress of reactions 
were monitored by TLC performed on F254 silica gel plates. The plates were visualized 
by UV light (254 nm) or by staining with ceric ammonium molybdate.42 Column 
chromatography was performed with Silica Flash P60 60 Å silica gel from Silicycle 
according to the Still method.43 
The 1H and 13C NMR data were obtained on 400 or 600 MHz spectrometers. All 
spectra were obtained in deuterated chloroform and were referenced to residual 
chloroform at δ 7.25 ppm for 1H spectra and the center peak of the triplet at δ 77.0 (t) for 
13C spectra. When peak multiplicities are given, the following abbreviations are used: s, 
singlet; d, doublet; dd, doublet of doublets; ddd, doublet of doublet of doublets; t, triplet; 
q, quartet; m, multiplet; br, broad; app, apparent. EI mass spectra were obtained on a 
Finnigan MAT 8200 spectrometer at an ionizing voltage of 70 eV. Melting points were 
obtained in an Electrothermal Mel-Temp instrument and are uncorrected. 
 
General Reductive Cyclization Procedure for the Preparation of Dihydrosiloles 
To a mixture of Rieke magnesium (1.5 equiv), prepared according to literature 
procedures,44 in THF was added the diene (1.0 equiv). After 30 min freshly distilled 
diphenyldichlorosilane (1.2 equiv) was added dropwise and the reaction mixture was 
stirred for an additional 16 h. The reaction mixture was diluted slowly with ½ saturated 
NH4Cl and the mixture was extracted with hexanes (3 x). The combined organic layers 
were washed with water, brine, and dried (MgSO4). After filtration through a pad of 
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celite the solvent was removed under reduced pressure. The resulting oil was then 
purified by flash chromatography (100% hexanes). 
 
General Epoxidation Procedure 
To a solution of dihydrosilole (1.0 equiv) in CH2Cl2 at 0 °C was added mCPBA 
(1.2 equiv) portion wise. The reaction was warmed to room temperature and stirred for 1 
h.  A half saturated solution of potassium carbonate was added and the reaction mixture 
was stirred for 15 min. The layers were separated and the aqueous layer was extracted 
with CH2Cl2 (2 x). The combined organic layers were washed with half saturated 
NaHCO3, water, brine, and dried (MgSO4). After filtration through a pad of celite the 
solvent was removed under reduced pressure. The residue was subsequently purified by 
flash chromatography (10:1 hexanes/EtOAc).  
 
General Epoxide Rearrangement Procedure 
To a solution of lithium diisopropylamide (2.0 equiv) in THF at 0 °C was added a 
solution of epoxide (1.0 equiv) in THF.  After the reaction was complete by TLC a half 
saturated NH4Cl solution was added and the aqueous layer was extracted with EtOAc (3 
x). The combined organic layers were washed with water, brine, and dried (MgSO4). 
After filtration through a pad of celite the solvent was removed under reduced pressure. 
The residue was purified by flash chromatography (5:1 hexanes/EtOAc). 
 
General Carbamate Formation Procedure 
A solution of allylic alcohol (1.0 equiv), phenyl isocyanate (1.5 equiv), and 
tin(ethylhexanoate)2 (2 mol %) in Et2O was heated to reflux. After 4 h the solution was 
allowed to cool to room temperature and the solvent was removed under reduced 
pressure. The resulting oil was purified by flash chromatography (10:1 hexanes/ EtOAc). 
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General Thermal Diels–Alder Procedure 
A solution of silole (1.0 equiv) and dienophile (1.0 equiv) in toluene or xylene 
(mixture of o,m,p isomers) was heated to reflux. After 16 h the solution was allowed to 
cool to room temperature, the solvent was removed under reduced pressure, and the 
residue was purified by column chromatography (hexanes/EtOAc). 
  
General Lewis Acid Catalyzed Diels–Alder Procedure 
To a solution of silole (1.0 equiv) and dienophile (1.0 equiv) in toluene was added 
a solution of Et2AlCl (1.8 M in toluene, 1.0 equiv) and stirred for 2 h. Water was added, 
followed by 1 M HCl to dissolve the aluminum salts, and the aqueous layer was extracted 
with EtOAc (3 x).  The combined organic layers were washed with half saturated 
NaHCO3, brine, and dried (MgSO4). After filtration through a pad of celite the solvent 
was removed under reduced pressure. The resulting residue was then purified by flash 
chromatography (hexanes/EtOAc). 
 
General High Pressure Diels–Alder Procedure 
A solution of silole (1.0 equiv) and dienophile (1.0 equiv) in CH2Cl2 was placed 
in a ~ 5 cm segment of heat shrinkable Teflon tubing which was pinched and sealed at 
one end with a brass screw clamp. Excess air was squeezed from the tube and the open 
end was sealed with a brass screw clamp. The vessel was then pressurized in a LECO 
Tempres HPC 200 system at 13 kbar for 16 h, after which time the solvent was removed 
under reduced pressure and the residue was purified by flash chromatography 
(hexanes/EtOAc).  
1.4.2 Experimental Details 
1,1-Diphenylsilacyclopent-3-ene (1-19) 
The title compound was prepared according to the general reductive cyclization 
procedure to afford a colorless oil (1.66 g, 58%).  Rf 0.66 (10:1 
hexanes/EtOAc); 1H NMR (400 MHz, CDCl3) δ 7.62-7.60 (m, 4 H), 7.44-7.38 (m, 6 H), 
6.07 (t, J = 1.1 Hz, 2 H), 1.89 (d, J = 1.0 Hz, 4 H); 13C NMR (100 MHz, CDCl3) δ 136.1, 
Ph2Si
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135.0, 129.8, 128.2, 17.1. 1H and 13C NMR spectra were in agreement with previously 
reported data.45 
 
1,1-Diphenylsilacyclopentane-3,4-diol (1-70) 
 To a mixture of alkene 1-19 (1.41g, 5.96 mmol, 1.0 equiv), 
methanesulfonamide (0.57 g, 5.96 mmol, 1.0 equiv), K3Fe(CN)6 (5.89 g, 
17.66 mmol, 3.0 equiv), and K2CO3 (2.47 g, 17.88 mmol, 3.1 equiv) in H2O (4 mL) and 
CH2Cl2 (10 mL) was added OsO4 (30 mg, 0.118 mmol) and stirred until reaction 
completion by TLC. The reaction mixture was diluted with H2O and extracted with 
CH2Cl2 (3 x 40 mL). The combined organic layers were washed with brine, dried 
(MgSO4) and filtered through a pad of celite. The solvent was removed under reduced 
pressure and the residue was purified by column chromatography (1:2 hexanes/EtOAc) to 
afford the title compound as a white foam (1.54 g, 80%).  Rf 0.20 (1:1 hexanes/EtOAc); 
1H NMR (400 MHz, CDCl3) δ 7.56-7.38 (m, 10 H), 4.04-3.97 (m, 2 H), 2.65 (s, 2 H), 
1.77 (dd, J = 14.8, 5.7 Hz, 2 H), 1.21 (dd, J = 14.4, 10.5 Hz, 2 H); 13C NMR (100 MHz, 
CDCl3) δ 134.9, 134.6, 129.7, 128.1, 78.1, 18.8. 1H and 13C NMR spectra were in 
agreement with previously reported data.46 
 
1,1-diphenylsilacylopentane-3,4-diyl dimethanesulfonate (1-34) 
To a solution of diol 1-70 (232 mg, 0.86 mmol, 1.0 equiv) and 
triethylamine (0.74 mL, 5.4 mmol, 6.3 equiv) in THF (5 mL) at 0 °C was 
added methanesulfonyl chloride (0.17 mL, 2.1 mmol, 2.5 equiv). After 20 min the 
reaction mixture was diluted with a half saturated solution of NaHCO3 and CH2Cl2, the 
layers were separated, and the aqueous layer was extracted with CH2Cl2 (3 x 10 mL). The 
combined organic layers were washed with brine and dried (MgSO4). After filtration 
through a pad of celite the solvent was removed under reduced pressure and the residue 
was purified by flash chromatography (5:1 hexanes/EtOAc) to afford the title compound 
as a white solid (290 mg, 79%).  Rf 0.36 (5:1 hexanes/EtOAc); mp 100 °C, 
decomposition; 1H NMR (400 MHz, CDCl3) δ 7.53-7.41 (m, 10 H), 5.14-5.06 (m, 2 H), 
3.09 (s, 6 H), 2.10-2.05 (m, 2 H), 1.57-1.51 (m, 2 H); 13C NMR (100 MHz, CDCl3) δ 
134.5, 132.3, 130.7, 128.5, 83.8, 39.0, 17.0. 
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3,3-Diphenyl-6-oxa-3-silabicyclo[3.1.0]hexane (1-20) 
The title compound was prepared according to the general epoxidation 
procedure to afford a white solid (1.71 g, 85%). Rf 0.44 (5:1 
hexanes/EtOAc); mp 75-76°C; 1H NMR (400 MHz, CDCl3) δ 7.57-7.53 (m, 4 H), 7.44-
7.35 (m, 6 H), 3.64 (t, J = 1.0 Hz, 2 H), 1.78 (dt, J = 16.2, 1.1 Hz, 2 H), 1.49 (ddd, J = 
16.2, 1.8, 0.6 Hz, 2 H); 13C NMR (100 MHz, CDCl3) δ 135.3, 134.8, 129.6, 129.4, 128.0, 
127.8, 58.0, 15.2. 1H and 13C NMR spectra were in agreement with previously reported 
data.47 
 
1,1-Diphenylsilacyclopent-2-en-4-ol (1-21) 
The title compound was prepared according to the general epoxide 
rearrangement procedure to afford an orange oil (0.83 g, 91%). Rf 0.56 (1:1 
hexanes/EtOAc); 1H NMR (400 MHz, CDCl3) δ 7.59-7.45 (m, 4 H), 7.45-7.36 (m, 6 H), 
7.07 (dd, J = 10.0, 2.1 Hz, 1 ), 6.41 (dd, J = 10.1, 1.8 Hz, 1 H), 5.01 (t,  J = 5.9, 1 H), 
1.94 (dd, J = 14.9, 7.5 Hz, 1 H), 1.80 (s, 1 H), 1.15 (dd, J = 14.9, 5.5 Hz, 1 H); 13C NMR 
(100 MHz, CDCl3) δ 157.6, 134.9, 134.8, 130.0, 129.8, 129.7, 128.0, 76.0, 21.6. 1H and 
13C NMR spectra were in agreement with previously reported data.47 
 
(Z)-buta-1,3-dienyldiphenylsilanol (1-35) 
To a solution of 1-21 (60 mg, 0.24 mmol, 1.0 equiv) in pyridine (2.0 mL) at 0 
°C was added p-toluenesulfonyl chloride (73 mg, 0.38 mmol, 1.6 equiv).  After 
the reaction was complete by TLC, ½ NaHCO3 and CH2Cl2 were added and the layers 
were separated. The aqueous layer was extracted with CH2Cl2 (2 x) and the combined 
organic layers were washed with 1M HCl, water, brine and dried (MgSO4). After 
filtration through a pad of celite the solvent was removed under reduced pressure and the 
residue was purified by flash chromatography (10:1 hexanes/EtOAc) to afford the 
product as a colorless oil (42 mg, 70%). Rf 0.35 (5:1 hexanes/EtOAc); 1H NMR (400 
MHz, CDCl3) δ 7.66 (d, J =7.2 Hz, 4 H), 7.46-7.38 (m, 6 H), 7.11 (t, J = 11.9 Hz, 1 H), 
6.71 (dt, J = 16.8, 10.6 Hz, 1 H), 6.00 (d, J = 14.3 Hz, 1 H), 5.34 (d, J = 16.6 Hz, 1 H), 
5.23 (d, J = 10.0 Hz, 1 H), 2.39 (s, 1 H); 13C NMR (100 MHz, CDCl3) δ 150.1, 137.0, 
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136.2, 134.4, 130.0, 128.0, 127.1, 121.5; HRMS m/z 252.0964 (calcd for C16H16OSi, 
252.0970). 
 
1,1-diphenyl-3-methyl-silacyclopent-3-ene (1-36) 
The title compound was prepared according to the general reductive 
cyclization procedure to afford a colorless oil (3.42 g, 81%). Rf 0.52 (5:1 
Hex/EtOAc); 1H NMR (400 MHz, CDCl3) δ 7.57-7.55 (m, 4 H), 7.42-7.34 (m, 6 H), 5.64 
(s, 1 H), 1.84 (s, 5 H), 1.77 (s, 1 H); 13C NMR (100 MHz, CDCl3) δ 140.3, 136.4, 129.7, 
128.1, 124.9, 22.8, 22.0, 17.8. 1H and 13C NMR spectra were in agreement with 
previously reported data.44 
 
1-methyl-3,3-diphenyl-6-oxa-3-silabicyclo[3.1.0]hexane (1-37) 
The title compound was prepared according to the general epoxidation 
procedure to afford a white solid (2.95 g, 85%). Rf 0.40 (5:1 Hex: EtOAc); 
mp 75-76°C; 1H NMR (400 MHz, CDCl3) δ 7.55-7.32 (m, 10 H), 3.42 (s, 1 H), 1.74 (t, J 
= 17.4 Hz, 1 H), 1.53 (d, J = 15.8 Hz, 1 H) 1.51 (s, 3 H), 1.44 (d, J = 15.8 Hz, 1 H); 13C 
NMR (100 MHz, CDCl3) δ 135.7, 135.4, 135.3, 134.8, 129.5, 129.4, 128.0, 127.7, 65.3, 
64.9, 22.6, 20.2, 16.5; HRMS m/z 266.1135 (calcd for C17H18OSi, 266.1127). 
 
1,1-diphenyl-4-methylsilacyclopent-2-en-4-ol (1-38) 
The title compound was prepared according to the general epoxide 
rearrangement procedure to afford an orange oil (2.34 g, 90%).  Rf 0.20 (5:1 
hexanes/EtOAc); 1H NMR (400 MHz, CDCl3) δ 7.64-7.60 (m, 4 H), 7.48-7.40 (m, 6 H), 
6.97 (d, J = 9.9 Hz, 1 H), 6.31 (d, J = 9.9 Hz, 1 H), 2.19 (s, 1 H), 1.71 (d, J = 15.2 Hz, 1 
H), 1.53 (d, J = 15.4 Hz, 1 H), 1.48 (s, 3 H); 13C NMR (100 MHz, CDCl3) δ 161.5, 134.9, 
129.7, 129.6, 128.0, 127.1, 81.4, 30.8, 27.4; HRMS m/z 266.1119 (calcd for C17H18OSi, 
266.1127). 
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1,1-diphenyl-3-methylsilacyclopent-2-en-4-yl phenylcarbamate (1-39) 
The title compound was prepared according to the general carbamate 
formation procedure to afford the title compound as a white foam (0.41 
g, 95%). Rf 0.38 (5:1 hexanes/EtOAc); mp 106-108 °C; 1H NMR (400 
MHz, CDCl3) δ 7.52-7.44 (m, 4 H), 7.36-7.26 (m, 8 H), 7.23-7.18 (m, 2 H), 7.09 (d, J = 
10.2 Hz, 1 H), 6.98-6.95 (m, 1 H), 6.41 (s, 1 H), 6.27 (d, J = 10.2 Hz, 1 H), 1.97 (s, 1 H), 
1.96 (d, J = 9.4 Hz, 1 H), 1.96 (s, 1 H), 1.66 (d, J = 14.8 Hz, 1 H), 1.50 (s, 3 H); 13C 
NMR (100 MHz, CDCl3) δ 159.0, 138.1, 135.1, 134.94, 134,87, 134.3, 129.8, 129.7, 
128.9, 128.0, 127.9, 127.7, 123.1, 90.5, 28.6, 25.0; HRMS m/z 385.1489 (calcd for 
C24H23NO2Si, 385.1498). 
 
1,1-diphenyl-3-methylsilole dimer (1-41) 
A solution of carbamate 1-39 (120 mg, 0.31 mmol) in toluene (2.0 mL) 
was heated to reflux. After 16 h, the reaction mixture was allowed to cool 
to room temperature and the solvent was removed under reduced pressure. 
Purification of the residue by flash chromatography afforded the silole dimer as a white 
solid (63 mg, 82%). Rf 0.61 (5:1 hexanes/EtOAC); 1H NMR (400 MHz, CDCl3) δ 7.53-
7.06 (m, 20 H), 5.77 (t, J = 1.3 Hz, 1 H), 4.91 (dt, J = 5.7, 1.7 Hz, 1 H), 3.58 (d, J =8.8 
Hz, 1 H), 2.54 (s, 1 H), 2.35 (ddd, J = 5.7, 2.0, 0.9 Hz, 1 H), 2.20 (dd, J = 8.8, 2.2 Hz, 1 
H), 1.96 (s, 3 H), 1.58 (d, J = 1.6 Hz, 3 H); 13C NMR (100 MHz, CDCl3) δ 166.0, 138.7, 
138.5, 137.1, 137.0, 135.8, 135.6, 134.9, 134.0, 133.7, 129.4, 129.3, 128.9, 128.8, 128.2, 
127.6, 127.4, 127.3, 123.9, 56.5, 38.6, 30.9, 29.5, 22.2, 20.9; HRMS m/z 347.1110 (calcd 
for C21H18O3Si + H+, 347.1103). 
 
(±)-endo-2,3-maleicanhydro-5-methyl-7,7-diphenyl-7-silabicyclo[2.2.1]hept-5-ene  
(1-42) 
A solution of carbamate 1-39 (80 mg, 0.21 mmol, 1.0 equiv) and maleic 
anhydride (23 mg, 0.23 mmol, 1.0 equiv) in toluene (2.0 mL) was heated to 
reflux and stirred for 16 h after which time the reaction mixture was 
allowed to cool to room temperature, filtered, and the solvent was removed under 
reduced pressure to afford the product as a orange solid (60 mg, 83%). Rf decomposition 
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(SiO2); 1H NMR (400 MHz, CDCl3) δ 7.49-7.19 (m, 10 H), 6.03-6.01 (m, 1 H), 3.56 (dd, 
J = 5.1, 2.7 Hz, 1 H), 2.98 (ddd, J = 5.5, 2.8, 1.3 Hz, 1 H), 2.87-2.86 (m, 1 H), 1.83 (d, J 
= 1.6 Hz, 3 H); 13C NMR (100 MHz, CDCl3) δ 173.5, 173.2, 156.1, 150.6, 135.8, 134.9, 
133.5, 130.8, 130.7, 128.8, 128.0, 127.1, 47.5, 46.8, 37.7, 33.2, 20.39.; HRMS m/z 
347.1110 (calcd for C21H18O3Si + H+, 347.1103). 
 
3,4-dimethyl-1,1-diphenyl-silacyclopent-3-ene (1-43) 
The title compound was prepared according to the general reductive 
cyclization procedure to afford a colorless oil (6.15 g, 66%). Rf 0.63 (5:1 
hexanes/EtOAc); 1H NMR (400 MHz, CDCl3) δ 7.59-7.56 (m, 4 H), 7.43-7.35 (m, 6 H), 
1.89 (d, J = 1.1 Hz, 4 H), 1.80 (s, 6 H); 13C NMR (100 MHz, CDCl3) δ 136.4, 134.7, 
130.7, 129.3, 127.9, 24.2, 19.3.  1H and 13C NMR spectra were in agreement with 
previously reported data.44 
 
1,5-dimethyl-3,3-diphenyl-6-oxa-3-silabicyclo[3.1.0]hexane (1-44) 
The title compound was prepared according to the general epoxidation 
procedure to afford a white solid (5.98 g, 96%). Rf 0.44 (5:1 
hexanes/EtOAc); mp 77-78; 1H NMR (400 MHz, CDCl3) δ 7.60-7.56 (m, 4 H), 7.46-7.35 
(m, 6 H), 1.84 (d, J = 15.8 Hz, 2 H), 1.56 (d, J = 15.8 Hz, 2 H), 1.52 (s, 6 H); 13C NMR 
(100 MHz, CDCl3) δ135.8, 135.5, 135.4, 134.8, 129.4, 129.3, 128.0, 127.7, 68.9, 22.4, 
20.3; HRMS m/z 280.1281 (calcd for C18H20OSi, 280.1283). 
 
3,4-dimethyl-1,1-diphenylsilacyclopent-2-en-4-ol (1-45) 
The title compound was prepared according to the general epoxide 
rearrangement procedure to afford an orange oil (5.69 g, 90%).  Rf 0.25 (5:1 
hexanes/EtOAc); 1H NMR (400 MHz, CDCl3) δ 7.59-7.56 (m, 4 H), 7.43-7.38 (m, 6 H), 
5.92 (q, J = 1.2 Hz, 1 H), 2.08 (d, J = 1.2 Hz, 3 H), 1.78 (d, J = 15.2 Hz, 1 H), 1.74 (s, 1 
H), 1.56 (d, J = 15.2 Hz, 1 H), 1.42 (s, 3 H); 13C NMR (100 MHz, CDCl3) δ 169.8, 135.8, 
135.1, 135.0, 134.9, 129.5, 129.5, 127.8, 122.8, 122.8, 82.3, 29.7, 29.7, 18.2; HRMS m/z 
280.1275 (calcd for C18H20OSi, 280.1283). 
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3,4-dimethyl-1,1-diphenylsilacyclopent-2-en-4-yl phenylcarbamate (1-46) 
The title compound was prepared according to the general carbamate 
formation procedure to afford the title compound as a white foam (4.17 
g, 95%). Rf 0.34 (5:1 hexanes/EtOAc); mp 108-111°C; 1H NMR (400 
MHz, CDCl3) δ 7.60-7.57 (m, 4 H), 7.41-7.21 (m, 10 H), 7.03 (t, J = 7.2, 1 H), 6.56 (s, 1 
H), 5.94 (d, J = 1.6, 1 H), 2.28 (d, J = 14.4 Hz, 1 H), 2.00 (d, J = 1.2 Hz, 1 H), 1.76 (d, J 
= 14.4 Hz, 1 H), 1.42 (s, 3 H); 13C NMR (100 MHz, CDCl3) δ 167.7, 152.4, 138.1, 135.3, 
135.1, 129.8, 129.6, 129.5, 129.0, 128.9, 127.8, 123.2, 122.6, 118.6, 91.3, 28.3, 25.6, 
18.3; HRMS m/z 399.1655 (calcd for C25H25NO2Si, 399.1655). 
 
3,4-dimethyl-1,1-diphenylsilole (1-47) 
A solution of carbamate 1-46 (3.78 g, 9.46 mmol, 1.0 equiv) in toluene (20 
mL) was heated to reflux. After 16 h the solution was allowed to cool to room 
temperature and the solvent removed under reduced pressure. The residue was purified 
by flash chromatography (10:1 hexanes/EtOAc) to afford the title compound as an 
opaque solid (2.26 g, 91%). Rf 0.64 (5:1 hexanes/EtOAc); mp 37-38 °C; 1H NMR (400 
MHz, CDCl3) δ 7.60-7.58 (m, 4 H), 7.40-7.34 (m, 6 H), 6.00 (d, J = 1.2 Hz, 2 H), 2.11 (d, 
J = 1.2 Hz, 6 H); 13C NMR (100 MHz, CDCl3) δ 159.9, 135.4, 133.2, 129.7, 127.9, 123.8, 
21.0; HRMS m/z 266.1189, (calcd for C18H18OSi, 262.1178). 
 
(±)-endo-2,3-maleicanhydro-5,6-dimethyl-7,7-diphenyl-7-silabicyclo[2.2.1]hept-5-ene 
(1-48a) 
To a solution of silole 1-46 (55 mg, 0.21 mmol, 1.0 equiv), in toluene was 
added maleic anhydride (21 mg, 0.21 mmol, 1.0 equiv). After 16 h the 
solvent was removed under reduced pressure and the residue was purified 
by flash chromatography to afford the title compound as a white solid (75 mg, 90%). Rf 
0.14 (5:1 hexanes/EtOAc); mp 165-168 °C; 1H NMR (400 MHz, CDCl3) δ 7.54-7.28 (m, 
10 H), 3.64 (dd, J = 1.8 Hz, 2 H), 2.88 (dd, J = 1.8 Hz, 2 H), 1.84 (s, 6 H); 13C NMR (100 
MHz, CDCl3) δ 173.6, 135.5, 133.6, 133.5, 132.8, 130.8, 130.6, 129.4, 128.8, 128.1, 
47.5, 38.8, 16.7; HRMS m/z 360.1186 (calcd for C22H20O3Si, 360.1182). 
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(±)-endo-2,3-maleimido-5,6-dimethyl-7,7-diphenyl-7-silabicyclo[2.2.1]hept-5-ene  
(1-48b) 
To a solution of silole 1-46 (55 mg, 0.21 mmol, 1.0 equiv) in toluene was 
added maleimide (21 mg, 0.21 mmol, 1.0 equiv). After 16 h the solvent was 
removed under reduced pressure and the residue was purified by flash 
chromatography to afford the title compound as a white solid a white solid (70 mg, 85%). 
Rf 0.10 (5:1 hexanes/EtOAc); mp 175-177 °C; 1H NMR (400 MHz, CDCl3) δ 7.86 (s, 1 
H), 7.46-7.19 (m, 10 H), 3.32 (dd, J = 1.6 Hz, 2 H), 2.71 (dd, J = 1.6 Hz, 2 H), 1.71 (s, 6 
H); 13C NMR (100 MHz, CDCl3) δ 179.1, 135.5, 133.7, 131.7, 130.4, 130.3, 128.6, 
128.0, 110.8, 47.9, 37.9, 16.7; HRMS m/z 359.1229 (calcd for C22H21NO2Si, 359.1342). 
 
(2R*,3S*)-5,6-dimethyl-7,7-diphenyl-7-silabicyclo[2.2.1]hept-5-ene-2,3-
dicarbonitrile (1-48c) 
The title compound was prepared according to the general thermal Diels–
Alder procedure to afford a colorless oil (67 mg, 85%). Rf 0.11 (5:1 
hexanes/EtOAc); 1H NMR (400 MHz, CDCl3) δ 7.61-7.31 (m, 10 H), 3.56 
(dd, J = 5.9, 2.3 Hz, 1 H), 2.83 (dd, J = 5.9, 1.8 Hz, 1 H), 2.72 (s, 1 H), 2.64 (s, 1 H), 1.94 
(s, 3 H), 1.90 (s, 3 H); 13C NMR (100 MHz, CDCl3) δ 135.7, 135.6, 134.2, 132.3, 131.1, 
130.8, 128.8, 128.7, 128.2, 120.9, 118.9, 39.8, 39.4, 35.3, 35.1, 16.8, 15.6; HRMS m/z 
340.1388 (calcd for C22H20N2Si, 340.1396). 
 
(2R*,3S*)-dimethyl 5,6-dimethyl-7,7-diphenyl-7-silabicyclo[2.2.1]hept-5-ene-2,3-
dicarboxylate (1-48d) 
The title compound was prepared according to the general thermal 
Diels–Alder procedure, the general Lewis acid Diels–Alder procedure or 
the general high pressure Diels–Alder procedure to afford a pale yellow 
oil.  Rf 0.30 (5:1 hexanes/EtOAc); 1H NMR (400 MHz, CDCl3) δ 7.51-7.50 (m, 2 H), 
7.40-7.33 (m, 6 H), 7.26-7.23 (m, 2 H), 3.78-3.76 (m, 1 H), 3.70 (s, 3 H), 3.26 (s, 3 H), 
3.24-3.23 (m, 1 H), 2.73 (m, 1 H), 2.69 (m, 1 H), 1.86 (s, 3 H), 1.9 (s, 3 H); 13C NMR 
(100 MHz, CDCl3) δ 175.3, 173.2, 135.5, 134.8, 134.4, 134.2, 131.9, 131.7, 129.8, 129.7, 
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128.0, 127.7, 51.9, 51.5, 48.3, 47.4, 39.2, 38.4, 16.4, 15.6; HRMS m/z 406.1590 (calcd 
for C24H26O4Si, 406.1600). 
 
(±)-endo-5,6-(5,6-dimethyl-7,7-diphenyl-7-silabicyclo[2.2.1]hept-5-en-2-
yl)dihydrobenzoquinone (1-48e) 
The title compound was prepared according to the general thermal Diels–
Alder procedure or the general high pressure Diels–Alder procedure to 
afford an orange oil.  Rf decomposition (SiO2); 1H NMR (400 MHz, CDCl3) 
δ 7.51-7.45 (m, 2 H), 7.34-7.29 (m, 8 H), 7.20-7.16 (m, 2 H), 6.62 (s, 2 H), 3.33 (s, 2 H), 
1.60 (s, 6 H); 13C NMR (100 MHz, CDCl3) δ 200.6, 142.9, 135.6, 134.9,134.3, 133.8, 
132.8, 130.2, 128.6, 127.9, 49.3, 43.3, 16.7;  HRMS m/z 370.1406 (calcd for C22H24O2Si, 
370.1389). 
 
(±)-endo-1-(5,6-dimethyl-7,7-diphenyl-7-silabicyclo[2.2.1]hept-5-en-2-yl)ethanone 
(1-48g) 
The title compound was prepared according to the general Lewis acid 
Diels–Alder procedure or the general high pressure Diels–Alder procedure 
to afford a pale yellow oil. Rf 0.38 (5:1 hexanes/EtOAc); 1H NMR (400 
MHz, CDCl3) δ 7.56-7.54 (m, 2 H), 7.43-7.33 (m, 6 H), 7.27-7.23 (m, 2 H), 3.19 (ddd, J 
= 9.6, 5.6, 2.0 Hz, 1 H), 2.56 (t, J = 1.8 Hz, 1 H), 2.16 (s, 3 H), 2.08-1.96 (m, 2 H), 1.77 
(d, J = 0.9 Hz, 3 H), 1.71 (d, J = 0.9 Hz, 3 H); 13C NMR (100 MHz, CDCl3) δ 209.6, 
136.2, 135.6, 134.9, 133.9, 132.5, 129.8, 129.7, 129.6, 128.3, 127.6, 52.4, 39.9, 35.2, 
28.7, 16.9, 15.7; HRMS m/z 332.1592 (calcd for C22H24OSi, 332.1596). 
 
(±)-endo-methyl 5,6-dimethyl-7,7-diphenyl-7-silabicyclo[2.2.1]hept-5-ene-2-
carboxylate (1-48h) 
The title compound was prepared according to the general Lewis acid 
Diels–Alder procedure or the general high pressure Diels–Alder procedure 
to afford a pale yellow oil.  Rf 0.44 (5:1 hexanes/EtOAc); 1H NMR (400 MHz, CDCl3) δ 
7.55-7.52 (m, 2 H), 7.45 (m, 6 H), 7.28 (m, 2 H), 3.64 (d, 3 H), 3.15 (ddd, J = 10.2, 5.2, 
2.4 Hz, 1 H), 2.21-2.15 (m, 2 H), 1.99 (ddd, J = 13.0, 5.7, 2.4 Hz, 1 H), 1.79 (d, J = 1.1 
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Hz, 3 H), 1.74 (d, J = 1.1 Hz, 3 H); 13C NMR (100 MHz, CDCl3) δ 176.5, 136.0, 135.6, 
134.9, 133.9, 132.4, 130.5, 129.7, 129.6, 128.2, 127.6, 51.5, 43.6, 39.6, 35.1, 29.7, 16.6, 
15.9; HRMS m/z 348.1531 (calcd for C22H24O2Si, 348.1546). 
 
(±)-endo-ethyl 5,6-dimethyl-7,7-diphenyl-7-silabicyclo[2.2.1]hept-5-ene-2-
carboxylate (1-48i) 
The title compound was prepared according to the general Lewis acid 
Diels–Alder procedure to afford a pale yellow oil (100 mg, 92%). Rf 0.45 
(5:1 Hexanes/EtOAc); 1H NMR (400 MHz, CDCl3) δ 7.55-7.24 (m, 10 H), 
4.12-4.04 (m, 2 H), 3.13 (ddd, J = 9.8, 4.7, 2.0 Hz, 1 H), 2.57 (dd, J = 2.3, 1.7 Hz, 1 H), 
2.20-2.14 ( m, 2 H), 1.99 (ddd, J = 12.9, 5.9, 2.3 Hz, 1 H), 1.78 (d, J = 1.7 Hz, 3 H), 1.74 
(d, J = 1.7 Hz, 3 H), 1.25 (t, J = 7.2 Hz, 3 H); 13C NMR (100 MHz, CDCl3) δ 176.0, 
136.1, 135.6, 134.8, 133.9, 132.5, 130.5, 129.61, 129.57, 128.2, 127.6, 60.2, 43.8, 39.6, 
35.1, 29.6, 16.7, 15.7, 14.3; HRMS m/z 362.1708 (calcd for C23H26O2Si, 362.1702). 
 
(±)-endo-p-bromophenyl 5,6-dimethyl-7,7-diphenyl-7-silabicyclo[2.2.1]hept-5-ene-2-
carboxylate (1-48j) 
The title compound was prepared according to the general Lewis 
acid Diels–Alder procedure to afford a pale yellow oil (100 mg, 
75%). Rf 0.50 (5:1 Hexanes/EtOAc); 1H NMR (400 MHz, CDCl3) δ 7.61-7.60 (m, 1 H), 
7.50-7.27 (m, 10 H), 6.98 (m, 2 H), 3.41 (ddd, J = 10.0, 5.3, 2.3 Hz, 1 H), 2.77 (t, J = 1.8 
Hz, 1 H), 2.33-2.29 (m, 2 H), 2.10 (ddd, J = 12.3, 4.1, 1.8 Hz, 1 H), 1.84 (s, 6 H); 13C 
NMR (100 MHz, CDCl3) δ 174.3, 150.1, 135.8, 135.6, 135.4, 133.9, 132.3, 132.0, 130.1, 
129.8, 129.7, 128.3,127.7, 123.3, 118.5, 44.0, 39.9,35.1, 29.7, 16.9, 15.7; HRMS m/z 
488.0799 (calcd for C27H25BrO2Si, 488.0807).  
 
(±)-endo-5,6-dimethyl-7,7-diphenyl-7-silabicyclo[2.2.1]hept-5-ene-2-carbaldehyde 
(1-48f) 
The title compound was prepared according to the general high pressure 
Diels–Alder procedure to afford a yellow oil (50 mg, 84%). Rf 0.42 (5:1 
hexanes/EtOAc); 1H NMR (400 MHz, CDCl3) δ 9.44 (d, J = 2.3 Hz, 1 H), 
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7.45 (m, 2 H), 7.36-7.26 (m, 6 H), 7.19-7.17 (m, 2 H), 3.02 (m, 1 H), 2.51 (t, J = 1.8 Hz, 
1 H), 2.19 (d, J = 1.8 Hz, 1 H), 2.02 (ddd, J = 12.3, 9.4, 2.3 Hz, 1 H), 1.90 (ddd, J = 12.7, 
5.1, 2.1 Hz, 1 H), 1.71 (s,3 H), 1.66 (s, 3 H); 13C NMR (100 MHz, CDCl3) δ 204.6, 
137.9, 135.8, 135.6, 133.9, 131.9, 130.0, 129.8, 129.8, 128.3, 127.7, 52.5, 37.7, 35.2, 
26.9, 17.2, 15.7; HRMS m/z 318.1441(calcd for C21H22OSi, 318,1440). 
 
2,2-diphenyl-1,3,4,5,6,7-hexahydrobenzo[c]silole (1-58) 
The title compound was prepared according to the general reductive 
cyclization procedure to afford a colorless oil (2.70 g, 93%).  Rf 0.29 (100% 
hexanes); 1H NMR (400 MHz, CDCl3) δ 7.65-7.63 (m, 4 H), 7.46-7.41 (m, 6 H), 2.13 (br 
s, 4 H), 1.88 (br s, 4 H), 1.70 (p, J = 3.3 Hz, 4 H); 13C NMR (100 MHz, CDCl3) δ 136.6, 
134.8, 133.2, 129.3, 127.8, 31.1, 23.5, 22.5; HRMS m/z 290.1505 (calcd for C20H22Si, 
290.1491). 
 
2,2-diphenyl-1,3,4,5,6,7-hexahydro-7a-oxo-benzo[c]silole (1-59) 
The title compound was prepared according to the general epoxidation 
procedure to afford a colorless oil (0.774 g, 92%). Rf 0.59 (5:1 hexanes/EA) 
1H NMR (400 MHz, CDCl3) δ 7.62-7.58 (m, 4 H), 7.47-7.36 (m, 6 H), 2.15 (dt, J = 14.9, 
7.0 Hz, 2 H), 1.91 (dt, J = 15.6, 6.3 Hz, 2 H), 1.88 (d, J = 15.6 Hz, 2 H), 1.56-1.49 (m, 2 
H), 1.50 (d, J = 15.6 Hz, 2 H), 1.37-1.32 (m, 2 H); 13C NMR (100 MHz, CDCl3) δ 136.0, 
135.7, 135.3, 134.9, 129.4, 129.2, 127.9, 127.7, 68.5, 30.9, 21.8, 20.6; HRMS m/z 
306.1441 (calcd for C20H22OSi, 306.1440).  
 
2,2-diphenyl-1,4,5,6,7,-hexahydro-benzo[c]silol-7a-ol (1-60) 
The title compound was prepared according to the general epoxide 
rearrangement procedure to afford an orange oil (1.52 g, 90%). Rf 0.36 (5:1 
hexanes/EA) 1H NMR (400 MHz, CDCl3) δ 7.60-7.54 (m, 4 H), 7.42-7.36 
(m, 6 H), 5.86 (d, J = 1.2 Hz, 1 H), 2.62-2.50 (m, 2 H), 2.17 (dq, J = 13.7, 2.6 Hz, 1 H), 
1.92-1.80 (m, 2 H), 1.64-1.62 (m, 1 H), 1.59 (br s, 1 H), 1.55 (s, 2 H), 1.51-1.48 (m, 1 H), 
1.41-1.28 (m, 1 H); 13C NMR (100 MHz, CDCl3) δ 171.2, 136.1, 135.7, 134.9, 139.5, 
Ph2Si O
Ph2Si
36 
 
 
 
137.93, 127.90, 120.7, 81.1, 43.3, 32.7, 28.0, 27.8, 22.3; HRMS m/z 306.1461 (calcd for 
C20H22OSi, 306.1440). 
 
2,2-diphenyl-1,4,5,6,7-hexahydro-benzo[c]silol-7a-yl phenylcarbamate (1-61) 
The title compound was prepared according to the general carbamate 
formation procedure to afford an orange oil (0.625 g, 93%). Rf 0.58 (5:1 
hexanes/EA) 1H NMR (400 MHz, CDCl3) δ 7.65-7.59 (m, 4 H), 7.43 (m, 
10 H), 7.07 (t, J = 7.2 Hz, 1 H), 6.62 (br s, 1 H), 6.01 (d, J = 0.8 Hz, 1 H), 2.73 (d, J = 
14.1 Hz, 1 H), 2.62 (d, J = 12.9 Hz, 1 H), 2.49 (td, J = 13.0, 4.1 Hz, 1 H), 2.12 (d, J = 
15.6 Hz, 1 H), 1.94-1.90 (m, 1 H), 1.80 (tt, J = 13.7, 3.9 Hz, 1 H), 1.72 (d, J = 16.0 Hz, 1 
H), 1.61 (d, J = 14.1 Hz, 1 H), 1.43-1.36 (m, 2 H); 13C NMR (100 MHz, CDCl3) δ 169.7, 
152.3, 138.2, 135.4, 135.2, 135.0, 129.52, 129.48, 129.0, 128.0, 127.9, 127.8, 123.1, 
121.3, 118.5, 90.9, 41.2, 33.0, 28.3, 24.0, 22.2; Low res. mass spec. m/z 425.1 (calcd for 
C27H27NO2Si, 425.1). 
 
2,2-diphenyl-4,5,6,7-tetrahydro-benzo[c]silole (1-62) 
A solution of carbamate 1-61 (327 mg, 0.77 mmol, 1 equiv) in toluene (7 
mL) was heated to reflux. After 16 h the solution was allowed to cool to 
room temperature and the solvent was removed under reduced pressure.  The residue was 
purified by flash chromatography (10:1 hexanes/EtOAc) to afford the title compound as a 
pale yellow oil (204 mg, 94%). Rf 0.58 (10:1 hexanes/EtOAc); 1H NMR (400 MHz, 
CDCl3) δ 7.62-7.60 (m, 4 H), 7.43-7.34 (m,  6H), 5.93 (t, J = 1.4 Hz, 2 H), 2.64 (br s, 4 
H), 1.67 (p, J = 3.3 Hz, 4 H); 13C NMR (100 MHz, CDCl3) δ 160.7, 135.4, 133.5, 129.6, 
127.9,121.5,32.1, 23.9; HRMS m/z 288.1326 (calcd for C20H20Si, 288.1334). 
 
(±)-endo-2,3-maleicanhydro-tetrahydrobenzo[c]-7,7-diphenyl-7-
silabicyclo[2.2.1]hept-5-ene (1-68a) 
The title compound was prepared according to the general thermal Diels–
Alder procedure to afford a colorless oil (65 mg, 75%). Rf 0.21 (5:1 
hexanes/EtOAc); 1H NMR (400 MHz, CDCl3) δ 7.54-7.26 (m, 10 H), 3.65 
(t, J = 1.6 Hz, 2 H), 2.85 (t, J = 1.6 Hz, 2 H), 2.12 (br s, 4 H), 1.57 (br s, 4 H); 13C NMR 
Ph2Si
Ph2Si
O
O NHPh
Ph2Si
O
O
O
37 
 
 
 
(100 MHz, CDCl3) δ 173.6, 135.8, 135.5, 133.7, 133.6, 130.7, 130.6, 129.5, 128.8,47.6, 
36.9, 27.7, 22.8; HRMS m/z 386.1344 (calcd for C24H22O3Si , 386.1338). 
 
(2R*,3S*)-dimethyl tetrahydrobenzo[c]-7,7-diphenyl-7-silabicyclo[2.2.1]hept-5-ene-
2,3-dicarboxylate (1-68b) 
The title compound was prepared according to the general Lewis acid 
Diels–Alder procedure to afford a pale yellow oil (49 mg, 72%). Rf 
0.21 (5:1 hexanes/EtOAc); 1H NMR (400 MHz, CDCl3) δ 7.52-7.24 
(m, 10 H), 3.79 (dd, J = 5.5, 2.3 Hz, 1 H), 3.70 (s, 3 H), 3.26 (s, 3 H), 3.24 (dd, J = 5.7, 
2.2 Hz, 1 H), 2.72 (t, J = 1.8, Hz, 1 H), 2.66 (t, J = 2.0 Hz, 1 H), 2.29-2.24 (m, 1 H), 2.15-
2.08 (m, 1 H), 1.95-1.94 (m, 2 H), 1.60-1.47 (m, 4 H); 13C NMR (100 MHz, CDCl3) δ 
175.3, `73.3, 137.4, 135.5, 135.1, 134.9, 134.2, 132.0, 129.8, 128.0,127.8, 127.6, 51.9, 
51.5, 48.4,47.6, 37.3, 36.4, 27.7, 26.7,23.1, 23.0; Low res. mass spec. m/z 432.1 (calcd 
for C26H28O4Si, 432.1). 
 
(±)-endo-methyl tetrahydrobenzo[c]-7,7-diphenyl-7-silabicyclo[2.2.1]hept-5-ene-2-
carboxylate (1-68c) 
The title compound was prepared according to the general Lewis acid 
Diels–Alder procedure to afford a yellow oil (78 mg, 82%). Rf 0.29 (5:1 
hexanes/EtOAc); 1H NMR (400 MHz, CDCl3) δ 7.47-7.16 (m, 10 H), 3.55 (s, 3 H), 3.09 
(ddd, J = 9.9, 5.2, 2.2 Hz, 1 H), 2.46 (dd, J = 2.0, 1.2 Hz, 1 H), 2.14-2.07 (m, 3 H), 1.94-
1.89 (m, 4 H), 1.50-1.40 (m, 4 H); 13C NMR (100 MHz, CDCl3) δ 176.4, 137.7, 136.2, 
135.6, 133.9, 133.5, 132.6, 129.60,129.56, 128.2, 127.5, 51.5, 43.7, 37.8, 33.0, 29.8, 27.9, 
26.8, 23.3; HRMS m/z 374.1699 (calcd for C24H26O2Si, 374.1702).  
 
(±)-endo-1-(tetrahydrobenzo[c]-7,7-diphenyl-7-silabicyclo[2.2.1]hept-5-en-2-
yl)ethanone (1-68d) 
The title compound was prepared according to the general Lewis acid 
Diels–Alder procedure to afford a yellow oil (90 mg, 79%). Rf 0.30 (5:1 
hexanes/EtOAc); 1H NMR (400 MHz, CDCl3) δ 7.58-7.24 (m, 10 H), 3.23 
(ddd, J = 9.4, 5.3, 2.2 Hz, 1 H), 2.54 (t, J = 1.2 Hz, 1 H), 2.24-2.18 (m, 2 H), 2.16 (s, 3 
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H), 2.08 (ddd, J = 12.5, 5.1, 2.0 Hz, 1 H), 2.03-1.97 (m, 3 H), 1.56-1.43 (m, 4 H); 13C 
NMR (100 MHz, CDCl3) δ 209.4, 137.8, 136.3, 135.5, 133.9, 132.7, 132.6, 129.6, 128.7, 
127.5, 52.3, 38.0, 33.2, 28.7, 28.2, 27.4, 26.8, 23.1; HRMS m/z 358.1759 (calcd for 
C24H26OSi, 358.1753). 
 
(±)-endo-methyl 7,7-dimesityl-7-silabicyclo[2.2.1]hept-5-ene-2-carboxylate (1-69a) 
The title compound was prepared according to the general Lewis acid 
Diels–Alder procedure to afford a yellow oil (18 mg, 73%). Rf 0.26 (5:1 
hexanes/EtOAc); 1H NMR (400 MHz, CDCl3) δ 6.82 (s, 1 H), 6.78 (s, 
3H), 6.45 (t, J = 5.9 Hz, 1 H), 6.24 (t, J = 5.7 Hz, 1 H), 3.63 (s, 3 H), 3.14 (ddd, J = 10.0, 
5.4, 2.0 Hz, 1 H), 2.88 (d, J = 4.3 Hz, 1 H), 2.52(s, 3 H), 2.49 (s, 12 H), 2.29 (ddd, J = 
12.5, 10.2, 2.3 Hz, 1  H), 2.23 (s, 3 H), 2.22 (s, 3 H), 1.82 (ddd, J = 12.5, 5.5, 2.0 Hz, 1 
H); 13C NMR (100 MHz, CDCl3) δ 176.5, 144.8, 143.8, 143.7, 139.1, 139.0, 135.5, 
131.4, 130.2, 129.1, 121.0, 128.9, 128.4, 51.6, 42.4, 38.0, 37.9, 34.2, 29.4, 24.1, 22.9, 
22.8, 20.9; HRMS m/z 404.2161 (calcd for C26H32O2Si, 404.2172). 
 
(±)-endo-1-(7,7-dimesityl-7-silabicyclo[2.2.1]hept-5-en-2-yl)ethanone (1-69b) 
The title compound was prepared according to the general Lewis acid 
Diels–Alder procedure to afford a yellow oil (26 mg, 84%). Rf 0.25 (5:1 
hexanes/EtOAc); 1H NMR (400 MHz, CDCl3) δ 6.82 (d, J = 11.7 Hz, 2 H), 
6.78 (s, 2 H), 6.41 (t, J = 5.9 Hz, 1 H), 6.17 (t, J = 5.7 Hz, 1 H), 3.18 (ddd, J = 9.8, 5.5, 
2.0 Hz, 1 H), 2.86 (d, J = 3.5 Hz, 1 H), 2.54 (s, 3 H), 2.52 (s, 3 H), 2.49 (s, 6 H), 2.25 (s, 
3 H), 2.22 (s, 3 H), 2.14 (ddd, J = 12.5, 9.8, 2.3Hz, 1 H), 2.13 (s, 3 H), 1.89 (ddd, J = 
12.4, 5.6, 2.0 Hz, 1 H); 13C NMR (100 MHz, CDCl3) δ 209.9, 144.7, 143.9, 139.1, 139.0, 
135.6, 131.5, 129.5, 129.2, 129.0, 128.9, 128.4, 51.1, 37.9, 34.4, 28.8, 27.6, 24.1, 23.0, 
22.9, 22.8; HRMS m/z 388.2230 (calcd for C26H32OSi, 388.2222). 
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(±)-endo-5,6-(7,7-dimesityl-7-silabicyclo[2.2.1]hept-5-en-2-yl)dihydrobenzoquinone 
(1-69c) 
The title compound was prepared according to the general high pressure 
Diels–Alder procedure to afford an orange oil (20 mg, 86%). Rf 0.26 (5:1 
hexanes/EtOAc); 1H NMR (400 MHz, CDCl3) δ 6.83 (s, 2 H), 6.80 (s, 2 
H), 6.68 (s, 2 H), 6.31 (dd, J = 3.9, 3.1 Hz, 2 H), 3.43 (s, 2 H), 3.22 (s, 2 H), 2.56 (s, 6 H), 
2.48 (s, 6 H), 2.24 (s, 3 H), 2.23 (s, 3 H); 13C NMR (100 MHz, CDCl3) δ 200.5, 144.9, 
143.8, 143.1, 139.7, 139.6, 136.5,132.8, 130.0, 129.3, 129.1, 126.9, 126.6, 48.2, 41.5, 
29.7, 24.1, 23.0, 20.9; HRMS m/z 426.2016 (calcd for C28H30O2Si, 426.2015). 
 
1-((1R*,2S*,5R*)-2,5-dihydroxy-3,4-dimethylcyclohex-3-enyl)ethanone (1-70a) 
To a mixture of Diels–Alder adduct 1-48f (60 mg, 0.18 mmol, 1.0 equiv), 
KHCO3 (107 mg, 1.07 mmol, 6.0 equiv), KF (62 mg, 1.07 mmol, 6.0 equiv) 
in methanol (1.0 mL) and THF (1.0 mL) was added H2O2 (30% in H2O, 24 
μL, 0.21 mmol, 1.2 equiv). After 16 h a half saturated solution of Na2S2O3 (2 mL) was 
added and, after 30 min, CH2Cl2 (5 mL) was added and the aqueous layer was extracted 
with CH2Cl2 (3 x 10 mL). The combined organic layers were washed with brine, dried 
(MgSO4) and filtered through a pad of celite. After the solvent was removed under 
reduced pressure the residue was purified by flash chromatography (1:1 hexanes/EtOAc) 
to afford the title compound as a white solid (16 mg, 50%). Rf 0.22 (1:1 hexanes/EtOAc); 
mp 115-119 °C; 1H NMR (400 MHz, CDCl3) δ 4.05 (s, 3 H), 2.91-2.83 (m, 1 H), 2.20 (s, 
3 H), 2.11 (d, J = 8.8 Hz, 2 H), 2.07 (dt, J = 13.8, 3.1 Hz, 1 H), 1.77 (s, 3 H), 1.72 (s, 1 
H), 1.67 (s, 3 H), 1.58 (td, J = 13.3, 3.8 Hz, 1 H); 13C NMR (100 MHz, CDCl3) δ 211.4, 
129.8, 126.8, 69.1, 42.8, 33.8, 33.3, 28.2, 19.2, 16.7; HRMS m/z 185.1179 (calcd for 
C10H16O3 + H+, 185.1178). 
 
(1R*,2S*,5R*)-methyl 2,5-dihydroxy-3,4-dimethylcyclohex-3-enecarboxylate (1-70b) 
To a mixture of Diels–Alder adduct 1-48g (62 mg, 0.18 mmol, 1.0 equiv), 
KHCO3 (107 mg, 1.07 mmol, 6 equiv), KF (62 mg, 1.07 mmol, 6.0 equiv) 
in methanol (1 mL) and THF (1 mL) was added H2O2 (30% in H2O, 24 
μL, 0.21 mmol, 1.2 equiv). After 16 h a half saturated solution of Na2S2O3 
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(2 mL) was added and, after 30 min, CH2Cl2 (5 mL) was added and the aqueous layer 
was extracted with CH2Cl2 (3 x 10 mL). The combined organic layers were washed with 
brine, dried (MgSO4) and filtered through a pad of celite. After the solvent was removed 
under reduced pressure the residue was purified by flash chromatography (1:1 
hexanes/EtOAc) to afford the title compound as a white solid (17 mg, 50%). Rf 0.16 (1:1 
hexanes/EtOAc); mp 118-120 °C; 1H NMR (400 MHz, CDCl3) δ 4.27 (d, J = 8.2 Hz, 1 
H), 4.01(s, 1 H), 3.76 (s, 3 H), 2.84 (ddd, J = 12.9, 9.4, 2.9 Hz, 1 H), 2.71 (d, J = 4.7, 1 
H), 2.15 (dt, J = 13.5, 2.9 Hz, 1 H), 1.80 (dt, J = 12.5, 4.1 Hz, 1 H), 1.79 (s, 3 H), 1.77 (s, 
3 H), 1.55 (s, 2 H); 13C NMR (100 MHz, CDCl3) δ 175.7, 132.5,130.0, 71.3, 68.4, 52.0, 
43.5, 32.2, 17.1, 14.4; HRMS m/z 200.1056 (calcd for C10H16O4, 200.1049). 
 
(1S*,2R*,4R*)-methyl 1,4-dihydroxy-1,2,3,4,5,6,7,8-octahydronaphthalene-2-
carboxylate (1-71) 
To a mixture of Diels–Alder adduct 1-69c (150 mg, 0.40 mmol, 1.0 
equiv), KHCO3 (240 mg, 2.40 mmol, 6.0 equiv), KF (133 mg, 2.40 
mmol, 6.0 equiv) in methanol (2.0 mL) and THF (2.0 mL) was added 
H2O2 (30% in H2O, 54 μL, 0.48 mmol, 1.2 equiv). After 16 h a half saturated solution of 
Na2S2O3 (2 mL) was added and, after 30 min, CH2Cl2 (5 mL) was added and the aqueous 
layer was extracted with CH2Cl2 (3 x 10 mL). The combined organic layers were washed 
with brine, dried (MgSO4) and filtered through a pad of celite. After the solvent was 
removed under reduced pressure the residue was purified by flash chromatography (1:1 
hexanes/EtOAc) to yield the title compound as a white solid (16 mg, 50%). Rf 0.25 (1:1 
hexanes/EtOAc); 1H NMR (400 MHz, CDCl3) δ 4.25 (d, J = 9.4 Hz, 1 H), 3.92 (s, 1 H), 
3.75 (s, 3 H), 2.90 (br s, 1 H), 2.85 (ddd, J = 12.8, 9.5, 3.1 Hz, 1 H), 2.33 (br d, J = 15.2 
Hz, 2 H), 2.13 (dt, J = 13.8, 2.9 Hz, 1 H), 1.94 (br s, 2 H), 1.90 (br s, 1 H), 1.82 (dd, J = 
13.5, 3.7 Hz, 1 H), 1.77-1.71 (m, 2 H), 1.56-1.46 (m, 2 H); 13C NMR (100 MHz, CDCl3) 
δ 175.6, 134.2, 131.9, 71.0, 67.4, 52.0,43.5, 32.4, 27.6, 25.3, 22.42, 22.38; HRMS m/z 
226.1203 (calcd for C10H16O3, 226.1205). 
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Chapter 2.  Alkoxy-Activated Cyclobutane Dicarboxylates and their Application 
in Cycloaddition Chemistry 
This chapter describes the recently discovered annulation chemistry of alkoxy-
activated cyclobutane dicarboxylates with aldehydes, nitrones and nitrosoarenes. 
Relevant background information regarding the reactivity of donor-accepter cyclobutanes 
and the currently reported annulations of donor acceptor cyclobutanes with dipolar 
reagents will be presented. The research in this chapter was carried out in collaboration 
with colleagues Mahmoud Abd Rabo Moustafa (Ph.D.), Mr. Ben P. Machin, Mr. Cory 
Palmer, Mr. Naresh Vemula, and Mr. Tyler Schon. Results are those generated by the 
author unless otherwise attributed, which can be found below the presented examples. 
Portions of this work has been published in peer reviewed journals.1,2 Portions of text and 
schemes have been reprinted in part with permission from Moustafa, M. M. A. R.; 
Stevens, A. C.; Machin, B. P.; Pagenkopf, B. L. Org. Lett. 2010, 12, 4736–4738 and 
Stevens, A. C.; Palmer, C.; Pagenkopf, B. L. Org. Lett. 2011, 13, 1528–1531. Copyright 
© 2010-2011 American Chemical Society. 
 
2.1 Introduction 
2.1.1 Structure and Reactivity of Donor Acceptor Cyclobutanes 
The prevalence of polycyclic frameworks containing heteroatoms in biological, 
pharmaceutical, and other industrially relevant molecules (i.e., pesticides, herbicides, 
etc.) necessitates efficient routes for their formation. Ideally, this should be accomplished 
through a minimum number of steps and occur in high yield with control over 
diastereoselectivity and regioselectivity. In this regard, dipolar annulations of donor 
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acceptor (DA) cyclopropanes have been extensively developed as effective partners for 
the rapid assembly of highly functionalized molecules,3 including precursors in natural 
product total syntheses.4 In contrast, DA cyclobutanes have only recently been explored 
for application in dipolar annulations despite their preparation being known for a number 
of years5 and the similar magnitude of ring strain when compared to cyclopropanes (110 
kJ/mol for cyclobutanes vs 115 kJ/mol for cyclopropanes).6  
The strain present in the cyclobutane ring system originates from the constrained 
bond angles which, for a planar cyclobutane, are 90°. This is a significant deviation from 
the ideal 109.8° for a sp3 hybridized center, imparting a large degree of Baeyer strain. In 
a planar cyclobutane, the methylene groups would be in an eclipsed position, resulting in 
high levels of torsional strain. Puckering of the cyclobutane ring occurs to decrease the 
torsional strain, but this reduces the C-C-C bond angles leading to an increase in angle 
strain. Experimentally, cyclobutanes have been determined to deviate from planarity by 
approximately 35° resulting in C-C-C bond angles of 88° (Figure 2.1).7 
 
Figure 2.1. Geometry of the Cyclobutane Ring 
 
While the cyclobutane ring system has a high level of strain, forcing conditions 
are required to induce ring cleavage. Installation of vicinal electron-donating and 
electron-accepting functionalities allows for facile bond cleavage through maximizing 
bond polarization. A prominent example of successful application of this strategy can be 
seen in the de Mayo reaction where a transient cyclobutane is formed that rapidly 
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undergoes fragmentation to afford 1,5-dicarbonyl species (Scheme 2.1).8 This has been 
extensively applied for the formation of medium-sized rings, such as in the synthesis of 
taxol analogs.9 
Scheme 2.1. Reactivity of the Cyclobutane Ring System via the de Mayo Reaction 
 
 
If, however, the electron donating group is not capable of terminating the reaction 
sequence through formation of a neutral species, a stabilized zwitterionic intermediate 
can be formed. This intermediate can be considered a 1,4-dipole equivalent which can be 
quenched by nucleophilic or electrophilic sources to afford ring-opened products. The 
pinnacle of this principle can be seen when a nucleophilic and electrophilic component 
are tethered, such as in dipolar reagents, creating the opportunity for annulation events to 
occur and leading to the formation of a new ring system (Scheme 2.2). This mode of 
activation has been extensively developed for DA cyclopropanes;4 however, the 
analogous reactivity pattern in DA cyclobutanes has only recently been investigated.  
Scheme 2.2. Annulation of DA Cyclobutanes with Dipolar Reagents 
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2.1.2 Dipolar Cycloadditions of DA Cyclobutanes 
The first intermolecular cycloaddition of a DA cyclobutane was reported by Saigo 
in 1991.10 It was disclosed that an amino-activated cyclobutane underwent an annulation 
event with both aldehydes and ketones to generate tetrahydropyrans. This transformation 
required stoichiometric TiCl4 for the reaction to proceed in modest yield, affording a 
diastereomeric mixture of hemiketals after acidic hydrolysis of the intermediate aminal. 
Scheme 2.3. (4 + 2) Cycloaddition Between Amino-Activated Cyclobutanes and 
Aldehydes or Ketones 
 
 
Reactivity of this kind was seemingly abandoned until recently, with a number of 
contributions occurring in rapid succession. In 2009 near simultaneous reports by 
Johnson11 and Christie and Pritchard12 disclosed the reactivity of DA cyclobutanes with 
carbon-based activating groups undergoing annulation events with aldehydes (Scheme 
2.4). Both reports describe the process as being incredibly facile, requiring low catalytic 
loadings of Sc(OTf)3 and affording tetrahydropyran products in high yield with excellent 
diastereoselectivity. 
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Scheme 2.4. (4 + 2) Cycloaddition Between DA Cyclobutanes and Aldehydes 
 
 
While the report by Christie and Prichard demonstrated the feasibility of a highly 
diastereoselective (4 + 2) cycloaddition of DA cyclobutanes, the scope of the reaction 
was limited as only a single cyclobutane (2-10) was investigated and only electron-rich 
aldehydes underwent the reaction in good yield. Electron-poor aldehydes suffered from 
low yields and aliphatic aldehydes were found to not participate in the reaction. In 
contrast, the report by Johnson explored a number of carbon-based cyclobutane activating 
groups. They found that the annulation would occur between cyclobutanes and aromatic 
aldehydes with Sc(OTf)3 in good yield and high diastereoselectivity; however, a different 
catalyst (MADNTf2, 2-14) was required to facilitate the reaction between DA 
cyclobutanes and aliphatic aldehydes. Additionally, and more importantly, preliminary 
studies were undertaken to determine the mechanism of the reaction.  
In efforts to elucidate the mechanism of the cycloaddition, an enantiomerically 
enriched DA cyclobutane was prepared through a circuitous route (Scheme 2.5). The 
racemic DA cyclobutane 2-15 was monosaponified and esterified with (–)-menthol. The 
resulting diastereomers were separated and saponification of the pure (+)-diastereomer 
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provided diacid 2-18. Subsequent esterification with MeI afforded enantiomerically 
enriched DA cyclobutane (+)-2-15.  
Scheme 2.5. Synthesis of an Enantiomerically Enriched DA Cyclobutane 
 
 
Treatment of the enantiomerically enriched DA cyclobutane 2-15 to the 
cycloaddition conditions afforded surprising results (Scheme 2.6). Johnson found that at 
low reaction conversions, despite having enantiomerically enriched cyclobutane, the 
tetrahydropyran product was almost racemic. In addition, the enantiomeric purity of the 
DA cyclobutane slowly degraded throughout the reaction; at 45% conversion the 
enantiomeric excess of the DA cyclobutane was only 60%. This study demonstrated that, 
unlike the case of DA cyclopropanes,13 the analogous reaction with DA cyclobutanes 
may be mechanistically more complex. 
Scheme 2.6. (4 + 2) Cycloaddition Between Enantioenriched DA Cyclobutane 2-15 and 
Benzaldehyde 
51 
 
 
 
Other major reports in the field of DA cyclobutane annulation chemistry 
investigate the reactivity of cyclobutanones. The first example of an intermolecular 
annulation of cyclobutanones with a dipolar species was reported in 2008.14 While 
attempting to form ring-expansion products from cyclobutanone 2-20, a dimeric product 
(2-22) was isolated (Scheme 2.7). Realizing that the dimer had occurred through a (4 + 2) 
cycloaddition and cognizant of the potential of a (4 + 2) cycloaddition between 
cyclobutanones and carbonyl compounds, they quickly realigned their objectives and 
explored the annulation event.  
Scheme 2.7. (4 + 2) Cycloaddition of Cyclobutanones with Carbonyl Species 
 
 
The fused cyclobutane 2-23 underwent smooth cycloaddition with benzaldehyde, 
pivaldehyde, and acetophenone to afford the desired adducts in good yield and high 
diastereoselectivity (Scheme 2.7). However, when non-fused cyclobutanone 2-25 was 
subjected to the reaction conditions, the process was revealed to be stereorandom, and the 
regioselectivity was opposite to that of cyclobutanone 2-23. The poor diastereoselectivity 
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of the cycloaddition with ethoxy-substituted cyclobutanone 2-25 could be compensated 
for by allowing the reaction to warm to room temperature, facilitating elimination of 
ethanol and resulting in formation of dihydropyrone 2-27.  
With regards to the opposite regioselectivity observed between the two 
cyclobutanones, both steric and electronic factors were believed to be responsible. The 
regioselectivity of the reaction, in the case of the fused cyclobutanone (2-23), was due to 
high levels of ring strain that would be present if an eight-membered ring bearing two 
double bonds were formed (2-28), while the high diastereoselectivity was believed to be 
due to pseudo-equatorial approach of the carbonyl species (Scheme 2.8). In contrast, the 
ethoxy-substituted cyclobutanone 2-25 cleaved at the more substituted carbon. Matsuo 
attributed this reversal as cleaving at the bond more able to stabilize the developing 
positive charge (following Lewis acid coordination of the cyclobutanone). This rationale 
is likely incorrect, and cleavage at the more substituted carbon occured to form the more 
substituted (and thermodynamically favored) enolate. The low diastereoselectivity 
observed with cyclobutanone 2-25 was attributed to the reaction occurring through the 
open zwitterionic intermediate 2-31.  
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Scheme 2.8. Mechanistic Rationale for Observed Selectivity with Cyclobutanone 
Cycloadditions 
 
 
Following their initial disclosure, Matsuo explored the potential of the (4 + 2) 
cycloaddition to afford products in an enantioselective manner. This was realized through 
appendage of an inexpensive auxiliary via an ether linkage. In this case, the auxiliary 
would serve two purposes, to act as an activating group for the cyclobutanone and to 
facilitate chirality transfer (Scheme 2.9).15 After exploration of a number of candidates, it 
was shown that the L-ethyl lactate auxiliary (2-32) could afford dihydropyrone products 
with moderate to high levels of enantiopurity. Interestingly, the addition of a second 
metal chloride to the reaction mixture proved vital to achieving good levels of chirality 
transfer, the most successful combination being TiCl4 and SnCl2, both in super-
stoichiometric quantities. 
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Scheme 2.9. Asymmetric Annulation of Cyclobutanones and Aldehydes 
 
 
Matsuo has also demonstrated that the activating group required for 
cyclobutanone cleavage and subsequent annulation does not need to be an ether linkage, 
as cobalt-alkyne complexes could also facilitate the cycloaddition, though alkynes would 
not (Scheme 2.10).16 This is a similar finding to that of DA cyclopropanes where alkyne-
activated cyclopropanes dicarboxylates would react with nitrones to afford only trace 
quantities of products; however, upon cobalt-complexation of the alkyne, the yield 
dramatically increased to 90%.17 Surprisingly, the reaction between the cyclobutanone 
bearing the alkyne-cobalt complex (2-32) and aldehydes occurred in high 
diastereoselectivity, in sharp contrast to when an ether linkage was used where the 
diastereoselectivity was almost non-existent.  
Scheme 2.10. (4 + 2) Cycloaddition Between Cyclobutanones Bearing an Alkyne-Cobalt 
Complex and Aldehydes 
 
 
A number of alternative dipolarophile partners were also investigated by Matsuo 
with varying degrees of success. Electron-rich olefins were explored though the scope 
and selectivity of the processes were found to be somewhat limited.18 Electron-rich silyl 
enol ethers participated in (4 + 2) cycloadditions with cyclobutanone 2-25 to afford 
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cyclohexanone products (Scheme 2.11). A number of Lewis acids were explored and it 
was found that EtAlCl2 facilitated the reaction in the highest yield. The selectivity of the 
reaction with a number of acetophenone-derived silyl enol ethers was found to be high, 
however extension of the reaction to silyl enol ethers derived from propiophenone 
resulted in diastereomeric mixtures. Interesting the diastereomerically pure 
cyclobutanone 2-37 underwent the (4 + 2) cycloaddition with a silyl enol ether to afford a 
highly substituted cyclohexanone (2-38) with good control over the diastereoselectivity at 
all three stereocenters.  
Scheme 2.11. Cycloadditions Between Silyl Enol Ethers and Cyclobutanones 
 
 
The reactivity of allylsilanes with cyclobutanones was also investigated (Scheme 
2.12).19 In contrast to previously reported reactions with cyclobutanones, the reaction of 
allylsilanes was found to proceed with only catalytic amounts of Lewis acid. A number of 
Lewis acids were examined and SnCl4 was found to afford the products in the highest 
yield, though the diastereoselectivity was only 3:1. The diastereoselectivity issue could 
once again be solved though elimination of ethanol by treating the isolated product with 
TMSOTf. A number of symmetrically substituted cyclobutanones were examined, 
providing comparable yields and diastereoselectivities throughout. Substitution about the 
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silicon atom of the allyl silanes was also investigated and, upon examining allylsilane 2-
43, a peculiar rearrangement process occurred and a mixture of cyclohexanone 2-44 and 
tetrahydropyrone 2-45 was obtained. The rearrangement was believed to occur through a 
1,5-hydride shift followed by ring closure of the pendant enolate.  
Scheme 2.12. Cycloaddition Between Allylsilanes and Cyclobutanones 
 
 
Subsequently, the reactivity of DA cyclobutanones and N-sulfonyl imines was 
investigated and found to be a facile and useful process.20 As in previous cases, TiCl4 was 
found to be the Lewis acid of choice for the cycloaddition, mediating the reaction at –45 
°C within 1 h (Scheme 2.13). Fortuitously, the ethoxy-activating group was eliminated in 
situ to afford dihydropyridones directly. The reaction scope was quite broad, as 
substitution about the carbon portion of the imine was tolerant of electron-rich or poor 
aryl rings, as well as conjugated and aliphatic substituents. The effects of nitrogen 
substitution were not explored but N-tosyl groups can easily be cleaved, rendering 
alternative nitrogen substitution patterns a non-issue. Exploration of the stereochemical 
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outcome of the reaction with non-symmetrical cyclobutanones revealed that the process 
occurred with almost no stereoselectivity. However, they were able to demonstrate the 
applicability of this methodology by utilizing it in a rather rapid synthesis of the alkaloid 
(±)-bremazocine.  
Scheme 2.13. Cycloaddition Between N-Sulfonyl Imines and Cyclobutanones 
 
 
The most recent, and possibly most impressive, example to date of the utility of 
dipolar cycloaddition chemistry with cyclobutanones is the reactivity of cyclobutanones 
and indoles for the generation of hydrocarbazoles (Scheme 2.14).21 The reaction 
proceeded with high cis selectivity about the ring fusion; however, the relative 
stereochemistry between the ring fusion and the ethoxy substitutent was moderate to 
poor. The yield was moderate to excellent and once again they were able to remove the 
ethoxy activating group to install an α,β-unsaturated ketone, circumventing the poor 
diastereoselectivity of the reaction. Additionally, with proper substitution about the 
indole nucleus, the cycloaddition could be influenced to occur with opposite 
regioselectivity, revealing the strong influence that electronics play in the reaction.  
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Scheme 2.14. (4 + 2) Dipolar Cycloaddition Between Cyclobutanones and Indoles 
 
 
The utility of this process was demonstrated through the synthesis of (±)-
aspidospermidine (Scheme 2.15). An amino-activated cyclobutanone was synthesized 
over seven steps to afford 2-50. An extensive Lewis acid screen was required to identify 
that TMSOTf was capable of mediating the desired (4 + 2) intramolecular cycloaddition, 
though once again a mixture of two diastereomers was formed. Another three steps were 
required to complete the synthesis.  
Scheme 2.15. Synthesis of (±)-Aspidospermidine from the (4 + 2) Cycloaddition of 
Indoles and Cyclobutanones 
 
 
While a number of DA cyclobutanes have been employed in dipolar cycloaddition 
chemistry, the bulk of the examples explore chemistry of cyclobutanones. Additionally, 
the reactions typically lack control over the diastereoselectivity of the process and require 
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super-stoichiometric amounts of Lewis acid activators. It would therefore be useful to 
investigate DA cyclobutanes bearing alternative donating and accepting groups and 
explore their reactivity in cycloaddition chemistry. 
The Pagenkopf group has previously explored the dipolar cycloaddition chemistry 
of DA cyclopropanes activated by alkoxy donating groups and ester withdrawing 
groups.3c,4c,22 It was believed, based the precedent set by Saigo,10 Matsuo14 and 
Johnson,11 that alkoxy-activated cyclobutane dicarboxylates could undergo cycloaddition 
chemistry with a number of dipolarophiles to afford diverse and unique molecular 
scaffolds. 
2.2 Cycloadditions of Alkoxy-Activated Donor-Acceptor Cyclobutanes and 
Dipolar Reagents 
2.2.1 Synthesis of Alkoxy-Substituted Donor-Acceptor Cyclobutanes 
At the outset of this work, Mahmoud Moustafa (Ph.D.) had developed a modified 
procedure for the synthesis of alkoxy-activated DA cyclobutanes based upon the method 
of Roberts (Table 2.1).23 The original procedure required stoichiometric zinc bromide to 
form the cyclobutanes; however, this proved to be too aggressive of a Lewis acid, as only 
cyclobutanes bearing the bulky t-butyl esters were stable enough under the reaction 
conditions to be successfully isolated in appreciable quantities. Much weaker Lewis acids 
were necessary to produce cyclobutanes bearing the less protective and more reactive 
ethyl and methyl esters. This was readily accomplished using Yb(OTf)3, which was only 
required in catalytic amounts (10 mol %). It should be noted that prior to our report 
Johnson had also observed this phenomenon and utilized Sc(OTf)3 as a catalyst for the 
formation of a carbon-activated cyclobutane dicarboxylate through this method.11
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Table 2.1. Synthesis of Alkoxy-Activated Cyclobutane Dicarboxylates 
  
  
2-54; R = Et,   93%; 
2-55; R = iPr,  61%; 
2-56; R = tBu, 72%; 
2-57; R = Et, 84% 2-58; R = Me, 56% 
2-59; R = Et,   80% 
2-60; R = Et, 70% 
 
 
 
 
 2-61; R = Et, 81%  2-62; R = Me, 51% 
2-63; R = Et,   71% 
2-64; R = tBu, 59% 
 
2.3 Results and Discussion 
2.3.1 Annulation of Alkoxy-activated Cyclobutane Dicarboxylates and Aldehydes 
With access to DA cyclobutanes bearing a variety of alkoxy-activating groups and 
ester substitutions, we examined possible dipolar reagents for feasibility in cycloaddition 
chemistry. Aldehydes were selected among the first dipolarophiles to be evaluated as 
potential annulation partners with alkoxy-activated cyclobutane dicarboxylates.24  
Our studies in this area began by examining the cycloaddition between 
cyclobutane 2-54 and benzaldehyde (Table 2.2). After a brief Lewis acid screen, 
Yb(OTf)3 was found to be the optimal choice, affording fused acetal 2-65a as a single 
diastereomer in 70% yield.25 Screening of the reaction conditions revealed that 
temperature had little effect on the yield or diastereoselectivity (entries 1 – 3), and that 
catalyst loadings as low as 0.5 mol % (entry 7) could be used, though prolonged reaction 
times were necessary. At 2 mol % catalyst loadings, the reactions were complete in 2 min 
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when quickly heated in the microwave reactor and allowed to cool (entry 8). For 
convenience, however, 10 mol % of Yb(OTf)3 (entry 4) was used throughout this study as 
the reactions were complete in 15 min at 0 °C. It is important to note that only a single 
diastereomer was observed by NMR spectroscopy in this case, and in all subsequent 
examples. 
Table 2.2. Optimization of the (4 + 2) Cycloaddition Between DA Cyclobutane 2-54 and 
Benzaldehyde 
 
entry 
conditionsa
yieldb (%) 
Yb(OTf)3  
(mol %) 
PhCHO 
(equiv) 
temp 
(°C) 
time 
(min) 
1 10 3.0 -40 120 70 
2 10 3.0 0 15 84 
3 10 3.0 20 15 78 
4 10 1.1 0 15 78 
5 10 0.9 0 15 68 
6   2 1.1 0 45 74 
7a      0.5 1.1 25 18 h 79 
8b   2 1.1 60 2 76 
a No reaction was observed at 0 °C. b Reaction was conducted in a microwave reactor. 
Optimization studies were conducted in conjunction with Ben Machin. 
  
Having identified suitable reaction conditions, the scope of the transformation 
was explored (Figure 2.2). Aromatic aldehydes were found to be excellent reaction 
partners regardless of whether they were electron rich (2-65b), halogenated (2-65c), 
electron poor (2-65d, 2-65e), or conjugated (2-65g to 2-65i). Heteroaromatic aldehydes 
also underwent the cycloaddition (2-furfural, 2-thiofurfural, and indole-2-
carboxaldehyde, 2-65j to 2-65l).  
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2-65a, X = H, 78% 
2-65b, X = OMe, 80% 
2-65c, X = Cl, 89% 
2-65d, X = CN, 88% 
2-65e, X = NO2, 75% 
2-65f, 80% 2-65g, 62% 
  
 
2-65h, R = Ph, 87% 
2-65i, R = Me, 51% 
2-65j, X = O, 71% 
2-65k, X = S, 69% 
2-65l, 81% 
Compounds 2-65d, 2-65f, 2-65j and 2-65l were synthesized by Ben Machin. 
Figure 2.2. Scope of the (4 + 2) Cycloaddition of DA Cyclobutanes and Aromatic and 
Heteroaromatic Aldehydes 
 
Related studies indicated that aliphatic aldehydes may require stronger Lewis 
acids;11 however, in this study it was observed that the same Lewis acid, Yb(OTf)3, could 
effectively catalyze the (4 + 2) cycloaddition between the alkoxy-substituted cyclobutane 
dicarboxylates and aliphatic aldehydes (Figure 2.3). Examination of the reaction scope 
revealed that linear (2-65m, 2-65n), branched (2-65o), acetaldehyde (2-65p), and 
cyclopropyl aldehydes (2-65q) all underwent the cycloaddition to provide exclusively the 
cis bicyclic acetals.  
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2-65m, 68% 2-65n, 56% 2-65o, 58% 
 
 
2-65p, 51% 2-65q, 72% 
Figure 2.3. (4 + 2) Cycloaddition of DA Cyclobutanes and Aliphatic Aldehydes 
 
Lastly, several additional DA cyclobutanes were investigated (Table 2.3). Pyran-
fused cyclobutane 2-57 underwent successful cycloaddition with both aromatic and 
aliphatic aldehydes to afford the all cis-products (2-66a, 2-66b). The ethoxy-substituted 
cyclobutane 2-59 also participated in the cycloaddition with aromatic and aliphatic 
aldehydes (2-67a, 2-65b). Furthermore, the cyclohexyl-fused cyclobutane 2-60 
underwent cycloadditions with aromatic aldehydes to afford the fused ring systems 2-68a 
to 2-68e, each as a single diastereomer. 
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Table 2.3. Additional DA Cyclobutanes for the (4 + 2) Cycloaddition with Aldehydes 
 
cyclobutane tetrahydropyran 
2-57 2-66a, R = Ph, 60% 
2-66b, R = (CH2)2Ph, 62% 
 
O
CO2Et
CO2Et
R
H H
EtO
 
 
2-59  2-67a, R = Ph, 72% 
2-67b, R = (CH2)2Ph, 70% 
 
 
2-60  2-68a, R = p-C6H4OMe, 76% 
2-68b, R = p-C6H4Cl, 69% 
2-68c, R = m-C6H4NO2, 60% 
2-68d, R = trans-C2H2Ph, 71% 
2-68e, R = 2-thiophene, 56% 
Compounds 2-68a to 2-68e were synthesized by Mahmoud Moustafa. 
 
The assignment of stereochemistry of the cycloadducts was based on NMR 
analysis (Figure 2.4). Observed nOe interactions between protons HA and HB indicated a 
cis relationship in all adducts. Additionally, the small 3JH coupling constant between the 
ring fusion protons (HA and HC) of furan-fused (2-65) and pyran-fused (2-66) 
cycloadducts indicated cis-ring fusions in both cases. The cyclohexyl-fused adducts (2-
68) were believed to bear trans-ring fusions based upon the lack of observed nOe 
between the methoxy substituent and ring fusion proton, as well as other coupling 
experiments. 
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 Figure 2.4. Selected NMR Interactions 
 
The mechanism of (3 + 2) cycloadditions of carbon-activated cyclopropane 
dicarboxylates has been the subject of study.13 The reaction is believed to occur through 
an intimate ion-pair (2-69) as seen in Scheme 2.16. The aldehyde acts as a nucleophile 
and, following addition, a 120° rotation about the C-2/C-3 bond occurs to allow 
nucleophilic ring closure via envelope-shaped intermediate 2-71. Overall, a net inversion 
occurs at C-3 as if a SN2 reaction had taken place. Due to the formation of an ion-pair, 
and the potential for the cyclopropane starting material to undergo racemization, this 
mechanism has been exploited for use in dynamic kinetic asymmetric transformations.26  
Scheme 2.16. Mechanism of the (3 + 2) Cycloadiditon Between DA Cycloproanes and 
Aldehydes 
 
 
When the (4 + 2) cycloaddition between alkoxy-activated cyclobutane 
dicarboxylates and aldehydes is compared to the above (3 + 2) cycloaddition of 
cyclopropanes, it is immediately evident that a similar mechanism is not operating 
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(Scheme 2.17). Overall a net retention occurs at the carbon center bearing the activating 
group, ruling out a direct SN2 type reaction which would lead to a net inversion 
(mechanism A). Alkylation of the aldehyde by the cyclobutane ring (mechanism B) 
would lead to the observed stereochemistry; however, this mechanism is not believed to 
be operating due to preliminary competition experiments between electron-rich 
anisaldehyde and electron-deficient para-nitrobenzaldehyde (Scheme 2.18). The reaction 
showed complete preference for the electron-rich aldehyde, indicating that the most likely 
mechanism involves a nucleophilic, rather than electrophilic component. The remaining 
pathway is similar to that proposed by Matsuo,14 where cleavage of the cyclobutane 
occurs to form a zwitterionic intermediate (2-79), followed by annulation with an 
aldehyde to afford the tetrahydropyran (2-78, mechanism C). Currently, the favored 
pathway for the above reasons is that of mechanism C. 
Scheme 2.17. Plausible Mechanisms for the (4 + 2) Cycloaddition of DA Cyclobutanes 
and Aldehydes 
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Scheme 2.18. Competition Experiment Between Electron-Rich and Deficient Aldehydes 
 
 
In conclusion, we have developed an efficient Yb(OTf)3 catalyzed (4 + 2) dipolar 
cycloaddition between alkoxy-activated DA cyclobutanes and aldehydes. This process 
occurs in high diastereoselectivity and yield to afford fused acetals under mild conditions.  
2.3.2 Annulation of Alkoxy-Activated Cyclobutane Dicarboxylates and Nitrones 
Having successfully demonstrated that alkoxy-activated DA cyclobutanes can 
undergo annulations with aldehydes1 and imines,24 alternative dipolarophiles were 
investigated. The abundance of cycloaddition chemistry with nitrones,27 combined with 
the lack of exploration of 3-atom dipolarophiles in cyclobutane annulation chemistry, led 
us to investigate their feasibility as annulation partners. A successful (4 + 3) 
cycloaddition would result in a unique oxazepane structure. This intriguing structural 
motif, though not naturally occurring, has been shown to be relevant as oxazepane 
analogs of eudistomin natural products display antiviral28 and antiproliferative29 activity. 
Yb(OTf)3 has previously been shown to be an effective catalyst for the reaction 
between nitrones and DA cyclopropanes,30,31 as well as in the previous section where it 
catalyzed the cyclization of DA cyclobutanes with aldehydes, and thus was selected 
initially for optimization studies (Table 2.4). Much to our delight, upon addition of 
cyclobutane 2-54 to a solution of nitrone and 10 mol % Yb(OTf)3 in CH2Cl2 the 
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anticipated cycloadduct 2-81a was formed as a single diastereomer in 60% isolated yield 
(entry 1).32 Control tests demonstrated that a metal catalyst was not required for the 
reaction to occur; however, extended reaction times were necessary and a mixture of two 
apparently non-equilibrating diastereomers resulted (entry 2). A modest increase in yield 
was observed when the nitrone, rather than the cyclobutane, was used as the limiting 
reagent (compare entries 1 and 3). When the catalytic loading was decreased from 10 mol 
% to 5 mol %, a mixture of two diastereomers was found if the reaction was stopped after 
10 minutes (entry 4), and the diastereomeric ratio reversed when the reaction was 
conducted at 0 °C (entry 5). In all cases, increasing the reaction time or catalyst loading 
led ultimately to the single diastereomer 2-81a (entry 6) and, as expected, exposure of 2-
82a to Yb(OTf)3 resulted in isomerization to 2-81a. Further decreasing the reaction 
temperature resulted in a complex mixture of diastereomers, and thus was not explored as 
a viable option. Additionally, decreasing the catalytic loading of Yb(OTf)3 to 1 mol % 
resulted in the formation of three diastereomers.33 To date conditions have not been 
identified that allow for exclusive formation of the trans diastereomer (2-82a). 
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Table 2.4. Optimization of the (4 + 3) Cycloaddition of DA Cyclobutanes and Nitrones 
 
entry nitrone (equiv) 
2-54 
 (equiv) 
Yb(OTf)3 
(mol %) 
time 
(min) 
2-81a 
: 2-82a 
yield 
(%) 
1 1.5 1.0 10  10 1.0:0.0 60 
2 1.5 1.0 0 60 1.3:1.0 87a 
3 1.0 1.2 10 10 1.0:0.0 81 
4 1.0 1.2 5 10 1.7:1.0 78 
5 1.0 1.2 5 10 1.0:2.2 91b 
6 1.0 1.2 5 60 1.0:0.0 76 
aReaction conducted in the presence of 4 Å molecular sieves. In the absence of both 
molecular sieves and Lewis acids, no reaction occurs. bReaction conducted at 0 °C. 
 
The breadth of the cycloaddition reaction was then examined, and separate 
experiments were conducted to obtain both diastereomeric mixtures and a single 
diastereomer. The length of time required for single diastereomer formation was 
dependent upon the electronic nature of the nitrone (Table 2.5). While electron-rich 
nitrones required less than an hour to afford a single diastereomer (entries 1 – 3), 
electron-deficient nitrones required extended reaction times (up to 24 h) to allow for full 
conversion (entries 4 and 5). Additionally, when electron-deficient nitrones (entries 4 and 
5) were subjected to the reaction condititions a third inseparable diastereomer (not 
shown) was observed with short reaction times. The yields were found to be consistent 
regardless of the electronic nature of the nitrone, though the extended times required for 
equilibrating the diastereomeric mixtures resulted in lower yields due to competing 
background decomposition of the product. 
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Table 2.5. Effect of C-Substitution on the Cyclobutane/Nitrone Cycloaddition 
 
entry nitrone 
diastereomeric 
mixturea 
single cis 
diastereomerb 
yield 
(%) 
d.r. 
(trans:cis:3rd)
yield 
(%) 
1 Ar = C6H5 91 69:31 76c 
2 Ar = p-C6H4OCH3 88 63:37 74c 
3 Ar = p-C6H4Cl 82 71:29 73c 
4 Ar = p-C6H4CN 95 57:15:27 76d 
5 Ar = p-C6H4NO2 90 63:11:26 73d 
aConditions: 0 °C, 15 min. bConditions: 22 °C, reaction allowed to proceed 
until only a single product was observable by TLC. cReactions required less 
than 1 hour to form single diastereomers. dReactions required 24 h to form 
single diastereomers. 
 
The stereochemistry of the cis and trans diastereomers were assigned based on 
nOe interactions. In the case of entry 3, the stereochemistry of both diastereomers was 
unambiguously confirmed by single crystal X-ray analysis (Figure 2.5). 
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Figure 2.5. X-ray Structures of the cis and trans Diastereomers (2-81c and 2-82c) 
 
Next, the effect of N-substitution on the nitrone was examined (Table 2.6). 
Nitrones bearing an electron-deficient N-aryl group were found to be viable reaction 
partners (entries 2 and 3), as were electron-rich N-PMP (entries 4 - 6). An N-aliphatic 
nitrone (N-benzyl) was also found to undergo the reaction; however, only a single 
diastereomer was observed even under short reaction times (entry 7). 
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Table 2.6. Effect of N-substitution on the Cycloaddition of DA Cyclobutanes and 
Nitrones 
 
entry nitrone 
diastereomeric  
mixturea 
 single cis 
diastereomerb 
yield 
(%) 
dr 
(cis:trans:3rd) 
 yield  
(%) 
1 R = C6H5 
Ar = C6H5 
91 31:69  76 
2 R = p-C6H4CO2Me 
Ar = C6H5 
68 16:40:44  52c 
3 R = p-C6H4CO2Me 
Ar = p-C6H4NO2 
74 7:58:35  68 
4 R = p-C6H4OMe 
Ar = C6H5 
69 34:66  43 
5 R = p-C6H4OMe 
Ar = p-C6H4CN 
66 32:68  55 
6 R = p-C6H4OMe  
Ar = p-C6H4OMe 
70 56:44  54 
7 R = Bn 
Ar = C6H5 
- -  60 
aConditions: 0 °C, 15 min. bConditions: 22 °C, reaction allowed to proceed until only a 
single product was observable by TLC. cIncomplete conversion, 72:28 cis:trans after 24 
h and 10 mol % Yb(OTf)3. Entry 7 was conducted by Cory Palmer. 
 
Having found the reaction to be compatible with a variety of nitrones, additional 
functionalities of the C-substituents were explored (Table 2.7). It was discovered that 
heteroaromatic nitrone substituents worked well in the cycloaddition (entries 1 and 2). 
Surprisingly, when naphthyl- or cinnamyl-substituted nitrones were subjected to the 
reaction conditions, only single diastereomers were observed rather than diastereomeric 
mixtures, similar to the results obtained with N-alkyl substitution (Table 2.7, entries 3 and 
4 vs Table 2.6, entry 7). It was found that C-substitution was not necessary for the 
reaction as a C-unsubstituted benzyl nitrone underwent the reaction to form exclusively 
the cis adduct (entry 5).  
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Table 2.7. Exploration of Nitrone Functionality Tolerance in the Cycloaddition 
 
entry nitrone oxazepane 
diastereomeric 
mixturea 
 single cis 
diastereomerb 
yield (cis:trans)  yield 
1 
 
85% 
(55:45) 
 
75% 
2 
 
77% 
(55:45) 
 
 
67% 
3 
 
N/A 
 
70% 
4 
 
N/A 
 
74% 
5 
 
N/A 
 
78% 
aConditions: 0 °C, 15 min. bConditions: 22 °C, reaction allowed to proceed until only a 
single product was observable by TLC. Entries 1, 2 and 5 were conducted by Cory 
Palmer. 
 
Lastly, two additional cyclobutanes were subjected to the reaction conditions with 
several nitrones (Table 2.8). Pyran-fused cyclobutane 2-57 was found to react with 
nitrones to produce diastereomeric cycloadducts (Table 2.8, entries 1-3). Unlike the 
furan-fused examples, a mixture of three diastereomers was obtained that failed to 
coalesce to a single product. Ethoxy-substituted cyclobutane 2-59 also successfully 
formed the oxazepanes in good yield (entries 4 and 5), though a mixture of two 
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diastereomers was formed. The highly crystalline material of entry 5 allowed for the 
collection of single crystal X-ray data which permitted unambiguous assignment of the 
two diastereomers formed during the reaction. 
Table 2.8. Alternative Cyclobutane Substitution for the (4 + 3) Cycloaddition 
 
entry cyclobutane oxazepane (ratio) yield 
 
 
  
 
1 Ar = C6H5 76:21 3 65% 
2 Ar = p-C6H4OMe 56:21 23 51% 
3 Ar = p-C6H4Cl 46:46 8 60% 
 
 
 
4 Ar = C6H5 79 21 85% 
5 Ar = p-C6H4OMe 69 31 82% 
Entries 1-5 were conducted by Cory Palmer 
Unlike the case of the (4 + 2) cycloaddition between DA cyclobutane and 
aldehydes, the (4 + 3) cycloaddition between DA cyclobutanes and nitrones occurs 
initially with poor selectivity. This result may indicate that a different mechanism is in 
operation, or that interception of the zwitterionic intermediate proposed in Scheme 2.17, 
mechanism C occurs with poor selectivity. Currently, it is believed that the nitrone 
intercepts zwitterion 2-80 with poor selectivity. 
The mixture of diastereomers obtained during this study coalesced into a single 
cis diastereomer when fused with a tetrahydrofuran ring system. The mechanism for 
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epimerization at two of the chiral centers is presented in Scheme 2.19. The epimerization 
adjacent to the quaternary center occurs in a retro-Mannich fashion following 
coordination of the esters by the Yb catalyst. It can therefore easily be rationalized why 
electron-deficient substrates would require extended reaction times for complete 
conversion to a single diastereomer. Epimerization about the acetal position occurs 
through acetal cleavage facilitated by either of the two acetal oxygen atoms.  
Scheme 2.19. Equilibration of Diastereomers 
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In conclusion, we have developed a formal (4 + 3) cycloaddition between alkoxy-
activated cyclobutane dicarboxylates and nitrones to afford structurally unique 2,3,4,6,7-
substituted oxazepanes. The reaction, in most cases, initially affords a diastereomeric 
mixture which equilibrates to a single diastereomer. To date, all nitrones examined 
successfully participated in the cycloaddition reaction.  
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2.3.3 Annulation of Alkoxy-Activated Donor-Acceptor Cyclobutanes and 
Nitrosoarenes 
Having investigated nitrones, imines and aldehydes, further dipolarophiles 
candidates were sought after. Nitroso compounds have been utilized in a variety of 
transformations,34 such as dienes in hetero-Diels–Alder cycloadditions35 and enophiles in 
nitroso-ene chemistry.36 The most intriguing reports originate in their dichotomous 
capacity to act as either nitrogen or oxygen transfer reagents in nitroso-aldol chemistry, 
which can be controlled by judicious catalyst choice.37 Surprisingly, nitrosoarenens have 
yet to see application in dipolar cycloaddition chemistry with strained ring systems such 
as DA cyclopropanes or cyclobutanes. 
Investigations into the reactivity of nitrosoarenes and DA cyclobutanes began 
with examination of the reaction between cyclobutane 2-54 and nitrosobenzene (Table 
2.9). While a variety of Lewis acids were found to catalyze the reaction, maximal yields 
were obtained with Yb(OTf)3. Additionally, decreasing the catalytic loading from 10 to 2 
mol % dramatically increased product yield (compare entries 1 and 8). 
Table 2.9. Catalyst Screening for the Cycloaddition Between DA Cyclobutanes and 
Nitrosoarenes 
 
entry catalyst mol % yield (%) 
1 Yb(OTf)3 10 60 
2 Sc(OTf)3 10 55 
3 La(OTf)3 10 22 
4 Zn(OTf)2 10 61 
5 Pr(OTf)3 10 63 
6 Yb(OTf)3 5 72 
7 Sc(OTf)3 5 61 
8 Yb(OTf)3 2 92 
Optimization conducted in conjunction with Tyler Schon. 
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With optimal conditions at hand, the scope of the cycloaddition was examined 
(Table 2.10). It was discovered that aryl halogen,38 ester, or ketone substituents were 
tolerated (entries 2 – 5). Strong electron-withdrawing groups afforded moderate yields 
(entries 6 and 7); however, a second, inseparable compound was detected comprising up 
to 33% of the isolated mixture. Substrates with weakly electron-donating substituents 
resulted in a substantially decreased yield (entry 8) and upon addition of a strongly 
electron-donating group (entry 9), only trace quantities of product were detected. 
Substrates that could sequester the Lewis acid did not react (entry 12), and hydroxamic 
acid–derived nitroso compounds did not participate in the reaction, and only cyclobutane 
decomposition was observed (entry 13). 
Table 2.10. Examination of Nitrosoarene Compatibility in the (4 + 2) Cycloaddition 
 
entry nitrosoarene regioselectivity yield (%) 
1 Ar = C6H5 >20:1 92 
2 Ar = p-C6H4Br >20:1 89 
3 Ar = 2,4-C6H3Br2 >20:1 47 
4 Ar = p-C6H4C(O)Me >20:1 69 
5 Ar = p-C6H4CO2Et 13:1 82 
6 Ar = p-C6H4CN 3:1 61 
7 Ar = p-C6H4NO2 4:1 59 
8 Ar = p-C6H4CH3 >20:1 29 
9 Ar = p-C6H4OCH3 – trace 
10 Ar = p-C6H4N(CH3)2 – –a 
12 Ar = o-pyridine – –a 
13 Ar = C(O)C6H5 – –b 
aNo reaction. bCyclobutane decomposition observed. Entries 4,7,8,9 
were conducted by Tyler Schon. 
 
A second Lewis acid catalyst screen was undertaken to improve reactivity with 
electron-rich nitrosoarenes and MgI2 was found to facilitate the reaction of para-methoxy 
nitrosobenzene (Table 2.11, entry 1), though a complete reversal of regiochemistry 
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occurred (vide infra). Interestingly, when prolonged reaction times were used or when the 
isolated compound 2-90a was exposed to MgI2, deoxygenation occurred to afford 
pyrrolidine 2-91a. The more electron-rich para-dimethylaminonitroso benzene (entry 2) 
afforded the pyrrolidine 2-91b directly, and isolation of the tetrahydrooxazine was not 
possible. It was also found that MgI2 could catalyze the reaction with 2-nitrosopyridine 
(entry 3) or electron-deficient nitrosoarenes (compare Table 2.11, entry 4 and Table 2.10, 
entry 6); however, only the tetrahydrooxazines with electron donating groups (i.e., Table 
2.11, entry 1 and 2) could be converted to the corresponding pyrrolidines with MgI2. 
Table 2.11. MgI2 Catalyzed (4 + 2) Cycloadditon of DA Cyclobutanes and Nitrosoarenes 
 
entry nitrosoarene product yield  (%) 
1 Ar = C6H4OCH3 2-90a 26 
2 Ar = p-C6H4N(Me)2 2-91b 21 
3 Ar = o-pyridine 2-90b 28 
4 Ar = p-C6H4CN 2-90b, 2-89i 13, 22 
Entries 1-4 conducted by Naresh Vemula. 
 
Two additional alkoxy-activated cyclobutane dicarboxylates were investigated 
and found to display analogous reactivity with nitrosoarenes under Yb(OTf)3 or MgI2 
conditions, though the reaction yields were rather poor (Table 2.12). 
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Table 2.12. Alternative Cyclobutanes in the (4 + 2) Cycloaddition with Nitrosoarenes 
 
entry cyclobutane 
product yield 
Yb(OTf)3  MgI2 
 
  
 
 
1 Ar = C6H5 2-92, 45%  - 
2 Ar = p-C6H4OMe -  2-93, 35% 
3 Ar = p-C6H4NMe2 -  2-94, 15% 
 
  
 
 
4 Ar = C6H5 2-95, 21%  - 
5 Ar = p-C6H4OMe -  2-96, 38% 
Entries 1-5 conducted by Naresh Vemula. 
 
The stereo- and regiochemistry of the tetrahydrooxazines and pyrrolidines were 
established by a combination of single crystal X-ray and NMR analyses. X-ray quality 
crystals of compound 2-89b (Table 2.10, entry 2) and 2-93b (Table 2.12, entry 2) were 
obtained and the ORTEP structures are depicted in Figure 2.6. The structures 
unambiguously establish both the regiochemistry of the cyclization and the relative 
stereochemistry at the ring fusion. 
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Figure 2.6. X-ray Crystal Structures of 2-89b and 2-93 
 
While the structure of 2-89b was firmly established by single crystal X-ray 
diffraction, we set out to identify the structures of the product mixtures formed with 
electron-deficient nitrosoarenes (Table 2.10, entries 5–7). The major product in each of 
the cases was found to have nOe and 15N-1H HMBCAD interactions that were consistent 
with those observed for 2-89b (Figure 2.7). The minor component of the mixtures 
showed nOe interactions suggesting a cis ring fusion, and 15N-1H HMBCAD data 
indicated that a regioisomer, rather than a diastereomer, was formed. 
 
 
Figure 2.7. Key 1H-1H nOe and 15N-1H HMBCAD Correlations for Structural 
Determination of 2-89 
 
Once again, the mechanism of the transformation has not yet been intensively 
investigated, though it is currently believed to occur through a zwitterionic intermediate. 
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With regards to the formation of pyrrolidine products from the tetrahydrooxazines, a 
plausible mechanism is proposed in Scheme 2.20. A net reduction is occurring, and it is 
believed that MgI2 is acting as the reductant in this case, as 50 mol % was required to 
effect the transformation. Following formation of the tetrahydrooxazine, coordination of 
oxygen by MgI2 occurs (2-98). The acetal is cleaved and the resulting oxacarbenium ion 
is attacked by the pendant nitrogen atom (2-99). Finally, the initially displaced iodide 
reacts with the attached Lewis acid, causing the N-O bond reduction and producing I2, 
MgO, and the pyrrolidine (2-101). Theoretically, one full equivalent of MgI2 is required 
for the transformation; however, maximum yields were observed only for 50 mol % of 
MgI2. Additionally, the fate of the I2 in this reaction was not determined, as attempts to 
detect I2 were not successful. The low yield of the process also proved troublesome, as 
decomposition occurs which convolutes the process of determining the operational 
mechanism. 
Scheme 2.20. Mechanism of Pyrrolidine Formation 
 
 
In conclusion, we have developed the first example of a dipolar cycloaddition 
between DA cyclobutanes and nitrosoarenes. The regiochemistry and stereochemistry of 
the cycloadducts has been determined by a combination of NMR and X-ray diffraction 
analyses. The reaction proceeds well with electron-deficient or neutral nitrosoarenes to 
form tetrahydrooxazines; however, other nitroso reagents are currently outside the scope 
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of this reaction. Though the cycloaddition of DA cyclobutanes and nitrosoarenes is a 
fascinating process, the poor yields even after extensive optimization studies leave much 
to be desired.  
2.4 Conclusions 
In summary, cycloadditions of alkoxy-activated cyclobutane dicarboxylates with 
aldehydes, nitrones, and nitrosoarenes have been developed. These processes facilitate 
rapid access to structurally intriguing heterocyclic frameworks in moderate to excellent 
yield. While a range of dipolarophile partners for annulation events have been reported, 
this reactivity pattern with cyclobutanes is only in its infancy and further exploration will 
surely prove a rich source of study. The mechanism for the high diastereoselectivity of 
the cycloadditions with aldehydes and nitrosoarenes has not yet been extensively 
investigated. Revelation of the mechanism will surely bring about new and intriguing 
opportunities for this field of chemistry. In addition, elaboration of these cycloaddition 
adducts remains to be explored which could prove invaluable in the synthesis of complex 
natural products. 
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2.5 Experimental 
2.5.1 General Experimental Details 
All reactions were run under an argon atmosphere. Flasks were oven dried and 
cooled in a dessicator prior to use. Solvents and reagents were purified by standard 
methods.39 Dichloromethane and toluene were purified by passing the solvent through 
activated alumina columns. Aldehydes were distilled immediately prior to use. All other 
chemicals were of reagent quality and used as obtained from commercial sources unless 
otherwise noted. The progress of reactions was monitored by thin layer chromatography 
performed on F254 silica gel plates. The plates were visualized by UV light (254 nm) or 
by staining with ceric ammonium molybdate,40 or KMnO4. Column chromatography was 
performed with Silica Flash P60 60 Å silica gel from Silicycle according to the Still 
method.41 
The 1H and 13C NMR data were obtained on 400 or 600 MHz spectrometers. All 
spectra were obtained in deuterated chloroform and were referenced to the residual 
chloroform at δ 7.25 ppm for 1H spectra and the center peak of the triplet at δ 77.0 for 13C 
spectra. EI mass spectra were obtained on a Finnigan MAT 8200 spectrometer at an 
ionizing voltage of 70 eV. 
Compounds 2-65d, 2-65f, 2-65j, 2-65l and 2-68a to 2-68e were prepared by 
others and are not included below. 
2.5.2 Experimental Details 
2.5.2.1 Cycloadditions of Aldehydes and Cyclobutanes 
General Procedure for the Yb(OTf)3 Catalyzed Cycloaddition of Aldehydes and 
Cyclobutanes 
To a solution of Yb(OTf)3 (26 mg, 0.042 mmol, 10 mol %) in CH2Cl2 (2 mL) at 0 
°C was added aldehyde (0.45 mmol, 1.1 equiv) followed by cyclobutane (0.41 mmol, 1 
equiv). After 15 min the reaction was flushed through a plug of SiO2 and the solvent was 
removed under reduced pressure and the residue was purified by flash chromatography 
(hexanes/EtOAc).   
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(3aR*,6R*,7aR*)-diethyl 6-phenyltetrahydro-2H-furo[2,3-b]pyran-5,5(3H)-
dicarboxylate (2-65a) 
The title compound was prepared according to the general cycloaddition 
procedure to afford a pale yellow oil (111 mg, 78%). Rf 0.14 (5:1 
hexanes/EtOAc); 1H NMR (600 MHz, CDCl3)  7.32 (d, J = 7.0 Hz, 2 
H), 7.14 - 7.21 (m, 3 H), 5.41 (s, 1 H), 5.23 (d, J = 4.7 Hz, 1 H), 4.24 (dq, J = 7.1, 10.8 
Hz, 1 H), 4.17 (dq, J = 7.2, 10.6 Hz, 1 H), 4.09 (td, J = 6.4, 8.5 Hz, 1 H), 3.91 (td, J = 3.5, 
7.9 Hz, 1 H), 3.59 (dq, J = 7.2, 10.6 Hz, 1 H), 3.31 (dq, J = 7.1, 10.8 Hz, 1 H), 2.37 (dd, J 
= 11.7, 13.5 Hz, 1 H), 2.30 (dd, J = 5.9, 13.5 Hz, 1 H), 2.10 - 2.17 (m, 1 H), 2.03 - 2.10 
(m, 1 H), 1.70 - 1.75 (m, 1 H), 1.20 (t, J = 7.3 Hz, 3 H), 0.77 (t, J = 7.0 Hz, 3 H); 13C 
NMR (101 MHz, CDCl3) δ 171.3, 169.2, 138.2, 128.0, 127.6, 127.4, 102.3, 75.6, 67.5, 
61.9, 61.1, 59.3, 36.0, 31.4, 30.2, 14.0, 13.4; HRMS m/z 348.1583 (calcd for C19H24O6, 
348.1573). 
 
(3aR*,6R*,7aR*)-diethyl 6-(4-methoxyphenyl)tetrahydro-2H-furo[2,3-b]pyran-
5,5(3H)-dicarboxylate (2-65b) 
The title compound was prepared according to the general 
cycloaddition procedure to afford a viscous colorless oil (150 mg, 
80%). Rf 0.14 (5:1 hexanes/EtOAc); 1H NMR (400 MHz, CDCl3) δ 
7.31 (d, J = 9.0 Hz, 2 H), 6.79 (d, J = 9.0 Hz, 2 H), 5.44 (s, 1 H), 5.28 (d, J = 4.7 Hz, 1 
H), 4.19 - 4.36 (m, 2 H), 4.11 - 4.19 (m, 1 H), 3.96 (td, J = 3.9, 8.0 Hz, 1 H), 3.76 (s, 3 
H), 3.70 (dq, J = 7.1, 10.8 Hz, 1 H), 3.44 (dq, J = 7.3, 10.6 Hz, 1 H), 2.33 - 2.45 (m, 2 H), 
2.09 - 2.24 (m, 2 H), 1.74 - 1.84 (m, 1 H), 1.27 (t, J = 7.2 Hz, 3 H), 0.89 (t, J = 7.2 Hz, 3 
H); 13C NMR (101 MHz, CDCl3) δ 171.3, 169.2, 159.2, 130.4, 128.5, 112.9, 102.2, 75.2, 
67.4, 61.8, 61.1, 59.2, 55.2, 36.0, 31.3, 30.1, 14.0, 13.5; HRMS m/z 378.1689 (calcd for 
C20H26O7, 378.1679). 
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(3aR*,6R*,7aR*)-diethyl 6-(4-chlorophenyl)tetrahydro-2H-furo[2,3-b]pyran-
5,5(3H)-dicarboxylate (2-65c) 
The title compound was prepared according to the general 
cycloaddition procedure to afford a colorless oil (140 mg, 89%). Rf 
0.14 (5:1 hexanes/EtOAc); 1H NMR (600 MHz, CDCl3) δ 7.35 (d, J = 
8.8 Hz, 2 H), 7.25 (d, J = 8.8 Hz, 2 H), 5.42 (s, 1 H), 5.28 (d, J = 4.7 
Hz, 1 H), 4.31 (dq, J = 10.5, 7.6 Hz, 1 H), 4.224 (dq, J = 10.5, 7.3 Hz, 1 H), 4.15 (td, J = 
8.5, 6.4 Hz, 1 H), 3.98 (ddd, J = 7.6, 7.6, 3.8 Hz, 1 H), 3.73 (dq, J = 11.1, 7.6 Hz, 1 H), 
3.49 (dq, J = 10.5, 7.0 Hz, 1 H), 2.40 (dq, J = 11.1, 13.5 Hz, 2 H), 2.17 - 2.24 (m, 1 H), 
2.11 - 2.17 (m, 1 H), 1.78 - 1.83 (m, 1 H), 1.27 (t, J = 7.3 Hz, 3 H), 0.90 (t, J = 7.6 Hz, 3 
H); 13C NMR (101 MHz, CDCl3) δ 171.1, 169.0, 136.8, 133.7, 128.8, 127.7, 102.4, 75.0, 
67.5, 62.0, 61.3, 59.2, 36.0, 31.2, 30.2, 14.0, 13.5; HRMS m/z 382.1171 (calcd for 
C19H23ClO6, 382.1183). 
 
(3aR*,6R*,7aR*)-diethyl 6-(4-nitrophenyl)tetrahydro-2H-furo[2,3-b]pyran-5,5(3H)-
dicarboxylate (2-65e) 
The title compound was prepared according to the general 
cycloaddition procedure to afford a white solid (121 mg, 75%). Rf  
0.21 (5:1 hexanes/EtOAc); 1H NMR (400 MHz, CDCl3) δ 8.14 (d, J 
= 9.0 Hz, 2 H), 7.62 (d, J = 8.6 Hz, 2 H), 5.48 (s, 1 H), 5.30 (d, J = 5.1 Hz, 1 H), 4.23 - 
4.37 (m, 2 H), 4.14 - 4.23 (m, 1 H), 4.01 (ddd, J = 7.8, 7.8, 4.3 Hz, 1 H), 3.74 (dq, J = 
7.1, 10.8 Hz, 1 H), 3.51 (dq, J = 7.2, 10.8 Hz, 1 H), 2.39 - 2.54 (m, 2 H), 2.21 - 2.32 (m, 1 
H), 2.08 - 2.20 (m, 1 H), 1.79 - 1.89 (m, 1 H), 1.28 (t, J = 7.2 Hz, 3 H), 0.90 (t, J = 7.2 
Hz, 3 H); 13C NMR (101 MHz, CDCl3) δ 170.9, 168.7, 147.5, 145.6, 128.3, 122.7, 102.7, 
74.9, 67.7, 62.2, 61.4, 59.1, 35.9, 30.8, 30.4, 14.0, 13.5; HRMS m/z 393.1419 (calcd for 
C19H23NO8, 393.1424). 
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(3aR*,6R*,7aR*)-diethyl 6-(phenylethynyl)tetrahydro-2H-furo[2,3-b]pyran-5,5(3H)-
dicarboxylate (2-65g) 
The title compound was prepared according to the general 
cycloaddition procedure to afford a pale yellow oil (80 mg, 62%). Rf 
0.14 (5:1 hexanes/EtOAc); 1H NMR (600 MHz, CDCl3) δ 7.33 (dd, J = 
7.6, 1.8 Hz, 2 H), 7.22 - 7.24 (m, 2 H), 7.19 - 7.22 (m, 1 H), 5.31 (s, 1 H), 5.24 (d, J = 4.7 
Hz, 1 H), 4.20 (q, J = 7.0 Hz, 2 H), 4.16 (qd, J = 7.2, 1.8 Hz, 2 H), 4.07 (td, J = 8.6, 6.7 
Hz, 1 H), 3.83 (td, J = 8.2, 3.5 Hz, 1 H), 2.41 (dd, J = 14.1, 6.4 Hz, 1 H), 2.28 (dd, J = 
13.8, 10.2 Hz, 1 H), 2.15 - 2.22 (m, 1 H), 1.99 - 2.09 (m, 1 H), 1.71 - 1.76 (m, 1 H), 1.22 
(t, J = 7.3 Hz, 3 H), 1.18 (t, J = 7.0 Hz, 3 H); 13C NMR (101 MHz, CDCl3) δ 168.7, 
168.0, 131.7, 128.4, 128.2, 122.4, 101.2, 86.0, 85.0, 66.3, 64.4, 62.1, 61.9, 56.9, 33.6, 
30.6, 27.1, 14.0, 13.9; HRMS m/z 372.1570 (calcd for C21H24O6, 372.1573). 
 
(3aR*,6R*,7aR*)-diethyl 6-styryltetrahydro-2H-furo[2,3-b]pyran-5,5(3H)-
dicarboxylate (2-65h) 
The title compound was prepared according to the general 
cycloaddition procedure to afford a viscous colorless oil (133 mg, 
87%). Rf 0.20 (5:1 hexanes/EtOAc); 1H NMR (400 MHz, CDCl3) δ 
7.19 - 7.38 (m, 5 H), 6.60 (d, J = 16.0 Hz, 1 H), 6.47 (dd, J = 16.0, 7.4 Hz, 1 H), 5.25 (d, 
J = 4.3 Hz, 1 H), 4.71 (dd, J = 7.0, 0.8 Hz, 1 H), 4.09 - 4.26 (m, 5 H), 3.86 - 3.94 (m, 1 
H), 2.50 (dq, J = 7.0, 14.5 Hz, 2 H), 2.17 - 2.27 (m, 1 H), 1.96 - 2.06 (m, 1 H), 1.87 (dq, J 
=12.1, 7.8 Hz, 1 H), 1.19 (t, J = 7.2 Hz, 3 H), 1.21 (t, J = 7.0 Hz, 3 H); 13C NMR (101 
MHz, CDCl3) δ 170.4, 169.3, 136.6, 132.6, 128.4, 127.7, 126.6, 125.8, 102.0, 76.5, 67.7, 
61.8, 61.4, 57.1, 36.0, 29.8, 28.8, 14.0, 14.0; HRMS m/z 374.1727 (calcd for C21H26O6, 
374.1729). 
 
(3aR*,6R*,7aR*)-diethyl 6-((E)-prop-1-enyl)tetrahydro-2H-furo[2,3-b]pyran-
5,5(3H)-dicarboxylate (2-65i) 
The title compound was prepared according to the general cycloaddition 
procedure to afford a colorless oil (65 mg, 51%). Rf 0.14 (5:1 
hexanes/EtOAc); 1H NMR (400 MHz, CDCl3) δ 5.67 - 5.83 (m, 2 H), 
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5.18 (d, J = 4.3 Hz, 1 H), 4.51 (d, J = 7.4 Hz, 1 H), 4.12 - 4.28 (m, 4 H), 4.08 (td, J = 8.0, 
5.9 Hz, 1 H), 3.86 (td, J = 7.9, 6.4 Hz, 1 H), 2.40 (dd, J = 6.8, 4.1 Hz, 2 H), 2.09 - 2.19 
(m, 1 H), 1.93 - 2.05 (m, 1 H), 1.73 - 1.83 (m, 1 H), 1.67 (d, J = 5.5 Hz, 3 H), 1.25 (t, J = 
7.0 Hz, 3 H), 1.24 (t, J = 7.0 Hz, 3 H); 13C NMR (101 MHz, CDCl3) δ 170.5, 169.3, 
130.1, 127.3, 101.7, 76.5, 67.4, 61.7, 61.2, 56.8, 35.8, 29.5, 29.0, 17.7, 14.02, 13.99; 
LRMS 312.1 (calcd for C16H24O6, 312.1). 
 
(3aR*,6S*,7aR*)-diethyl 6-(thiophen-2-yl)tetrahydro-2H-furo[2,3-b]pyran-5,5(3H)-
dicarboxylate (2-65k) 
The title compound was prepared according to the general cycloaddition 
procedure to afford a yellow oil (100 mg, 69%). Rf 0.15 (4:1 
hexanes/EtOAc); 1H NMR (600 MHz, CDCl3) δ 7.22 (dd, J = 5.3, 1.2 
Hz, 1 H), 6.99 (d, J = 3.5 Hz, 1 H), 6.90 (dd, J = 5.3, 3.5 Hz, 1 H), 5.75 (s, 1 H), 5.30 (d, 
J = 5.3 Hz, 1 H), 4.31 (dq, J = 7.0, 10.5 Hz, 1 H), 4.24 (dd, J = 7.0, 10.5 Hz, 1 H), 4.12 - 
4.18 (m, 1 H), 3.95 (td, J = 4.7, 8.2 Hz, 1 H), 3.86 (dq, J = 7.1, 10.8 Hz, 1 H), 3.71 (dq, J 
= 7.2, 10.6 Hz, 1 H), 2.44 (d, J = 8.2 Hz, 2 H), 2.18 - 2.25 (m, 1 H), 2.08 - 2.16 (m, 1 H), 
1.84 (ddt J = 11.9, 7.0, 4.9 Hz, 1 H), 1.28 (t, J = 7.6 Hz, 4 H), 1.00 (t, J = 7.3 Hz, 3 H); 
13C NMR (101 MHz, CDCl3) δ 170.9, 168.7, 140.8, 125.8, 125.7, 125.0, 101.9, 72.8, 
67.6, 62.0, 61.4, 59.0, 36.3, 30.7, 29.7, 14.0, 13.6; HRMS m/z 354.1145 (calcd for 
C17H22O6S, 354.1137). 
 
(3aR*,6R*,7aR*)-diethyl 6-phenethyltetrahydro-2H-furo[2,3-b]pyran-5,5(3H)-
dicarboxylate (2-65m) 
The title compound was prepared according to the general 
cycloaddition procedure to afford a colorless oil (105 mg, 68%). Rf 
0.25 (5:1 hexanes/EtOAc); 1H NMR (400 MHz, CDCl3) δ 7.17 - 7.23 
(m, 2 H), 7.08 - 7.14 (m, 3 H), 5.02 (d, J = 4.3 Hz, 1 H), 4.00 - 4.16 (m, 5 H), 3.74 - 3.82 
(m, 2 H), 2.89 (ddd, J = 13.8, 9.5, 4.5 Hz, 1 H), 2.57 (ddd, J = 13.7, 9.0, 7.8 Hz, 1 H), 
2.42 (dd, J = 14.1, 6.6 Hz, 1 H), 2.13 - 2.27 (m, 2 H), 2.04 - 2.12 (m, 1 H), 1.77 - 1.93 
(m, 2 H), 1.67 - 1.77 (m, 1 H), 1.18 (t, J = 7.0 Hz, 3 H), 1.14 (t, J = 7.0 Hz, 3 H); 13C 
NMR (101 MHz, CDCl3) δ 170.6, 169.7, 141.7, 128.6, 128.2, 125.7, 102.6, 74.7, 67.6, 
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61.6, 61.3, 56.2, 35.9, 33.2, 32.7, 30.3, 28.8, 13.94, 13.93; HRMS m/z 376.1880 (calcd 
for C21H28O6, 376.1886). 
 
(3aR*,6R*,7aR*)-diethyl 6-pentyltetrahydro-2H-furo[2,3-b]pyran-5,5(3H)-
dicarboxylate (2-65n) 
The title compound was prepared according to the general 
cycloaddition procedure to afford a pale yellow oil (68 mg, 56%).  Rf 
0.28 (5:1 hexanes/EtOAc); 1H NMR (600 MHz, CDCl3) δ 5.11 (d, J 
= 4.1 Hz, 1 H), 4.17 - 4.26 (m, 4 H), 4.08 (td, J = 7.9, 5.9 Hz, 1 H), 3.82 - 3.89 (m, 2 H), 
2.49 (dd, J = 14.1, 7.0 Hz, 1 H), 2.32 (dd, J = 14.1, 5.9 Hz, 1 H), 2.12 - 2.18 (m, 1 H), 
1.91 - 1.98 (m, 1 H), 1.83 - 1.90 (m, 2 H), 1.58 - 1.66 (m, 1 H), 1.44 - 1.51 (m, 1 H), 1.23 
- 1.34 (m, 11 H), 0.88 (t, J = 7.0 Hz, 3 H); 13C NMR (101 MHz, CDCl3) δ 171.0, 169.9, 
102.6, 75.8, 67.6, 61.6, 61.3, 56.4, 36.0, 31.8, 31.6, 30.5, 28.9, 26.6, 22.6, 14.1, 13.99, 
13.98; HRMS m/z 342.2042 (calcd for C18H30O6, 342.2042). 
 
(3aR*,6R*,7aR*)-diethyl 6-isopropyltetrahydro-2H-furo[2,3-b]pyran-5,5(3H)-
dicarboxylate (2-65o) 
The title compound was prepared according to the general cycloaddition 
procedure to afford a yellow oil (85 mg, 58%). Rf  0.29 (5:1 
hexanes/EtOAc); 1H NMR (600 MHz, CDCl3) δ 5.10 (d, J = 4.7 Hz, 1 
H), 4.14 - 4.29 (m, 5 H), 4.07 (dd, J = 14.6, 7.6 Hz, 1 H), 3.83 - 3.88 (m, 2 H), 2.46 (dd, J 
= 13.5, 7.6 Hz, 1 H), 2.30 (dd, J = 13.8, 6.1 Hz, 1 H), 2.19 (sxt, J = 6.4 Hz, 1 H), 2.08 - 
2.14 (m, 1 H), 1.93 - 2.00 (m, 1 H), 1.78 - 1.85 (m, 1 H), 1.29 (t, J = 7.4 Hz, 3 H), 1.27 (t, 
J = 7.4 Hz, 3 H), 0.97 (d, J = 5.3 Hz, 3 H), 0.98 (d, J = 5.9 Hz, 3 H); 13C NMR (101 
MHz, CDCl3) δ 171.7, 170.1, 102.6, 79.8, 67.8, 61.7, 61.4, 56.3, 36.3, 31.9, 30.9, 29.5, 
20.6, 18.3, 13.92, 13.90; HRMS m/z 314.1730 (calcd for C15H24O6, 314.1729).  
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(3aR*,6R*,7aR*)-diethyl 6-methyltetrahydro-2H-furo[2,3-b]pyran-5,5(3H)-
dicarboxylate (2-65p) 
The title compound was prepared according to the general cycloaddition 
procedure to afford a yellow oil (61 mg, 51%). Rf 0.20 (5:1 
hexanes/EtOAc); 1H NMR (400 MHz, CDCl3) δ 5.12 (d, J = 4.3 Hz, 1 
H), 4.15 - 4.25 (m, 5 H), 4.05 (q, J = 7.8 Hz, 1 H), 3.84 (q, J = 7.4 Hz, 1 H), 2.38 (dd, J = 
14.1, 7.4 Hz, 1 H), 2.30 (dd, J = 14.1, 6.2 Hz, 1 H), 2.07 - 2.16 (m, 1 H), 1.91 - 2.00 (m, 1 
H), 1.78 - 1.86 (m, 1 H), 1.34 (d, J = 6.6, 3 H), 1.26 (t, J = 7.1 Hz, 3 H), 1.25 (t, J = 7.1 
Hz, 3 H); 13C NMR (101 MHz, CDCl3) δ 170.9, 169.7, 102.0, 71.0, 67.5, 61.7, 61.3, 56.3, 
35.9, 29.9, 29.7, 29.2, 17.8, 14.0; HRMS m/z 287.1503 (calcd for C14H22O6 + H+, 
287.1489). 
 
(3aR*,6R*,7aR*)-diethyl 6-cyclopropyltetrahydro-2H-furo[2,3-b]pyran-5,5(3H)-
dicarboxylate (2-65q) 
The title compound was prepared according to the general cycloaddition 
procedure to afford a yellow oil (107, 72%). Rf 0.21 (5:1 
hexanes/EtOAc); 1H NMR (400 MHz, CDCl3) δ 5.07 (d, J = 4.3 Hz, 1 
H), 4.14 - 4.28 (m, 4 H), 4.09 (td, J = 8.0, 6.6 Hz, 1 H), 3.86 (td, J = 8.0, 5.9 Hz, 1 H), 
3.29 (d, J = 9.8 Hz, 1 H), 2.40 (d, J = 7.0 Hz, 2 H), 2.05 - 2.14 (m, 1 H), 1.94 - 2.04 (m, 1 
H), 1.69 - 1.79 (m, 1 H), 1.35 - 1.45 (m, 1 H), 1.28 (t, J = 7.2 Hz, 6 H), 0.57 - 0.65 (m, 1 
H), 0.37 - 0.48 (m, 2 H), 0.21 - 0.28 (m, 1 H); 13C NMR (101 MHz, CDCl3) δ 170.8, 
169.7, 101.9, 79.5, 67.3, 61.7, 61.2, 56.7, 35.9, 30.0, 29.3, 14.0, 14.0, 12.7, 3.8, 3.7; 
HRMS m/z 312.1581 (calcd for C16H24O6, 312.1573). 
 
(2R*,4aS*,8aR*)-diethyl 2-phenylhexahydropyrano[2,3-b]pyran-3,3(2H)-
dicarboxylate (2-66a) 
The title compound was prepared according to the general cycloaddition 
procedure to afford a colorless oil (92 mg, 60%). Rf 0.33 (4:1 
hexanes/EtOAc); 1H NMR (400 MHz, CDCl3) δ 7.36 - 7.42 (m, 2 H), 
7.16 - 7.26 (m, 3 H), 5.00 (d, J = 2.3 Hz, 1 H), 5.00 (s, 1 H), 4.09 - 4.20 (m, 1 H), 4.01 - 
4.09 (m, 1 H), 3.88 - 4.01 (m, 3 H), 3.64 - 3.70 (m, 1 H), 2.57 (dd, J = 14.2, 3.7 Hz, 1 H), 
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2.47 (dd, J = 14.4, 5.1 Hz, 1 H), 1.90 - 1.98 (m, 1 H), 1.69 - 1.81 (m, 1 H), 1.50 - 1.63 
(m, 3 H), 1.10 (t, J = 7.0 Hz, 3 H), 1.02 (t, J = 7.0 Hz, 3 H); 13C NMR (101 MHz, CDCl3) 
δ 170.8, 169.4, 138.5, 127.5, 127.4, 127.1, 99.2, 80.8, 62.5, 61.8, 60.7, 56.9, 35.2, 33.0, 
24.9, 24.0, 13.8, 13.7; HRMS m/z 362.1729 (calcd for C20H26O6, 362.1729). 
 
(2R*,4aS*,8aR*)-diethyl 2-phenethylhexahydropyrano[2,3-b]pyran-3,3(2H)-
dicarboxylate (2-66b) 
The title compound was prepared according to the general 
cycloaddition procedure to afford a colorless oil (94 mg, 62%). Rf  
0.31 (4:1 hexanes/EtOAc); 1H NMR (600 MHz, CDCl3) δ 7.25 - 7.29 
(m, 2 H), 7.15 - 7.21 (m, 3 H), 4.83 (d, J = 2.9 Hz, 1 H), 4.13 - 4.21 (m, 5 H), 3.94 - 3.98 
(m, 1 H), 3.51 - 3.55 (m, 1 H), 3.05 (ddd, J = 13.6, 9.5, 4.4 Hz, 1 H), 2.63 (ddd, J = 13.6, 
9.5, 6.7 Hz, 1 H), 2.52 - 2.57 (m, 1 H), 2.50 (dd, J = 14.1, 8.8 Hz, 1 H), 2.11 (dd, J = 
13.8, 4.4 Hz, 1 H), 1.73 - 1.78 (m, 1 H), 1.62 - 1.70 (m, 3 H), 1.58 (br. s., 1 H), 1.45 - 
1.52 (m, 1 H), 1.40 - 1.45 (m, 1 H), 1.25 - 1.30 (m, 1 H), 1.22 (t, J = 7.3 Hz, 3 H), 1.23 (t, 
J = 7.3 Hz, 3 H); 13C NMR (101 MHz, CDCl3) δ 170.2, 169.4, 142.3, 128.6, 128.2, 125.6, 
98.4, 75.7, 64.9, 61.7, 61.2, 56.9, 33.8, 32.7, 32.3, 28.7, 26.0, 22.5, 14.0, 13.9; HRMS 
m/z 390.2037 (calcd for C22H30O6 390.2042). 
 
(2R*,6R*)-diethyl 6-ethoxy-2-phenyldihydro-2H-pyran-3,3(4H)-dicarboxylate  
(2-67a) 
The title compound was prepared according to the general 
cycloaddition procedure to afford a colorless oil (75 mg, 72%). Rf 
0.33 (4:1 hexanes/EtOAc); 1H NMR (400 MHz, CDCl3) δ 7.43 - 7.47 
(m, 2 H), 7.24 - 7.31 (m, 3 H), 5.10 (s, 1 H), 4.70 (dd, J = 9.4, 2.3 Hz, 1 H), 4.11 - 4.19 
(m, 2 H), 4.00 - 4.08 (m, 1 H), 3.87 - 3.98 (m, 2 H), 3.53 (dq, J = 9.7, 7.1 Hz, 1 H), 2.62 
(dt, J = 13.7, 4.3 Hz, 1 H), 2.15 (td, J = 13.4, 4.5 Hz, 1 H), 1.97 (tdd, J = 13.2, 9.2, 4.3 
Hz, 1 H), 1.82 - 1.89 (m, 1 H), 1.22 (t, J = 7.0 Hz, 3 H), 1.16 (t, J = 7.0 Hz, 3 H), 0.96 (t, 
J = 7.2 Hz, 3 H); 13C NMR (101 MHz, CDCl3) δ 171.0, 168.3, 139.2, 127.4, 127.3, 127.2, 
102.5, 79.4, 64.4, 61.4, 60.7, 58.5, 31.1, 27.9, 15.1, 13.9, 13.5; HRMS m/z 350.1654 
(calcd for C19H26O6 350.1729). 
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(2R*,6R*)-diethyl 6-ethoxy-2-phenethyldihydro-2H-pyran-3,3(4H)-dicarboxylate 
(2-67b) 
The title compound was prepared according to the general 
cycloaddition procedure to afford a colorless oil (79 mg, 70%). Rf 
0.30 (4:1 hexanes/EtOAc); 1H NMR (400 MHz, CDCl3)  7.10 - 
7.28 (m, 5 H), 4.41 (d, J = 9.4 Hz, 1 H), 4.03 - 4.27 (m, 4 H), 3.90 - 4.01 (m, 1 H), 3.74 
(d, J = 10.2 Hz, 1 H), 3.40 - 3.54 (m, 1 H), 2.83 - 2.97 (m, 1 H), 2.49 - 2.70 (m, 1 H), 
2.42 - 2.49 (m, 1 H), 2.10 - 2.33 (m, 1 H), 1.91 - 2.03 (m, 1 H), 1.67 - 1.91 (m, 2 H), 1.44 
- 1.67 (m, 2 H), 1.11 - 1.28 (m, 9 H); 13C NMR (101 MHz, CDCl3)  170.8, 168.7, 141.8, 
128.5, 128.3, 125.8, 102.4, 78.0, 70.7, 64.5, 61.3, 61.1, 56.2, 33.7, 33.5, 33.4, 33.1, 30.7, 
28.1, 15.1, 14.0, 13.9; HRMS m/z 377.1962 (calcd for C21H30O6-H 377.1964). 
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2.5.2.2 Cycloadditions of Nitrones and Cyclobutanes 
All nitrones were prepared according to the following methods: a) Gautheron-
Chapoulaud, V.; Pandya, S. U.; Cividino, P.; Masson, G.; Py, S.; Vallee, Y. Synlett, 2001, 
1281. b) Lo, M. M.-C.;Fu, G. C. J. Am. Chem. Soc. 2002, 124, 4572-4573. 
Compounds 2-81k, 2-81l, 2-81m, 2-81p, 2-83a to 2-83c, 2-85a and 2-85b were 
prepared by Cory Palmer and are not included below. 
 
General Cycloaddition Procedure for the Formation of a Single Diastereomer:  
To a mixture of nitrone (0.30 mmol, 1.0 equiv), Yb(OTf)3 (9.0 mg, 0.015 mmol, 
0.05 equiv) and 4 Å molecular sieves (1.0 g) in CH2Cl2 (2 mL) at room temperature was 
added cyclobutane (0.36 mmol, 1.2 equiv). Following convergence of the products to a 
single diastereomer (as indicated by TLC) the reaction mixture was layered directly onto 
a SiO2 column and eluted with EtOAc/hexanes to afford the cis oxazepane compounds. 
 
General Cycloaddition Procedure for the Formation of a Diastereomeric Mixture: 
To a mixture of nitrone (0.30 mmol, 1.0 equiv), Yb(OTf)3 (9.0 mg, 0.015 mmol, 
0.05 equiv) and 4 Å molecular sieves (1.0 g) in CH2Cl2 (2 mL) at 0 °C was added 
cyclobutane (0.36 mmol, 1.2 equiv). Following consumption of the cyclobutane the 
reaction mixture was layered directly onto a SiO2 column and eluted with hexanes/EtOAc 
to afford the oxazepane product as a mixture of cis and trans isomers. 
 
Compound 2-81a, cis diastereomer 
The title compound was prepared according to the general cycloaddition 
procedure for the formation of a single diastereomer to afford a pale 
yellow oil (100 mg, 76%). Rf 0.60 (33% EtOAc/hexanes); 1H NMR 
(600 MHz, CDCl3)  7.40 (d, J = 5.9 Hz, 2 H), 7.08 - 7.22 (m, 7 H), 
6.85 (t, J = 6.7 Hz, 1 H), 5.58 (s, 1 H), 5.36 (d, J = 5.3 Hz, 1 H), 4.35 - 4.41 (m, 1 H), 
4.29 - 4.35 (m, 1 H), 4.21 - 4.27 (m, 1 H), 3.99 (td, J = 2.3, 7.9 Hz, 1 H), 3.83 (dq, J = 
7.1, 11.1 Hz, 1 H), 3.72 (dq, J = 7.2, 10.6 Hz, 1 H), 2.94 - 3.00 (m, 1 H), 2.60 - 2.66 (m, 1 
H), 2.46 (dd, J = 2.9, 14.6 Hz, 1 H), 2.23 - 2.32 (m, 1 H), 1.81 - 1.87 (m, 1 H), 1.32 (t, J = 
7.3 Hz, 3 H), 0.94 (t, J = 7.0 Hz, 3 H); 13C NMR (101 MHz, CDCl3)  170.2, 168.8, 
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149.2, 134.5, 130.7, 128.6, 128.2, 127.8, 122.0, 116.8, 108.5, 70.4, 68.1, 62.0, 61.9, 61.6, 
40.4, 34.2, 31.8, 14.2, 13.6; HRMS m/z 439.1993(calcd for C25H29NO6, 439.1995). 
 
Compound 2-81a, trans diastereomer 
The title compound was prepared according to the general cycloaddition 
procedure for the formation of a diastereomeric mixture, affording an 
inseparable mixture of cis and trans isomers (120 mg, 91%, cis:trans 
31:61). Rf 0.60 (40% EtOAc/hexanes); 1H NMR (400 MHz, CDCl3) Identifiable, 
distinguishable, and diagnostic peaks for the trans diastereomer: 5.90 (s, 1 H), 5.17 (d, J 
= 7.8 Hz, 1 H). See spectra.  
 
Compound 2-81b, cis diastereomer 
The title compound was prepared according to the general 
cycloaddition procedure for the formation of a single diastereomer 
to afford a white solid (100 mg, 74%). Rf 0.24 (20% 
EtOAc/hexanes); 1H NMR (400 MHz, CDCl3)  7.30 - 7.36 (m, 2 
H), 7.13 - 7.22 (m, 4 H), 6.83 - 6.89 (m, 1 H), 6.63 - 6.69 (m, 2 H), 5.52 (s, 1 H), 5.36 (d, 
J = 5.1 Hz, 1 H), 4.27 - 4.43 (m, 2 H), 4.18 - 4.27 (m, 1 H), 3.99 (td, J = 2.3, 8.2 Hz, 1 
H), 3.82 - 3.91 (m, 1 H), 3.70 - 3.78 (m, 1 H), 3.69 (s, 3 H), 2.95 (dd, J = 14.1, 14.1 Hz, 1 
H), 2.56 - 2.66 (m, 1 H), 2.43 (dd, J = 2.7, 14.5 Hz, 1 H), 2.20 - 2.32 (m, 1 H), 1.81 - 1.81 
(m, 1 H), 1.32 (t, J = 7.0 Hz, 3 H), 0.98 (t, J = 7.2 Hz, 3 H); 13C NMR (101 MHz, CDCl3) 
 170.2, 168.9, 159.2, 149.3, 131.8, 128.6, 126.6, 122.0, 116.8, 113.1, 108.4, 69.9, 68.0, 
62.1, 61.8, 61.6, 55.0, 40.4, 34.2, 31.7, 14.2, 13.7; HRMS m/z 469.2107 (calcd for 
C26H31NO7, 469.2101). 
 
Compound 2-81b, trans diastereomer 
The title compound was prepared according to the general 
cycloaddition procedure for the formation of a diastereomeric 
mixture to afford a mixture of separable cis and trans isomers (124 
mg, 88%, cis:trans 37:63). Rf 0.21 (20% EtOAc/hexanes); 1H NMR 
(400 MHz, CDCl3)  7.33 (d, J = 7.8 Hz, 2 H), 7.16 - 7.25 (m, 2 H), 7.03 - 7.10 (m, 2 H), 
N
O
O
Ph
CO2Et
CO2Et
H
H
N
O
O
Ph
CO2Et
CO2Et
H
H
MeO
N
O
O
Ph
CO2Et
CO2Et
H
H
MeO
94 
 
 
 
6.91 (t, J = 7.2 Hz, 1 H), 6.65 - 6.71 (m, 2 H), 5.83 (s, 1 H), 5.17 (d, J = 7.8 Hz, 1 H), 
4.33 (qq, J = 7.0, 10.6 Hz, 2 H), 3.97 - 4.11 (m, 2 H), 3.73 - 3.84 (m, 2 H), 3.71 (s, 3 H), 
2.84 (d, J = 14.9 Hz, 1 H), 2.74 - 2.83 (m, 1 H), 2.66 (dd, J = 10.9, 14.9 Hz, 1 H), 1.85 - 
2.03 (m, 2 H), 1.30 (t, J = 7.0 Hz, 3 H), 0.83 (t, J = 7.0 Hz, 3 H); 13C NMR (101 MHz, 
CDCl3)  170.8, 168.4, 159.2, 150.4, 131.5, 128.5, 125.6, 121.9, 116.8, 112.8, 111.7, 
73.4, 66.0, 62.2, 61.6, 61.5, 55.0, 37.2, 29.0, 28.1, 14.1, 13.5. 
 
Compound 2-81c, cis diastereomer 
The title compound was prepared according to the general 
cycloaddition procedure for the formation of a single diastereomer 
to afford a highly crystalline colorless solid (104 mg, 73%), Rf 0.40 
(33% EtOAc/hexanes); 1H NMR (400 MHz, CDCl3)  7.34 (d, J = 
8.6 Hz, 2 H), 7.16 - 7.21 (m, 4 H), 7.13 (d, J = 8.6 Hz, 2 H), 6.86 - 6.92 (m, 1 H), 5.55 (s, 
1 H), 5.36 (d, J = 5.5 Hz, 1 H), 4.36 - 4.44 (m, 1 H), 4.29 - 4.36 (m, 1 H), 4.18 - 4.25 (m, 
1 H), 4.03 (dt, J = 2.2, 8.1 Hz, 1 H), 3.89 (dq, J = 7.2, 10.8 Hz, 1 H), 3.75 (dq, J = 7.1, 
10.8 Hz, 1 H), 2.91 (dd, J = 12.9, 14.5 Hz, 1 H), 2.58 - 2.69 (m, 1 H), 2.46 (dd, J = 2.7, 
14.8 Hz, 1 H), 2.23 - 2.34 (m, 1 H), 1.88 - 1.83 (m,1 H), 1.33 (t, J = 7.2 Hz, 3 H), 0.98 (t, 
J = 7.2 Hz, 3 H); 13C NMR (101 MHz, CDCl3)  170.0, 168.7, 149.0, 134.2, 133.0, 
131.9, 128.7, 128.0, 122.3, 116.9, 108.5, 70.0, 68.1, 62.0, 61.9, 61.8, 40.4, 34.1, 31.7, 
14.2, 13.7; HRMS m/z 473.1607 (calcd for C25H28ClNO6, 473.1605). 
 
Compound 2-81c, trans diastereomer 
The title compound was prepared according to the general 
cycloaddition procedure for the formation of a diastereomeric 
mixture to afford a mixture of separable cis and trans isomers (117 
mg, 82%, cis:trans 29:71). Rf 0.36  (33% EtOAc/hexanes); 1H NMR 
(400 MHz, CDCl3)  7.30 (d, J = 7.4 Hz, 2 H), 7.19 - 7.25 (m, 2 H), 7.08 - 7.17 (m, 2 H), 
7.01 - 7.06 (m, 2 H), 6.92 (t, J = 7.4 Hz, 1 H), 5.83 (s, 1 H), 5.13 (d, J = 7.8 Hz, 1 H), 
4.25 - 4.39 (m, 2 H), 3.95 - 4.11 (m, 2 H), 3.70 - 3.85 (m, 2 H), 2.88 (d, J = 14.8 Hz, 1 
H), 2.75 - 2.84 (m, 1 H), 2.64 (dd, J = 11.3, 14.9 Hz, 1 H), 1.82 - 1.99 (m, 2 H), 1.29 (t, J 
= 7.2 Hz, 3 H), 0.82 (t, J = 7.0 Hz, 3 H); 13C NMR (101 MHz, CDCl3)  170.6, 168.2, 
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150.1, 134.1, 131.8, 131.5, 128.6, 127.7, 122.3, 116.9, 111.6, 73.5, 66.1, 62.4, 61.7, 61.2, 
37.1, 29.1, 28.0, 14.1, 13.5.  
 
Compound 2-81d, cis diastereomer 
The title compound was prepared according to the general 
cycloaddition procedure for the formation of a single diastereomer 
to afford a white solid (106 mg, 76%). Rf 0.42 (33% 
EtOAc/hexanes); 1H NMR (400 MHz, CDCl3)  7.47 - 7.52 (m, 2 H), 7.42 - 7.47 (m, 2 
H), 7.12 - 7.21 (m, 4 H), 6.87 - 6.92 (m, 1 H), 5.61 (s, 1 H), 5.36 (d, J = 5.5 Hz, 1 H), 
4.28 - 4.44 (m, 2 H), 4.22 (ddd, J = 5.3, 8.4, 10.6 Hz, 1 H), 4.01 (td, J = 2.1, 8.1 Hz, 1 H), 
3.86 (dq, J = 7.2, 10.8 Hz, 1 H), 3.74 (dq, J = 7.1, 10.9 Hz, 1 H), 2.88 (dd, J = 12.9, 14.5 
Hz, 1 H), 2.57 - 2.68 (m, 1 H), 2.48 (dd, J = 2.7, 14.5 Hz, 1 H), 2.22 - 2.34 (m, 1 H), 1.82 
- 186 (m, , 1 H), 1.33 (t, J = 7.0 Hz, 3 H), 0.94 (t, J = 7.0 Hz, 3 H); 13C NMR (101 MHz, 
CDCl3)  169.6, 168.4, 148.7, 139.8, 131.5, 131.3, 128.8, 122.7, 118.5, 116.9, 112.1, 
108.6, 70.4, 68.1, 62.2, 61.9, 61.6, 40.3, 34.1, 31.9, 14.1, 13.6; HRMS m/z 464.1929 
(calcd for C26H28N2O6, 464.1947).  
 
Compound 2-81d, trans diastereomer 
The title compound was prepared according to the general 
cycloaddition procedure for the formation of a diastereomeric 
mixture to afford a mixture of separable cis, trans, and a third 
isomer (132 mg, 95%, cis:trans:3rd 15:57:27). Rf 0.30 (33% 
EtOAc/hexanes); 1H NMR (400 MHz,CDCl3)  7.46 (d, J = 8.2 Hz, 2 H), 7.29 (d, J = 8.2 
Hz, 2 H), 6.95 (t, J = 7.2 Hz, 1 H), 5.91 (s, 1 H), 5.12 (d, J = 8.2 Hz, 1 H), 4.30 - 4.40 (m, 
2 H), 4.19 - 4.28 (m, 1 H), 3.98 - 4.10 (m, 2 H), 3.74 - 3.83 (m, 2 H), 2.94 (d, J = 15.2 
Hz, 3 H), 2.79 - 2.89 (m, 1 H), 2.65 (dd, J = 11.3, 15.2 Hz, 3 H), 1.32 (t, J = 7.0 Hz, 3 H), 
0.80 (t, J = 7.0 Hz, 3 H); 13C NMR (101 MHz, CDCl3)  170.3, 168.0, 149.8, 138.7, 
131.2, 130.7, 128.7, 122.6, 118.4, 116.8, 112.0, 111.6, , 73.9, 66.1, 62.6, 61.9, 60.8, 37.0, 
29.4, 28.0, 14.1, 13.4. 
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Compound 2-81e, cis diastereomer 
The title compound was prepared according to the general 
cycloaddition procedure for the formation of a single diastereomer 
to afford bright yellow solid (106 mg, 73%). Rf 0.39 (33% 
EtOAc/hexanes); 1H NMR (400 MHz, CDCl3)  8.01 (d, J = 8.6 Hz, 
2 H), 7.7 (d, J = 9.0 Hz, 2 H), 7.14 - 7.21 (m, 4 H), 6.87 - 6.93 (m, 1 H), 5.68 (s, 1 H), 
5.37 (d, J = 5.5 Hz, 1 H), 4.29 - 4.45 (m, 2 H), 4.24 (ddd, J = 5.5, 8.6, 10.6 Hz, 1 H), 4.01 
(dt, J = 2.3, 8.2 Hz, 1 H), 3.87 (dq, J = 7.2, 10.8 Hz, 1 H), 3.74 (dq, J = 7.2, 10.8 Hz, 1 
H), 2.89 (dd, J = 12.9, 14.5 Hz, 1 H), 2.59 - 2.69 (m, 1 H), 2.50 (dd, J = 2.7, 14.8 Hz, 1 
H), 2.23 - 2.36 (m, 1 H), 1.84 - 1.87 (m, 1 H), 1.34 (t, J = 7.0 Hz, 3 H), 0.96 (t, J = 7.0 
Hz, 3 H); 13C NMR (101 MHz, CDCl3)  169.6, 168.4, 148.7, 147.6, 141.9, 131.5, 128.8, 
122.8, 122.8, 116.9, 108.6, 70.1, 68.2, 62.3, 62.0, 61.6, 40.3, 34.1, 31.9, 14.2, 13.6.  
 
Compound 2-81e, trans diastereomer 
The title compound was prepared according to the general 
cycloaddition procedure for the formation of a diastereomeric 
mixture to afford a mixture of separable cis, trans, and a third 
isomer (131 mg, 90%, cis:trans:3rd 11:63:26). Rf 0.27 (33% EtOAc/hexanes); 1H NMR 
(400 MHz, CDCl3)  8.04 (d, J = 8.6 Hz, 2 H), 7.32 (d, J = 9.0 Hz, 2 H), 7.22 - 7.28 (m, 3 
H), 7.15 - 7.22 (m, 3 H), 6.96 (t, J = 7.2 Hz, 1 H), 6.31 (s, 1 H), 5.18 (d, J = 7.4 Hz, 1 H), 
4.16 - 4.28 (m, 2 H), 3.96 - 4.13 (m, 4 H), 3.85 (dq, J = 7.1, 10.8 Hz, 1 H), 2.71 (dd, J = 
5.1, 14.5 Hz, 1 H), 2.61 (dd, J = 11.3, 14.5 Hz, 1 H), 2.45 - 2.56 (m, 1 H), 2.10 - 2.20 (m, 
1 H), 1.81 - 1.97 (m, 1 H), 1.22 (t, J = 7.2 Hz, 3 H), 1.01 (t, J = 7.2 Hz, 3 H); 13C NMR 
(101 MHz, CDCl3)  170.8, 169.8, 149.2, 147.0, 143.3, 130.2, 129.0, 122.9, 122.3, 116.0, 
111.0, 71.3, 68.3, 62.8, 62.3, 62.0, 43.1, 30.9, 30.0, 13.9, 13.6; HRMS m/z 484.1845 
(calcd for C25H28N2O8, 484.1846).  
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Compound 2-81f, cis diastereomer 
The title compound was prepared according to the general 
cycloaddition procedure for the formation of a single 
diastereomer to afford a white solid (78 mg, 52%). Rf 0.32 (33% 
EtOAc/hexanes); 1H NMR (400 MHz, CDCl3)  7.85 (d, J = 9.0 
Hz, 2 H), 7.41 (dd, J = 2.3, 7.4 Hz, 2 H), 7.21 (d, J = 9.0 Hz, 2 H), 7.12 - 7.18 (m, 3 H), 
5.71 (s, 1 H), 5.34 (d, J = 5.5 Hz, 1 H), 4.20 - 4.41 (m, 3 H), 4.00 (td, J = 2.9, 8.1 Hz, 1 
H), 3.82 - 3.91 (m, 2 H), 3.81 (s, 3 H), 3.71 - 3.80 (m, 1 H), 2.94 (dd, J = 12.5, 14.5 Hz, 1 
H), 2.56 - 2.65 (m, 1 H), 2.49 (dd, J = 3.1, 14.5 Hz, 1 H), 2.22 - 2.34 (m, 1 H), 1.81 - 1.89 
(m, 1 H), 1.31 (t, J = 7.0 Hz, 3 H), 0.96 (t, J = 7.2 Hz, 3 H); 13C NMR (101 MHz, CDCl3) 
 170.0, 168.5, 166.9, 153.0, 134.3, 130.7, 130.3, 128.4, 128.0, 123.0, 115.2, 108.8, 69.0, 
68.3, 62.0, 61.9, 61.8, 51.7, 40.5, 34.0, 31.6, 14.1, 13.6; HRMS m/z 497.2043 (calcd for 
C27H31NO8, 497.2043). 
 
Compound 2-81f, trans diastereomer 
The title compound was prepared according to the general 
cycloaddition procedure for the formation of a diastereomeric 
mixture, affording an inseparable mixture of three diastereomers 
(101 mg, 68%, cis:trans:3rd 16:40:44). Rf 0.32 (33% 
EtOAc/hexanes); 1H NMR (400 MHz, CDCl3) Identifiable, distinguishable, and 
diagnostic peaks of the trans diastereomer: 6.05 (s, 1 H), 5.19 (d, J = 7.4 Hz, 1 H); See 
spectra. 
 
Compound 2-81g, cis diastereomer 
The title compound was prepared according to the general 
cycloaddition procedure for the formation of a single 
diastereomer to afford bright yellow solid (111 mg, 68%). Rf 0.29 
(33% EtOAc/hexanes); 1H NMR (400 MHz, CDCl3)  8.03 (d, J 
= 8.6 Hz, 2 H), 7.93 (d, J = 9.0 Hz, 2 H), 7.39 (d, J = 9.0 Hz, 2 H), 7.30 (d, J = 9.0 Hz, 2 
H), 6.12 (s, 1 H), 5.15 (d, J = 7.8 Hz, 1 H), 4.28 - 4.41 (m, 2 H), 4.13 - 4.21 (m, 1 H), 
3.99 - 4.10 (m, 3 H), 3.86 (s, 3 H), 3.77 - 3.82 (m, 2 H), 2.97 (d, J = 14.5 Hz, 1 H), 2.65 - 
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2.81 (m, 2 H), 1.87 - 2.02 (m, 3 H), 1.31 (t, J = 7.0 Hz, 3 H), 0.83 (t, J = 7.2 Hz, 3 H) 13C 
NMR (101 MHz, CDCl3)  170.2, 167.7, 166.8, 153.4, 147.6, 140.6, 130.7, 130.5, 123.8, 
122.9, 115.6, 111.9, 72.4, 66.3, 62.8, 62.1, 60.6, 51.8, 37.0, 29.3, 27.9, 14.1, 13.5; HRMS 
m/z 542.1895 (calcd for C26H31NO7, 542.1900). 
 
Compound 2-81g, trans diastereomer 
The title compound was prepared according to the general 
cycloaddition procedure for the formation of a diastereomeric 
mixture, affording a separable mixture of three diastereomers 
(120 mg, 74%, cis:trans:3rd 7:58:35). Rf 0.27 (33% 
EtOAc/Hexanes);  1H NMR (400 MHz, CDCl3)  8.05 (d, J = 9.0 Hz, 2 H), 7.95 (d, J = 
9.0 Hz, 2 H), 7.29 (d, J = 9.0 Hz, 2 H), 7.23 (d, J = 9.0 Hz, 2 H), 6.47 (s, 1 H), 5.19 (d, J 
= 7.4 Hz, 1 H), 4.19 - 4.27 (m, 1 H), 4.06 - 4.17 (m, 2 H), 3.93 - 4.06 (m, 3 H), 3.87 (s, 3 
H), 2.70 (d, J = 8.6 Hz, 2 H), 2.30 - 2.43 (m, 1 H), 2.09 - 2.17 (m, 1 H), 1.83 - 1.96 (m, 1 
H), 1.19 (t, J = 7.2 Hz, 3 H), 1.08 (t, J = 7.0 Hz, 3 H); 13C NMR (101 MHz, CDCl3)  
170.4, 169.6, 166.7, 152.6, 147.1, 143.1, 131.1, 129.5, 123.2, 123.2, 114.1, 111.0, 69.6, 
68.6, 63.0, 62.3, 62.2, 51.9, 43.3, 31.3, 29.6, 13.9, 13.7. 
 
Compound 2-81h, cis diastereomer 
The title compound was prepared according to the general 
cycloaddition procedure for the formation of a single diastereomer 
to afford a white solid (61, 43%). Rf 0.37 (33% EtOAc/hexanes); 
1H NMR (600 MHz, CDCl3)  7.36 (d, J = 7.0 Hz, 2 H), 7.12 - 7.19 
(m, 3 H), 7.08 (d, J = 8.8 Hz, 2 H), 6.69 (d, J = 9.4 Hz, 2 H), 5.36 (d, J = 5.3 Hz, 1 H), 
5.36 (s, 1H), 4.39 (dq, J = 7.2, 10.6 Hz, 1 H), 4.32 (dq, J = 7.1, 10.8 Hz, 1 H), 4.20 - 4.26 
(m, 1 H), 3.95 - 4.01 (m, 1 H), 3.80 (dq, J = 7.0, 10.5 Hz, 1 H), 3.69 (s, 3 H), 2.97 (t, J = 
13.8 Hz, 1 H), 2.60 - 2.67 (m, 1 H), 2.44 (d, J = 14.6 Hz, 1 H), 2.22 - 2.30 (m, 1 H), 1.79 
- 1.88 (m, 1 H), 1.33 (t, J = 7.0 Hz, 3 H), 0.91 (t, J = 7.0 Hz, 3 H); 13C NMR (101 MHz, 
CDCl3)  170.2, 168.9, 142.9, 130.9, 128.1, 127.7, 119.3, 119.3, 113.6, 108.3, 71.7, 68.0, 
62.0, 61.8, 61.6, 55.3, 40.4, 34.3, 31.8, 14.2, 13.5; HRMS m/z 469.2102 (calcd for 
C26H31NO7, 469.2101). 
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Compound 2-81h, trans diastereomer 
The title compound was prepared according to the general 
cycloaddition procedure for the formation of a diastereomeric 
mixture to afford a mixture of separable cis and trans isomers (97 
mg, 69%, cis:trans 34:66). Rf 0.33 (33% EtOAc/hexanes); 1H NMR 
(400 MHz, CDCl3)  7.12 - 7.24 (m, 5 H), 7.08 (d, J = 7.0 Hz, 2 H), 6.75 (d, J = 9.4 Hz, 2 
H), 5.66 (s, 1 H), 5.15 (d, J = 7.8 Hz, 1 H), 4.27 - 4.42 (m, 2 H), 4.03 - 4.15 (m, 1 H), 
3.99 (td, 2.3, 9.0 Hz, 1 H), 3.73 (s, 3 H), 3.69 - 3.77 (m, 2 H), 2.80 - 2.92 (m, 2 H), 2.66 - 
2.75 (m, 1 H), 1.80 - 2.02 (m, 2 H), 1.33 (t, J = 7.0 Hz, 3 H), 0.76 (t, J = 7.2 Hz, 3 H); 13C 
NMR (101 MHz, CDCl3)  170.8, 168.4, 155.2, 144.2, 133.1, 130.5, 128.0, 127.4, 119.1, 
113.6, 111.5, 75.2, 66.0, 62.2, 61.5, 61.4, 55.4, 37.2, 29.2, 28.2, 14.1, 13.3. 
 
Compound 2-81i, cis diastereomer 
The title compound was prepared according to the general 
cycloaddition procedure for the formation of a single diastereomer 
to afford a white solid (82 mg, 55%). Rf 0.26 (33% 
EtOAc/hexanes); 1H NMR (600 MHz, CDCl3)  7.42 - 7.48 (m, 4 
H), 7.04 (d, J = 8.8 Hz, 2 H), 6.69 (d, J = 9.4 Hz, 2 H), 5.40 (br. s., 1 H), 5.35 (d, J = 5.3 
Hz, 1 H), 4.39 (dq, J = 7.1, 10.8 Hz, 1 H), 4.33 (dq, J = 7.0, 10.5 Hz, 1 H), 4.18 - 4.24 
(m, 1 H), 3.99 (td, J = 2.3, 8.2 Hz, 1 H), 3.83 (dq, J = 7.1, 11.1 Hz, 1 H), 3.70 (s, 3 H),  
3.67 - 3.74 (m, 1 H), 2.87 (dd, J = 13.5, 13.5 Hz, 1 H), 2.60 - 2.67 (m, 1 H), 2.47 (dd, J = 
2.3, 14.6 Hz, 1 H), 2.24 - 2.31 (m, 1 H), 1.83 (br. d, J = 8.8 Hz, 1 H), 1.33 (t, J = 7.0 Hz, 
3 H), 0.91 (t, J = 7.3 Hz, 3 H);  13C NMR (101 MHz, CDCl3)  169.7, 168.5, 155.7, 
142.3, 139.8, 131.4, 131.4, 119.2, 118.5, 113.8, 112.0, 108.4, 71.6, 68.0, 62.2, 61.8, 61.6, 
55.3, 40.3, 34.1, 31.9, 14.2, 13.6; HRMS m/z 494.2063 (calcd for C27H30N2O7, 494.2053).  
  
N
O
O
CO2Et
CO2Et
H
H
MeO
N
O
O
CO2Et
CO2Et
H
H
MeO
NC
100 
 
 
 
Compound 2-81i, trans diastereomer 
The title compound was prepared according to the general 
cycloaddition procedure for the formation of a diastereomeric 
mixture to afford a mixture of separable cis and trans isomers (98 
mg, 66%, cis:trans 32:68). Rf 0.23 (33% EtOAc/hexanes); 1H 
NMR (400 MHz, CDCl3)  7.46 (d, J = 8.6 Hz, 2 H), 7.15 (d, J = 9.0 Hz, 4 H), 6.76 (d, J 
= 9.4 Hz, 2 H), 5.69 (s, 1 H), 5.09 (d, J = 8.2 Hz, 1 H), 4.29 - 4.42 (m, 2 H), 3.99 (dt,  J = 
2.0, 9.0 Hz, 2 H), 3.73 (s, 3 H), 3.67 - 3.81 (m, 2 H), 2.91 (d, J = 14.9 Hz, 1 H), 2.79 - 
2.91 (m, 1 H), 2.63 (dd, J = 11.3, 15.2 Hz, 1 H), 1.82 - 2.03 (m, 2 H), 1.31 (t, J = 7.0 Hz, 
3 H), 0.78 (t, J = 7.0 Hz, 3 H); 13C NMR (101 MHz, CDCl3) 170.3, 168.0, 155.6, 143.5, 
138.4, 131.1, 131.0, 119.0, 118.5, 113.8, 111.9, 111.5, 75.0, 66.1, 62.5, 61.8, 60.9, 55.4, 
37.0, 29.3, 28.0, 14.1, 13.4). 
 
Compound 2-81j, cis diastereomer 
The title compound was prepared according to the general 
cycloaddition procedure for the formation of a single diastereomer 
to afford white solid (81 mg, 54%). Rf 0.29 (33% EtOAc/hexanes); 
1H NMR (400 MHz, CDCl3)  7.28 (d, J = 9.0 Hz , 2 H), 7.07 (d, J 
= 9.0 Hz, 2 H), 6.63 - 6.71 (m, 4 H), 5.35 (d, J = 5.5 Hz, 1 H), 5.31 (s, 1 H), 4.34 - 4.42 
(m, 1 H), 4.28 - 4.34 (m, 1 H), 4.24 - 4.18 (m, 1 H), 3.97 (td, J = 2.3, 8.2 Hz, 1 H), 3.79 - 
3.88 (m, 1 H), 3.70 (s, 3 H), 3.69 (s, 3 H), 3.68 - 3.73 (m, 1 H), 2.94 (app. t, J = 1.33 Hz, 
1 H), 2.56 - 2.70 (m, 1 H), 2.42 (br. d, J = 12.5 Hz, 1 H), 2.20 - 2.33 (m, 1 H), 1.82 (br. d, 
J = 10.9 Hz, 1 H), 1.32 (t, J = 7.0 Hz, 3 H), 0.95 (t, J = 7.2 Hz, 3 H); 13C NMR (101 
MHz, CDCl3)  170.3, 168.9, 159.2, 143.1, 132.0, 131.9, 126.5, 119.2, 113.6, 113.0, 
108.2, 71.1, 67.9, 62.1, 61.8, 61.5, 55.3, 55.0, 40.4, 34.3, 31.7, 14.2, 13.7; HRMS m/z 
499.2206  (calcd for C27H33NO8,  499.2206). 
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Compound 2-81j, trans diastereomer 
The title compound was prepared according to the general 
cycloaddition procedure for the formation of a diastereomeric 
mixture, affording an inseparable mixture of cis and trans isomers 
(105 mg, 70%, cis:trans d.r. 56:44). Rf 0.29 (33% EtOAc/hexanes); 
1H NMR (400 MHz, CDCl3) Identifiable, distinguishable, and diagnostic peaks for the 
trans diastereomer: 5.60 (s, 1 H), 5.13 (d, J = 8.2 Hz, 1 H); See spectra. 
 
Compound 2-81n, cis diastereomer 
The title compound was prepared according to the general cycloaddition 
procedure for the formation of a single diastereomer to afford a bright 
yellow solid (98 mg, 70%). Rf 0.37 (33% EtOAc/hexanes); 1H NMR (600 
MHz, CDCl3) δ 7.28 - 7.34 (m, 5 H), 7.27 (m, 4 H), 7.19 - 7.25 (m, 1 H), 
6.98 (t, J = 7.0 Hz, 1 H), 6.52 (dd, J = 9.4, 15.8 Hz, 1 H), 6.29 (d, J = 15.8 Hz, 1 H), 5.38 
(d, J = 5.3 Hz, 1 H), 5.01 (d, J = 9.4 Hz, 1 H), 4.39 - 4.45 (m, 1 H), 4.33 - 4.39 (m, 1 H), 
4.23 (ddd, J = 5.3, 8.2, 10.5 Hz, 1 H), 4.07 - 4.14 (m, 2 H), 4.00 (dt, J = 2.6, 8.1 Hz, 1 H), 
2.71 (dd, J = 12.3, 14.1 Hz, 1 H), 2.62 - 2.68 (m, 1 H), 2.44 (dd, J = 1.2, 14.1 Hz, 1 H), 
2.31 (tdd, J = 7.8, 10.7, 12.5 Hz, 1H), 1.87 (pd, J = 2.9, 12.3 Hz, 1 H), 1.38 (t, J = 7.0 Hz, 
3 H), 1.19 (t, J = 7.0 Hz, 3 H); 13C NMR (101 MHz, CDCl3) δ 169.8, 169.0, 149.5, 136.2, 
136.1, 128.7, 128.4, 127.8, 126.7, 122.3, 120.5, 116.9, 108.2, 70.5, 68.0, 61.9, 61.7, 61.7, 
40.3, 34.4, 30.9, 14.2, 14.1; HRMS m/z 465.2143 (calcd for C27H31NO6, 465.2151). 
  
Compound 2-81o, cis diastereomer 
The title compound was prepared according to the general 
cycloaddition procedure for the formation of a single diastereomer to 
afford a colorless crystalline solid (109 mg, 74%). Rf 0.38 (33% 
EtOAc/hexanes); 1H NMR (400 MHz, CDCl3) δ 8.18 (br. s., 1 H), 
7.78 (d, J = 7.0 Hz, 1 H), 7.48 (d, J = 8.2 Hz, 1 H), 7.45 (d, J = 9.4 Hz, 1 H), 7.22 (t, J = 
7.6 Hz, 1 H), 7.08 - 7.15 (m, 2 H), 7.03 - 7.05 (m, 3 H), 6.83 (t, J = 7.6 Hz, 2 H), 6.49 - 
6.58 (m, 2 H), 5.22 (d, J = 5.1 Hz, 1 H), 4.05 - 4.29 (m, 3 H), 3.82 (td, J = 2.1, 8.1 Hz, 1 
H), 3.12 - 3.27 (m, 1 H), 2.95 (t, J = 13.3 Hz, 1 H), 2.79 (br. t, J = 7.42 Hz, 1 H), 2.52 (br. 
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s, 1 H), 2.26 (dd, J = 2.3, 14.5 Hz, 1 H), 2.02 - 2.17 (m, 1 H), 1.68 (br. d, J = 7.8 Hz, 1 
H), 1.15 (t, J = 7.2 Hz, 3 H), 0.27 (t, J = 7.0 Hz, 3 H); 13C NMR (101 MHz, CDCl3) δ 
170.6, 168.6, 149.2, 133.4, 132.6, 131.0, 128.7, 128.7, 128.5, 128.4, 125.6, 125.1, 124.8, 
123.5, 122.3, 117.2, 108.7, 68.1, 62.3, 62.0, 61.6, 61.2, 40.6, 34.2, 32.2, 14.2, 12.9; 
HRMS m/z 489.2150 (calcd for C29H31NO6, 489.2151). 
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2.5.2.3 (4 + 2) Cycloaddition of Donor-Acceptor Cyclobutanes and Nitrosoarenes 
Scalar coupling was eliminated from nOe experiments by using acquisition delays 
of 500 ms. Signal intensity in 1H- 15N HMBCAD experiments is proportional to 1H-15N 
J-value, thus observed 2J1H-15N signals are significantly more intense than 3J1H-15N signals. 
EI mass spectra were obtained on a Finnigan MAT 8200 spectrometer at an ionizing 
voltage of 70 eV.  
All nitrosoarenes not available commercially were prepared from the 
corresponding anilines according to literature methods.42  
Compounds 2-89d, 2-89g and 2-89h were prepared in collaboration with Tyler 
Schon and are included below, compounds  2-89i, 2-90a, 2-90b, 2-91a, 2-91b and 2-92 
to 2-96 were prepared by Naresh Vemula and the data is not included below. 
 
General Procedure for the Yb(OTf)3 Catalyzed Cycloaddition of Nitrosoarenes and 
Cyclobutanes  
To a mixture of nitrosoarene (0.30 mmol, 1.0 equiv) and Yb(OTf)3 (4 mg, 0.006 
mmol, 2 mol %) in CH2Cl2 (3 mL) was added the cyclobutane (0.36 mmol, 1.2 equiv). 
After complete consumption of the cyclobutane (as indicated by TLC) the reaction 
mixture was layered directly onto a silica gel column and purified by flash 
chromatography. 
 
General Procedure for the MgI2 Catalyzed Cycloaddition of Nitrosoarenes and 
Cyclobutanes  
To a mixture of nitrosoarene (0.30 mmol, 1.0 equiv) and MgI2 (42 mg, 0.15 
mmol, 50 mol %) in CH2Cl2 (3 mL) was added the cyclobutane (0.36 mmol, 1.2 equiv). 
After complete consumption of the cyclobutane (as indicated by TLC) the reaction 
mixture was layered directly onto a silica gel column and purified by flash 
chromatography. 
  
104 
 
 
 
(4aR*,7aR*)-diethyl 1-phenyltetrahydro-1H-furo[2,3-c][1,2]oxazine-3,3(7aH)-
dicarboxylate (2-89a) 
The title compound was prepared according to the general Yb(OTf)3 
catalyzed cycloaddition procedure to afford a pale yellow oil (96 mg, 
92%). Rf 0.27 (2:1 hexanes/EtOAc); 1H NMR (400 MHz, CDCl3)  
7.26 - 7.35 (m, 4 H), 6.97 - 7.02 (m, 1 H), 5.44 (d, J = 5.9 Hz, 1 H), 
4.25 - 4.33 (m, 2 H), 4.15 - 4.24 (m, 2 H), 4.09 (td, J = 6.8, 8.5 Hz, 1 H), 3.93 (td, J = 3.9, 
8.2 Hz, 1 H), 2.80 - 2.90 (m, 1 H), 2.60 (dd, J = 6.6, 14.1 Hz, 1 H), 2.16 (dq, J = 8.2, 12.7 
Hz, 1 H), 2.04 (dd, J = 8.6, 14.1 Hz, 1 H), 1.83 - 1.92 (m, 1 H), 1.29 (t, J = 7.2 Hz, 3 H), 
1.18 (t, J = 7.2 Hz, 3 H); 13C NMR (101 MHz, CDCl3)  167.9, 167.6, 146.7, 128.5, 
123.0, 117.5, 88.6, 83.6, 67.0, 62.2, 62.0, 33.3, 30.6, 29.6, 14.0, 13.9; HRMS m/z 
349.1525 (calcd for C18H23NO6, 349.1525). 
 
(4aR*,7aR*)-diethyl 1-(4-bromophenyl)tetrahydro-1H-furo[2,3-c][1,2]oxazine-
3,3(7aH)-dicarboxylate (2-89b) 
The title compound was prepared according to the general Yb(OTf)3 
catalyzed cycloaddition procedure to afford a cream colored solid (114 
mg, 89%). Rf 0.27 (2:1 hexanes /EtOAc); 1H NMR (400 MHz, CDCl3)  
7.35 - 7.40 (m, 2 H), 7.18 - 7.23 (m, 2 H), 5.37 (d, J = 5.9 Hz, 1 H), 
4.24 - 4.33 (m, 2 H), 4.16 - 4.24 (m, 3 H), 4.08 (td, J = 7.0, 8.4 Hz, 1 
H), 3.92 (td, J = 3.9, 8.2 Hz, 1 H), 2.79 - 2.89 (m, 1 H), 2.59 (dd, J = 6.6, 14.1 Hz, 1 H), 
2.15 (dq, J = 8.1, 12.5 Hz, 1 H), 2.07 (dd, J = 7.8, 14.1 Hz, 1 H), 1.84 - 1.92 (m, 1 H), 
1.28 (t, J = 7.2 Hz, 3 H), 1.18 (t, J = 7.0 Hz, 3 H); 13C NMR (101 MHz, CDCl3)  167.8, 
167.5, 145.9, 131.4, 119.2, 115.8, 88.7, 83.6, 67.1, 62.3, 62.1, 33.4, 30.6, 29.4, 14.0, 
14.0; HRMS m/z 427.0614 (calcd for C18H22BrNO6, 427.0631). 
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(4aR*,7aR*)-diethyl 1-(2,4-dibromophenyl)tetrahydro-1H-furo[2,3-c][1,2]oxazine-
3,3(7aH)-dicarboxylate (2-89c) 
The title compound was prepared according to the general Yb(OTf)3 
catalyzed cycloaddition procedure to afford an orange oil (72 mg, 47%). 
Rf 0.37 (2:1 hexanes /EtOAc); 1H NMR (600 MHz, CDCl3)  7.88 (d, J 
= 8.8 Hz, 1 H), 7.64 (d, J = 2.3 Hz, 1 H), 7.38 (dd, J = 2.3, 8.8 Hz, 1 H), 
5.59 (d, J = 4.7 Hz, 1 H), 4.21 - 4.24 (m, 2 H), 4.13 - 4.18 (m, 2 H), 
4.06 - 4.11 (m, 1 H), 4.00 - 4.06 (m, 1 H), 3.87 (q, J = 7.8 Hz, 1 H), 2.73 - 2.80 (m, 2 H), 
2.52 - 2.56 (m, 1 H), 1.95 - 2.06 (m, 3 H), 1.19 (t, J = 7.3 Hz, 3 H), 1.04 (t, J = 7.3 Hz, 3 
H); 13C NMR (151 MHz, CDCl3)  168.0, 166.7, 143.9, 134.3, 130.2, 129.8, 123.4, 
120.2, 104.2, 69.0, 62.2, 62.0, 61.5, 36.1, 32.4, 27.4, 13.8, 13.6; HRMS m/z 504.9750 
(calcd for C18H21Br2NO6, 504.9736). 
 
(4aR*,7aR*)-diethyl 1-(4-acetylphenyl)tetrahydro-1H-furo[2,3-c][1,2]oxazine-
3,3(7aH)-dicarboxylate (2-89d) 
The title compound was prepared according to the general Yb(OTf)3 
catalyzed cycloaddition procedure to afford a cream colored solid (81 
mg, 69%). Rf 0.16 (2:1 hexanes /EtOAc); 1H NMR (400 MHz, CDCl3)  
7.88 (t, J = 2.0 Hz, 1 H), 7.55 - 7.61 (m, 2 H), 7.34 - 7.41 (m, 1 H), 5.49 
(d, J = 6.3 Hz, 1 H), 4.25 - 4.36 (m, 2 H), 4.20 (qd, J = 1.0, 7.1 Hz, 3 H), 
4.04 - 4.13 (m, 1 H), 3.94 (td, J = 3.9, 8.2 Hz, 1 H), 2.82 - 2.92 (m, 1 H), 2.60 (dd, J = 
7.8, 14.1 Hz, 1 H), 2.58 (s, 3 H), 2.17 (dq, J = 8.0, 12.7 Hz, 1 H), 2.09 (dd, J = 8.2, 14.1 
Hz, 1 H), 1.85 - 1.95 (m, 1 H), 1.30 (t, J = 7.0 Hz, 3 H), 1.18 (t, J = 7.2 Hz, 3 H); 13C 
NMR (101 MHz, CDCl3)  198.0, 167.8, 167.5, 147.2, 137.6, 128.8, 123.0, 122.2, 117.1, 
88.6, 83.7, 67.2, 62.3, 62.1, 33.4, 30.6, 29.4, 26.7, 14.0, 13.9; HRMS m/z 391.1623 (calcd 
for C20H25NO7, 391.1631). 
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 (4aR*,7aR*)-diethyl 1-(4-(ethoxycarbonyl)phenyl)tetrahydro-1H-furo[2,3-
c][1,2]oxazine-3,3(7aH)-dicarboxylate (2-89e) 
The title compound was prepared according to the general Yb(OTf)3 
catalyzed cycloaddition procedure to afford a pale yellow oil (104 mg, 
82%) as a 13:1 mixture of regioisomers (major regioisomer shown). Rf 
0.21 (2:1 hexanes /EtOAc); 1H NMR (400 MHz, CDCl3)  7.93 - 7.98 
(m, 2 H), 7.30 - 7.35 (m, 2 H), 5.54 (d, J = 5.9 Hz, 1 H), 4.26 - 4.36 (m, 
4 H), 4.13 - 4.22 (m, 3 H), 4.06 - 4.13 (m, 1 H), 3.93 (td, J = 3.9, 8.2 Hz, 1 H), 2.82 - 2.91 
(m, 1 H), 2.62 (dd, J = 6.4, 14.3 Hz, 1 H), 2.06 - 2.22 (m, 2 H), 1.90 (tdd, J = 4.2, 6.8, 
12.5 Hz, 1 H), 1.36 (t, J = 7.0 Hz, 3 H), 1.30 (t, J = 7.2 Hz, 3 H), 1.16 (t, J = 7.2 Hz, 3 
H); 13C NMR (151 MHz, CDCl3) 167.6, 167.3, 166.4, 150.5, 130.3, 124.2, 115.8, 88.1, 
83.7, 67.2, 62.3, 62.2, 60.5, 33.2, 30.5, 29.2, 14.3, 14.0, 13.9; HRMS m/z 421.1742 (calcd 
for C18H23NO6, 421.1737). 
 
(4aR*,7aR*)-diethyl 1-(4-cyanophenyl)tetrahydro-1H-furo[2,3-c][1,2]oxazine-
3,3(7aH)-dicarboxylate (2-89f) 
The title compound was prepared according to the general Yb(OTf)3 
catalyzed cycloaddition procedure to afford a cream colored solid (89 
mg, 61%) as a 3:1 mixture of regioisomers (major regioisomer shown). 
Rf 0.22 (2:1 hexanes /EtOAc); 1H NMR (600 MHz, CDCl3)  7.52 - 
7.59 (m, 2 H), 7.36 - 7.41 (m, 2 H), 5.52 (d, J = 6.4 Hz, 1 H), 4.25 - 4.34 
(m, 3 H), 4.16 - 4.23 (m, 3 H), 4.05 - 4.12 (m, 1 H), 3.93 (td, J = 4.7, 8.2 Hz, 1 H), 2.84 - 
2.91 (m, 1 H), 2.61 (dd, J = 6.4, 14.1 Hz, 1 H), 2.14 - 2.21 (m, 2 H), 1.87 - 1.94 (m, 2 H), 
1.30 (t, J = 7.0 Hz, 3 H), 1.17 (t, J = 7.0 Hz, 3 H); 13C NMR (151 MHz, CDCl3) see 
spectra; HRMS m/z 374.1482 (calcd for C19H22N2O6, 374.1478).  
Minor Regioisomer: Identifiable, distinguishable, and diagnostic peaks of the minor 
diastereomer: 1H NMR (600 MHz, CDCl3) 8.12 - 808 (m, 2 H), 7.08 - 7.05 (m, 2 H), 
5.59 (d, J = 4 Hz, 1 H), 1.15 (t, J = 7.03 Hz, 3 H); See spectra. 
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(4aR*,7aR*)-diethyl 1-(4-nitrophenyl)tetrahydro-1H-furo[2,3-c][1,2]oxazine-
3,3(7aH)-dicarboxylate (2-89g) 
The title compound was prepared according to the general Yb(OTf)3 
catalyzed cycloaddition procedure to afford a yellow solid (70 mg, 59%) 
as a 4:1 mixture of regioisomers (major regioisomer shown). Rf 0.19 (2:1 
hexanes /EtOAc); 1H NMR (400 MHz, CDCl3)  8.14 - 8.20 (m, 2 H), 
7.37 - 7.42 (m, 2 H), 5.58 (d, J = 6.3 Hz, 1 H), 4.27 - 4.36 (m, 2 H), 4.15 
- 4.24 (m, 2 H), 4.07 - 4.14 (m, 2 H), 3.95 (td, J = 4.3, 8.2 Hz, 1 H), 2.85 - 2.94 (m, 1 H), 
2.62 (dd, J = 6.3, 14.5 Hz, 1 H), 2.15 - 2.24 (m, 2 H), 1.94 (td, J = 4.7, 11.9 Hz, 1 H), 
1.31 (t, J = 7.2 Hz, 3 H), 1.18 (t, J = 7.0 Hz, 3 H); 13C NMR (151 MHz, CDCl3)  167.4, 
167.0, 152.0, 142.3, 124.7, 115.9, 88.0, 83.7, 67.5, 62.6, 62.4, 33.4, 30.3, 28.9, 14.0, 
13.9; HRMS m/z 394.1377 (calcd for C18H22N2O8, 394.1376). 
Minor Regioisomer: Identifiable, distinguishable, and diagnostic peaks of the minor 
diastereomer: 1H NMR (400 MHz, CDCl3) 8.12-808 (m, 2 H), 7.08-7.05 (m, 2 H), 5.59 
(d, J = 4 Hz, 1 H), 1.15 (t, J = 7.03 Hz, 3 H); See spectra. 
 
(4aR*,7aR*)-diethyl 1-p-tolyltetrahydro-1H-furo[2,3-c][1,2]oxazine-3,3(7aH)-
dicarboxylate (2-89h) 
The title compound was prepared according to the general Yb(OTf)3 
catalyzed cycloaddition procedure to afford a pale yellow oil (32 mg, 
29%). Rf 0.29 (2:1 hexanes /EtOAc); 1H NMR (600 MHz, CDCl3)  7.18 
- 7.21 (m, 2 H), 7.04 - 7.08 (m, 2 H), 5.34 (d, J = 5.9 Hz, 1 H), 4.22 - 
4.33 (m, 2 H), 4.14 - 4.22 (m, 3 H), 4.06 (q, J = 8.8 Hz, 1 H), 3.90 (td, J 
= 3.8, 8.3 Hz, 1 H), 2.78 - 2.85 (m, 1 H), 2.57 (dd, J = 6.4, 14.1 Hz, 1 H), 2.25 (s, 3 H), 
2.12 (dq, J = 8.1, 12.6 Hz, 1 H), 2.02 (dd, J = 8.2, 14.1 Hz, 2 H), 1.83 - 1.89 (m, 1 H), 
1.26 (t, J = 7.0 Hz, 3 H), 1.17 (t, J = 7.3 Hz, 3 H); 13C NMR (151 MHz, CDCl3)  168.0, 
167.8, 144.3, 132.7, 129.1, 118.0, 89.0, 83.6, 66.9, 62.1, 62.0, 33.3, 30.6, 29.6, 20.7, 20.6, 
14.0, 14.0, 13.9; HRMS m/z 363.1686 (calcd for C19H25NO6 363.1682). 
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Chapter 3.  Studies Towards the Synthesis of Grandilodine A 
This chapter describes studies towards the synthesis of grandilodine A. Relevant 
background information regarding the alkaloid, as well as previous reported studies 
directed towards the synthesis of the grandilodines and related alkaloids is presented. 
3.1 Introduction 
3.1.1  Grandilodine A 
Complex natural products provide a unique opportunity for the chemical and 
medicinal community, as many compounds isolated from natural sources have been 
found to possess potent biological activity. Indeed, from the development of 
chemotherapy for cancer treatment, greater than 48% of the small molecules used in the 
treatment of cancer are either natural products or natural product derived.1 New and 
intriguing compounds continue to be isolated, often times in such limited quantities to 
allow only a cursory examination of their potential biological activity. One such series of 
compounds isolated in 2011 are the grandilodines (Figure 3.1).2 Preliminary examination 
of the biological properties of the grandilodines revealed that both grandilodine A and C 
restored vincristine activity in multidrug resistant KB cells (IC50 4.35 and 4.11 μg/mL 
respectively, in the presence of 0.1 μg/mL of vincristine) without showing cytotoxicity 
against both drug-sensitive and drug-resistant cells in the absence of vincristine. While 
this was a promising preliminary result, the sparse availability of these compounds has 
hindered further studies from being undertaken. 
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Figure 3.1. Grandilodines A-C 
 
Synthetic organic chemistry provides a unique opportunity in this regard, as an 
efficient synthesis of the grandilodines would allow for sufficient material to facilitate 
full elucidation of the medicinal utility of this series of compounds. Additionally it would 
allow for potential enhancement of their biological properties through structure-activity 
relationship studies. The potential utility of these compounds aside, the grandilodines 
possess a rare carbon framework. The central [4.2.2] bicyclic system poses a significant 
synthetic challenge. Moreover, the adjacent quaternary and tertiary centers present in the 
indoline core create additional impediment as the high steric requirements of the centers 
would prove challenging to form. 
3.1.2 Synthetic Efforts Towards the Grandilodines and Related Alkaloids 
To date there have only been two reports of synthetic efforts towards the synthesis 
of any of the grandilodine natural products. There are, however, two series of compounds 
with closely related structures, the lapidilectines3 and the lundurines4 (Figure 3.2). Once 
again there have only been a few reports of efforts towards their synthesis, which have 
been summarized below. These studies can assist in illustrating some of the challenges 
faced when constructing molecules with the peculiar [4.2.2] framework.  
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Figure 3.2. The Lapidilectine and Lundurine Natural Products 
 
3.1.2.1 Synthesis of the Indoloazocine Ring via Intramolecular Alkyne Cyclization 
Echavarren and Van der Eycken have both developed methodologies for the 
synthesis of the central indoloazocine ring of the grandilodine, lapidilectine, and 
lundurine alkaloids, which utilize intramolecular alkyne cyclizations. Echavarren and 
coworkers described a method that employs a gold catalyst and terminal alkynes; 
however, the selectivity for the desired 8-endo-dig vs. the undesired 7-exo-dig processes 
appears to be highly substrate dependent, though it is difficult to draw conclusions as 
only four compounds were investigated (Scheme 3.1).5 Subsequently, Van der Eycken 
and coworkers developed a methodology using a propargyl amide as a cyclization 
precursor, as opposed to a propargyl amine substrate.6 This proved to be an advantageous 
and most likely crucial alteration as complete selectivity for the 8-endo-dig pathway was 
observed, affording the 8-membered ring products in good yield. Unfortunately, they 
found that internal alkynes were required, as terminal alkynes afforded extremely slow 
reactions (2 days) with low yield (21–25%) and extensive decomposition.  
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Scheme 3.1. Indole-Alkyne Cyclizations for the Formation of Indoloazocines 
 
 
Though the initial scope was limited, Echavarren and coworkers believed that 
their gold-catalyzed cyclization would facilitate synthesis of the lundurines, and thus 
embarked on the synthesis of the tetracyclic core (Scheme 3.2).7 Desiring an 
enantioselective route, they first studied the synthesis of the pyrrolidine portion of the 
molecule. Following a procedure developed by Germans and coworkers,8 chloral 
(trichloroacetaldehyde) and (S)-proline were condensed to form oxazolidinone 3-6 which 
was alkylated with ((2-iodoethoxy)methyl)benzene, affording 3-7 in low yield. 
Subsequent acidic cleavage of the oxazolidinone afforded the desired pyrrolidine. The 
indole moiety was appended through an SN2 reaction with indole derivative 3-9 to afford 
3-10. The poor yields obtained throughout (1.6% over 4 steps) necessitated abandoning 
this route and an alternative synthesis with a less complicated substrate was investigated. 
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Scheme 3.2. Echavarren's Synthetic Efforts Towards the Lundurines 
 
 
The second route investigated by Echavarren began with Boc protection and 
DIBAL reduction of commercially available indole-3-acetic acid methyl ester to afford 
aldehyde 3-12 (Scheme 3.3). A pendant pyrrolidinone was then installed via reductive 
amination and lactam formation with dimethyl (S)-glutamate. The synthesis of the 
cyclization precursor was completed through ester reduction, oxidation with DMP, 
alkyne formation with the Bestmann–Ohira reagent and Boc cleavage to afford alkyne 3-
14. Treatment of alkyne 3-14 with AuCl3 afforded the cyclized product (3-15) in 55% 
yield. Despite the poor overall efficiency (5% yield over 7 steps), the study demonstrated 
the feasibility of this methodology for the synthesis of the indoloazocine skeleton. 
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Scheme 3.3. Echavarren's Synthesis of the Tetracyclic Core 
 
 
3.1.2.2 Martin’s Approach Towards Lundurine A  
The Martin group has disclosed studies towards the synthesis of the lundurine 
alkaloids based on a double RCM approach.9 They began the synthesis by formation of 
amine partner 3-18 through bisalkylation of 3-16 with phenyl vinyl sulfoxide followed by 
acidic hydrolysis of the Schiff base. The indole portion was created through electrophilic 
bromination of indole derivative 3-19, N-tosylation and Suzuki cross-coupling to afford 
vinyl indole 3-22. Silyl-group deprotection with TBAF gave alcohol 3-23. Oxidation of 
the newly released alcohol with IBX and reductive amination with amine 3-23 afforded 
3-24. Lastly, pyrolytic elimination of the two phenyl sulfoxides afforded key triene 3-25.  
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Scheme 3.4. Preparation of the RCM Precursor 
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Installation of the fourth and final olefin was accomplished through alkylation of 
3-25 with either crotonyl chloride or allyl bromide to afford tetraenes 3-26 and 3-27 
(Scheme 3.5). It was found that amide 3-26 would not undergo RCM with a variety of 
different RCM catalysts. In contrast, amine 3-27 underwent RCM with all catalysts 
surveyed to afford 3-28; however, Grubbs I provided the superior yield. They 
subsequently described that the next RCM event could also be catalyzed by Grubbs I, 
Grubbs II, or Schrock catalysts to afford tetracycle 3-29. Regrettably, this process was 
found to be irreproducible approximately one year after being reported and the 
publication was retracted.10 
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Scheme 3.5. RCM for Formation of the Indoloazocine Skeleton of Lundurine A 
 
 
3.1.2.3 Studies towards Grandilodine C 
Sarpong recently disclosed studies towards the synthesis of lapidilectine-type 
alkaloids, including grandilodine C and the lapidilectine and lundurine natural products.11 
Key steps in his strategy include a four component Ugi coupling and three methods for 
formation of the indoloazocine ring system. The synthesis began with a four-component 
Ugi coupling leading to adduct 3-33. The undesired enamide artifact of the Ugi reaction 
was cleaved through acidic methanolysis to afford a methyl ester, which underwent 
subsequent Dieckmann condensation, dehydration and protection of the indole nitrogen 
through methyl carbamate formation, to afford 3-35. Fission of the cyclohexanone ring 
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was accomplished through silyl enol ether formation, dihydroxylation with OsO4 and 
oxidative cleavage with Pb(OAc)4 to afford 3-36 in 64% yield over the three steps.  
Scheme 3.6. Sarpong's Synthesis of the Cyclization Precursor 
 
 
With efficient access to 3-36, a number of methods to form the indoloazocine ring 
were investigated (Scheme 3.7). Conversion of 3-36 to aryl bromide 3-39, carboxcylic 
acid 3-37 or dimethyl acetal 3-38 was achieved efficiently through standard procedures. 
Friedel–Crafts reactions could be accomplished through carboxylic acid 3-37 or dimethyl 
acetal 3-38 to afford 3-40 or 3-41 respectively. The indoloazocine ring could also be 
formed through a radical cyclization by subjection of aryl bromide 3-39 to AIBN and 
dodecane thiol, affording ketone 3-40. This study represents the most efficient route to 
form the indoloazocine ring system to date and includes adequate functionality for further 
studies. 
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Scheme 3.7. Sarpong’s Synthesis of the Indoloazocine Ring 
 
 
3.1.2.4 Pearson’s Total synthesis of Lapidilectine B 
To date, the only completed synthesis of the lapidilectine, lundurine, or 
grandilodine natural products has been that of Pearson and coworkers who have 
successfully synthesized lapidilectine B.12 The successful route relied on construction of 
the [4.2.2] ring system at a late stage, preceded by a (3 + 2) cycloaddition between 
azaallyllithium 3-42 and vinylsulfide (Scheme 3.8). The cycloaddition precursor was 
synthesized from 3-oxindole 3-43, which was made available through a Smalley azido-
enolate cyclization of 3-44. 
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Scheme 3.8. Pearson's Retrosynthesis of Lapidilectine B 
 
 
The synthesis began with monobenzylation and oxidation of cis/trans-
cyclohexane-1,4-diol to give ketone 3-45 (Scheme 3.9). Enol-triflate formation and 
stannylation afforded stannane 3-47 which underwent a Stille carbonylative cross-
coupling to afford 3-48. Conjugate addition of vinylmagnesium bromide and cleavage of 
the nitrogen protecting group produced amine 3-49. Installation of an azide was 
accomplished by conversion of the amine to a diazonium salt with sodium nitrite and 
HCl, followed by displacement with sodium azide. Subsequent Smalley azido-enolate 
cyclization afforded 3-50 as a 2.2:1 mixture of separable diastereomers. N-Acylation with 
methylchloroformate and dihydroxylation of the terminal olefin afforded 3-51. Allylation 
of the ketone with allylmagnesium bromide and subsequent periodate cleavage afforded 
an aldehyde which was ketalized in acidic methanol to afford methyl acetal 3-52 as a 
single diastereomer whose stereochemistry was confirmed through X-ray 
crystallography. Ozonolysis of the newly installed terminal olefin with a reductive 
workup afforded a primary alcohol which was immediately protected as a TBDPS ether 
(3-53). Completion of the (3 + 2) cycloaddition precursor was accomplished through 
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reductive removal of the benzyl protective group with Pearlman’s catalyst followed by 
Ley oxidation to afford ketone 3-54. 
Scheme 3.9. Synthesis of the Cycloaddition Precursor 
 
 
With ketone 3-54 in hand, the stage was set for the key (3 + 2) cycloaddition 
(Scheme 3.10). Condensation of aminomethyltributylstannane with ketone 3-54 afforded 
intermediate 3-55 which, upon treatment with phenylvinyl sulfide and n-butyllithium, 
underwent the (3 + 2) cycloaddition to produce pyrrolidine 3-56 in 75% yield as an 
undetermined mixture of carbamate rotamers or regio- and stereoisomers. Protection of 
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the free secondary amine as a Teoc carbamate and oxidation of the sulfide to the 
sulfoxide followed by thermolysis coalesced the mixture of compounds into a single 
product, 3-57, in good overall yield. Demethylation of the methylacetal with BCl3 
followed by PCC oxidation installed the required lactone functionality, and deprotection 
of the TBDPS ether and mesylation afforded mesylate 3-58. The synthesis was completed 
by TFA deprotection of the Teoc-protected nitrogen and intramolecular ring closure, 
facilitated by heat and Hunig’s base, to afford (±)-lapidilectine B. Overall, the synthesis 
required 28 steps and provided the natural product in 0.14% yield from commercially 
available cyclohexane-1,4-diol. 
Scheme 3.10. Cycloaddition and Completion of the Total Synthesis of Lapidilectine B 
 
3.2 Studies Towards the Synthesis of Grandilodine A 
3.2.1 Retrosynthetic Analysis 
Our original retrosynthesis of grandilodine A is outlined in Scheme 3.11. 
Formation of the azabicyclo[4.2.2]becane system could occur via nucleophilic addition to 
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an imine species, creating the last quaternary center. It was believed that this could be 
accomplished through an aza-Baylis–Hillman reaction, similar to the procedure 
developed by Andrade and coworkers for the synthesis of the Strychnos alkaloids13 and 
subsequently applied by Andrew and Kwon for the synthesis of (+)-ibophyllidine.14 The 
central 8-membered ring (3-59), difficult to form due to increased strain from trans-
annular interactions, would rely on RCM, nucleophilic addition, or cross-coupling 
chemistry. Formation of the 8-membered ring precursor (3-60) would be achieved 
through reductive amination of pyrrolidine fragment 3-62 with oxindole fragment 3-61. 
The requisite oxindole (3-61) and pyrrolidine fragments (3-62), each in enantioenriched 
form, would arise from an asymmetric-organocatalytic aldol reaction and proline 
oxazolidinone-alkylation/homologation respectively. 
Scheme 3.11. Retrosynthetic Analysis of Grandilodine A 
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3.2.2  Synthesis of the Oxindole Fragment 
3.2.2.1 Model Study for Cross-Coupling or RCM Formation of the 8-Membered 
Ring 
It was deemed prudent to assess the viability of the cross-coupling chemistry 
necessary for the 8-membered ring formation prior to exploration with more complex 
substrates. There are examples of cross-coupling of both iminotriflates15 and 
iminochlorides,16 though the reports are relatively few. Test substrate 3-65 was 
synthesized through alkylation of commercially available 2-oxindole with methyl iodide 
to afford 3,3-dimethyl-2-oxindole (Scheme 3.12). Attempts to form the iminotriflate 
through treatment of oxindole 3-65 with triflation sources, such as Tf2O, N-phenyl 
triflamide or Comins reagent and a variety of bases all failed to provide the iminotriflate 
and thus cross-coupling chemistry though the iminotriflate was abandoned. Iminochloride 
3-67 was also synthesized through treatment of oxindole 3-65 with thionyl chloride and 
2,6-lutidine; however, subsequent Kumada couplings did not occur. 
Scheme 3.12. Model Study for Ring Closure via Cross-coupling Chemistry 
 
 
We next explored nucleophilic addition as a means of introducing either the 
pyrrolidine portion directly, or to introduce an olefin for subsequent RCM (Scheme 3.13). 
Protection of the nitrogen was necessary and was accomplished by introduction of a Boc 
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group. It was found that, similar to what has been described by Weinreb and coworkers,17 
nucleophilic addition of vinylmagnesium bromide afforded the desired product (3-69) in 
60% yield. With a means of introducing the functionality necessary for 8-membered ring 
formation, attention was focused on the synthesis of the oxindole and pyrrolidine 
fragments. 
Scheme 3.13. Nucleophilic Addition to Oxindole 
 
 
3.2.2.2 Quaternary Center Formation via Alkyation 
Several routes existed for the formation of the quaternary center present in 
oxindole fragment 3-61, two of which were developed by Overman and coworkers 
(Scheme 3.14). The first method was an asymmetric Heck reaction of iodoanilide 3-70 to 
afford oxindoles in high yield and acceptable enantioselectivity.18 The enantiomeric 
purity of the oxindole could be subsequently increased through recrystallization. 
Unfortunately, the preparation of the Heck precursor was non-trivial, utilized expensive 
reagents, and the enantioselectivity of the process was substrate-dependent. To avoid 
these pitfalls, they developed a second route that relied on alkylation with tartrate-derived 
electrophile 3-73.19 Unlike the Heck route, the alkylation substrates were readily 
available in few steps and afforded the product in good yield. Notably, the minor 
products in this transformation are diastereomers of the desired C2-symmetric product, 
allowing for facile isolation of the desired compound in very high ee.  
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Scheme 3.14. Overman’s Routes for Synthesis of Quaternary Oxindiole Substrates 
 
 
It was determined that alkylation with tartrate-derived bis-triflate 3-73 was the 
most promising route, and thus was elected as the first candidate to be explored (Scheme 
3.15). The oxindole substrate was prepared by Wolff–Kishner reduction of isatin, 
followed by attempted Boc protection of the nitrogen. Unfortunately, a mixture of N-Boc, 
O-Boc and C-3-Boc compounds were formed, requiring an alternative approach. To that 
end, treatment of 2-oxindole (3-75) with an excess of methyl chloroformate formed enol-
formate 3-76 which underwent O to C acyl transfer mediated by DMAP to affording the 
DMAP-enolate salt 3-77. Acidic workup produced the desired oxindole (3-63) as a 3:1 
keto to enol mixture. The unoptimized yield of this sequence is poor; however, it afforded 
the requisite starting material necessary for alkylation and could likely be optimized to 
increase efficiency. Unfortunately, the desired alkylation did not occur, as treatment of 
the enolate with bistriflate 3-73 afforded only starting material, even after extended 
reaction times at high temperatures. 
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Scheme 3.15. Asymmetric Alkylation with Tartarate-Derived Electrophile 
 
 
3.2.2.3 Organocatalytic Formation of the Quaternary Center 
When the alkylation route failed to produce the desired substrate, it occurred to us 
that an asymmetric aldol between an oxindole and formaldehyde would install the 
requisite functionality (Scheme 3.16). Fortunately, a recent report describing such a 
transformation was disclosed by Yuan and coworkers.20 Many asymmetric 
organocatalytic transformations for the synthesis of 3,3-disubstituted oxindoles are 
known; however, the number of direct aldol reactions involving formaldehyde are 
limited. The report described by Yuan makes use of bifunctional thiourea catalyst 3-79, 
paraformaldehyde and an oxindole bearing an N-Boc protecting group. It was 
demonstrated that the N-Boc protection was crucial in achieving good enantioselectivity. 
As this reaction would install the requisite functionality, the organocatalytic 
transformation was explored for inclusion into the total synthesis.  
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Scheme 3.16. Organocatalytic Aldol with Thiourea Catalyst 3-79 
 
 
To synthesize the requisite oxindole substrate, attention was turned towards older 
chemistry (Scheme 3.17). Indole was treated with oxalyl chloride followed by ethanol to 
form 3-81, which was subsequently reduced with LiAlH4 to afford tryptophol (3-82).21 
Oxidation of the indole ring with DMSO in concentrated hydrochloric acid gave oxindole 
3-8322 whose primary alcohol was protected as a TBS ether (3-84). As previously 
discussed, the very acidic 3-position proved problematic when attempting to Boc protect 
the amide nitrogen, forming mixtures of N-, O- and C-bound Boc groups under standard 
Boc protection conditions. This phenomenon has been noted by others, and Trost23 has 
developed an elegant solution whereby attenuation of the electrophilicity of the acylating 
reagent allowed for selective installation of the methoxylcarbonyl group. Following the 
procedure of Trost, N-methoxycarbonyl protection was readily accomplished using 
imidazole carboxylate 3-85, setting the stage for the organocatalytic transformation. 
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Scheme 3.17. Synthesis of the Organocatalytic Aldol Precursor 
 
 
Having synthesized the requisite starting material (3-86), the organocatalytic 
transformation was explored (Scheme 3.18). Fortunately, the reaction proceeded exactly 
as described to afford primary alcohol 3-87 in excellent yield and acceptable 
enantioselectivity (86% ee as confirmed by Mosher’s ester analysis). To control the 
reactivity of the newly generated primary alcohol, it was protected as a PMB ether (3-88) 
under standard conditions. At this stage it we elected to explore the potential for 
nucleophilic addition to the carbonyl. As such, oxindole 3-88 was treated with 
vinylmagnesium bromide which resulted in N-methoxylcarbonyl removal rather than 
installation of a vinyl group.  
Scheme 3.18. Organocatalytic Aldol Reaction 
 
132 
 
 
 
It was clear that the N-methoxylcarbonyl group was not robust enough to allow 
for nucleophilic addition, and thus it was removed and replaced with a Boc protecting 
group (Scheme 3.19). The addition was found to proceed well to afford the desired 
addition product (3-91) in 50% yield as a 1:1.2 mixture of two diastereomers. Ultimately, 
the stereochemistry at the newly generated center would be eliminated at a later stage, 
rendering the poor selectivity inconsequential and as such, the synthesis was carried 
forward. 
Scheme 3.19. Nucleophilic Addition to Oxindole 
 
 
With a viable coupling route in hand, the oxindole substrate was brought forward 
to a suitable point for coupling with an amine fragment (Scheme 3.20). To this end, the 
TBS group of compound 3-90 was removed with 10-CSA. Unfortunately, the newly 
released alcohol lactonized, resulting in Boc-protected aniline species 3-92. Deprotection 
under basic conditions (TBAF) induced similar lactonization, and thus it was necessary to 
cleave the TBS group prior to installation of the Boc protecting group. Subsequent 
oxidation of the primary alcohol with IBX afforded the requisite aldehyde (3-95) for 
reductive amination in good yield over the three steps. 
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Scheme 3.20. Preparation of the Oxindole Fragment for Coupling 
 
 
3.2.3 Synthesis of the Pyrrolidine Fragment 
In contrast to the multiple routes available for synthesis of the oxindole fragment, 
the route for the formation of the quaternary center on the pyrrolidine fragment was 
easily identified. The most obvious choice for a starting material, if one is looking for an 
enantiopure and readily available substance, is proline. In order to alkylate adjacent to the 
nitrogen, however, it is necessary to destroy the only chiral center present in the starting 
material (3-97), thus causing the product to be formed in a racemic sense (Scheme 3.21). 
This problem was addressed by Seebach24 and coworkers as they demonstrated that 
condensation of proline with pivaldehyde forms an oxazolidinone (3-99) whose 
stereochemistry is dictated by the concave nature of the newly-formed bicyclic ring 
system. Enolate formation destroys one of the stereocenters (3-100); however, the 
stereochemical information is preserved in the oxazolidinone ring and, upon treatment 
with an electrophile, the desired product can be formed with high diastereoselectivity. 
Following cleavage of the oxazolidinone ring, pyrrolidines of high enantiomeric purity 
can be obtained.  
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Scheme 3.21. Asymmetric Alkylation of Proline 
 
 
Despite this method’s historic successes, there are multiple drawbacks with which 
it is associated. The method relies upon using pivaldehyde as the condensation partner 
which is expensive ($535 for 100 g), must be used in large excess (> 7 equiv), and the 
condensation requires extended reaction times (5 – 7 days). In addition, the formed 
oxazolidinone is extremely moisture sensitive and must be isolated under inert 
atmosphere and used immediately. More recently, chloral has been identified as a 
superior alternative.7,8,25 Though chloral is a controlled substance, it is comparably 
inexpensive ($55 for 500 g) and readily forms the desired condensation product (3-6), 
which is a moisture stable and highly crystalline solid. Additionally, though the auxiliary 
is moisture stable and can be purified via column chromatography, as can the alkylation 
products, the auxiliary can be readily cleaved through basic hydrolysis. Despite the 
superior nature of the chloral-derived auxiliary, it has seen only sparse use in the 
literature.26 It was decided that this method would provide the most facile route to an 
enantiopure pyrrolidine fragment. 
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To this end, (S)-proline was condensed with chloral hydrate to form bicyclic 
oxazolidinone 3-6 (Scheme 3.22). Subsequent alkylation with methyl formate allowed for 
installation of a formyl group; however, the reaction had to be acidified at –40 °C as the 
methoxide byproduct quickly cleaved the auxiliary at temperatures above –40 °C. Wittig 
olefination of the aldehyde installed the desired olefin, and removal of the auxiliary by 
basic, then acidic conditions afforded alkylated proline fragment 3-105. Protection of the 
pyrrolidine nitrogen was necessary,27 thus a Boc protecting group was installed (3-106). 
The ester was then reduced with DIBAL and protected as the TBS ether (3-108). Finally, 
efficient removal of the Boc protecting group was achieved with TMSOTf and 2,6-
lutidine to afford pyrrolidine fragment 3-109 ready for reductive amination with the 
oxindole fragment. 
Scheme 3.22. Synthesis of Pyrrolidine Fragment 
 
 
At this point, the viability of the ester homologation procedure required for 
installation of the necessary enone for closure of the azabicyclo[4.2.2]decane system was 
explored. Starting from primary alcohol 3-107, oxidation under Parikh–Doering 
conditions and homologation with trimethyl phosphonoacetate afforded the required α,β-
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unsaturated ester (Scheme 3.23). The conjugated double bond of 3-111 would eventually 
need to be hydrogenated, possibly in the presence of other olefins, and as such the 
reduction was explored. Unfortunately, NaBH4, LiBH4, and NiBH4 were all incapable of 
reducing the enoate. However, treatment of 3-111 with Stryker’s reagent and PDMS 
successfully effected the reduction with complete selectively for the conjugated olefin, 
affording saturated ester 3-62 in high yield.  
Scheme 3.23. Ester Homologation and Reduction 
 
 
Following completion of the pyrrolidine fragment, it was deemed prudent to 
explore alternative options for closure of the eight-membered ring. Thus, several related 
substrates were synthesized, particularly those which could act as nucleophiles (Scheme 
3.24). A pyrrolidine fragment with a latent alkyne was synthesized by homologation of 
aldehyde 3-103 with PPh3 and CBr4. The substrate was carried forward through the same 
sequence of reactions found in Scheme 3.22 to afford pyrrolidine 3-116. Alternatively, 
dibromoolefin 3-115 was converted to the alkyne prior to Boc deprotection by exposure 
to n-BuLi, affording alkynyl-pyrrolidine 3-117. Subsequent hydrostannylation of the 
alkyne was performed and, following Boc deprotection, stannyl-pyrrolidine 3-119 was 
obtained. 
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Scheme 3.24. Alternative Pyrrolidine Fragment Synthesis 
 
 
3.2.4 Fragment Coupling and Attempted Ring Closure 
Pyrrolidine 3-109 and oxindole 3-95 were coupled smoothly via reductive 
amination and the product was subsequently N-Boc protected to afford 3-121 in good 
yield (Scheme 3.25). Analysis of the crude reaction mixture confirmed the previously 
determined enantiomeric purity of the oxindole substrate, as 7% of a separable 
diastereomer was observed by 1H NMR. Addition of vinylmagnesium bromide afforded 
the desired product 3-122 in 50% yield as a 1:1.3 mixture of diastereomers with the mass 
balance being Boc deprotected material (3-120). It was possible to suppress the formation 
of the Boc deprotection by using diethyl ether, as opposed to THF, as the reaction 
solvent. 
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Scheme 3.25. Installation of the Pyrrolidine via Reductive Amination 
 
 
 With compound 3-122 in hand, formation of the 8-membered ring by RCM was 
investigated (Scheme 3.26). Unfortunately, despite attempting multiple different catalysts 
and forcing conditions, only starting material was obtained and no RCM product was 
detected by NMR.  
Scheme 3.26. Attempted RCM for 8-Membered Ring Formation 
 
 
Due to the failure of the RCM event, the previously synthesized alternative 
pyrrolidine fragments (Scheme 3.24) were investigated. Dibromoolefin 3-116 and 
vinylstannane 3-119 were reductively aminated with oxindole 3-95 and subsequently N-
139 
 
 
 
Boc protected to afford substrates 3-125 and 3-126 (Scheme 3.27). Treatment of 
dibromoolefin 3-125 with n-BuLi afforded alkyne 3-127, though in moderate yield. 
Unfortunately, alkyne 3-127 would not undergo nucleophilic addition to the oxindole 
carbonyl upon treatment with base, most likely due to the inability of the alkyne 
nucleophile to approach the carbonyl in the correct geometry. The vinyl stannane 3-126 
was transmetallated with n-BuLi; however, once again no nucleophilic addition was 
observed and only destannylated product 3-121 was recovered.  
Scheme 3.27. Alternative Nucleophilic Addition Attempts 
 
 
3.2.5 Revision of the 8-Membered Ring Closure 
Due to the difficulties encountered with formation of the 8-membered ring, the 
retrosynthetic disconnections were revised (Scheme 3.28). The final ring closure was not 
altered; however, the use of an oxindole substrate was eliminated. Instead, it was believed 
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that a late-stage alkylation with the Corey–Kim reagent would be capable of installing the 
necessary quaternary center at the 3-position.28 It was believed that, though 8-membered 
rings are very flexible, the geometry of the indoloazocine would dictate the correct facial 
selectivity of the alkylation event.  Alternatively, allylation of the 3-position could be 
accomplished through direct allylation as shown by Rawal,29 though lengthy subsequent 
transformations would be necessary to afford the ester. The indoloazocine ring system of 
3-130 could arise through C-H activation or Heck reaction in an intramolecular fashion, 
and the pyrrolidine fragment could be appended to the indole by an SN2 reaction. 
Scheme 3.28. Revised Retrosynthetic Plan 
 
 
To this end, tryptophol (3-132) was converted to primary bromide 3-9 with CBr4 
and PPh3. Microwave heating of a mixture of bromide 3-9, pyrrolidine 3-109, NaI, 
K2CO3 and DMF facilitated the SN2 reaction to afford 3-131. Despite encouraging 
literature precedent for the C-H activation/Heck reaction,30 the desired product was not 
formed and only starting material was obtained. It was believed that the lack of reactivity 
may be due to a failure of the C-H activation event, and thus the indole substrate (3-131) 
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was exposed to bromination conditions to install an activating group. Unfortunately, 
rapid decomposition was observed and thus the route was abandoned. 
Scheme 3.29. Attempted Heck Coupling 
 
 
With the failure of the Heck route, a Friedel–Crafts reaction was investigated. A 
similar route was recently described by Sarpong and coworkers for the synthesis of 
related alkaloids (see Section 3.1.2.3).11 Accordingly, pyrrolidine 3-136 was synthesized 
in a similar manner as the previously described pyrrolidine fragments (Scheme 3.30). 
Pyrrolidine fragment 3-136 was then coupled with indole-3-acetic acid (3-137) and, 
following exhaustive reduction with Red-Al, primary alcohol 3-139 was obtained. 
Attempts at oxidation of the primary alcohol were met with frustration, as a variety of 
oxidation conditions failed to facilitate aldehyde formation. Protection of the indole 
nitrogen as a methyl carbamate failed to improve the situation; however, Swern oxidation 
conditions were found to afford the desired aldehyde (3-140), albeit in low yield. The 
difficulties associated with this oxidation most likely lie with the tertiary amine, as ring-
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expansion chemistry of pyrrolidines to piperidines via an aziridinium can be a facile 
process.31 
Scheme 3.30. Synthesis of Friedel-Crafts Precursor 
 
 
Though the Swern oxidation occurred in low yield, enough material was available 
for further study. Thus, HWE homologation of aldehyde 3-140 afforded enoate 3-141 
(Scheme 3.31). The next step was to oxidatively cleave the terminal olefin; however, it 
proved exceptionally resilient to oxidation as dihydroxylation with K2OsO4 failed to 
deliver the diol under a number of reaction conditions and only starting material was 
obtained.  
Scheme 3.31. Attempted Olefin Cleavage 
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To circumvent the poor yield of the oxidation of the primary alcohol (3-139 to 3-
140) and to effect cleavage of the terminal olefin, studies were conducted on the 
pyrrolidine fragment prior to indole installation (Scheme 3.32). It was discovered that 
oxidative cleavage of the terminal olefin could be accomplished by ozonolysis. Following 
ozonolysis, the aldehyde 3-145 was protected as the dimethylacetal and the ester was 
reduced with DIBAL. Oxidation and HWE homologation afforded 3-148. Removal of the 
Boc group formed secondary amine 3-149, ready for appendage to the indole fragment. 
Unfortunately, it was discovered that amine 3-149 would not undergo amide coupling 
with indole-3-acetic acid due to the increased steric bulk associated with installation of 
the α,β-unsaturated ester moiety. Hindered amines are known to be problematic when 
attempting to form amide bonds.32  
Scheme 3.32. Elaboration of the Pyrrolidine Prior to Coupling 
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3.2.6 Retrosynthesis dealing with C-2 bond formation prior to C-3 
Having encountered difficulties in forming the C-2 attachment, the retrosynthesis 
of grandilodine A was once again revisited (Scheme 3.33). As before, the late stage 
nucleophilic closure through aza-Baylis–Hillmann chemistry would be investigated and 
installation of the quaternary center at the indoline 3-position would be through indole 
addition to the Corey–Kim reagent followed by Pummerer rearrangement. Closure of the 
indoloazocine ring would originate from an intramolecular reductive amination, SN2 
displacement, or amide coupling (3-151). Accordingly, introduction of the pyrrolidine 
portion would be afforded through coupling at the 2-position of indole, rather than the 3 
position.  
Scheme 3.33. Revised Grandilodine A Retrosynthesis 
 
 
Installation of the pyrrolidine fragment at the 2-position of indole was 
investigated first through cross-coupling chemistry. The Sonogashira reaction has been 
successfully applied for the cross-coupling of 2-haloindoles with complex alkyne 
substrates by Fukuyama for the synthesis of aspidophytine33 and by Baran for the 
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synthesis of chartelline C.34 Similarly, it was believed that 2-bromoindole 3-154 would 
undergo Sonogashira coupling with alkyne 3-155 or 3-117 to afford the desired product. 
The requisite 2-bromo and 2-iodoindole substrates 3-15435 and 3-15736 were synthesized 
according to literature procedures. Unfortunately, the Sonogashira reaction was 
unsuccessful as treatment of alkyne 3-155 and indole 3-154 afforded only starting 
material and traces of alkyne dimer. Similar results were obtained whether the pyrrolidine 
nitrogen was protected (3-117) or not (3-155), as well as when the more reactive 2-
iodoindole 3-157 was used as the cross-coupling partner. 
Scheme 3.34. Sonogashira Cross-Coupling for Installation of the Pyrrolidine Fragment 
 
 
Alternatively, a tandem Ullman/Sonsogashira reaction was investigated (Scheme 
3.35). This tandem reaction has been shown to be an effective method for the synthesis of 
2-alkynyl indoles by Lautens.37 To this end, 2-nitrobenzaldehyde (3-158) was treated 
with PPh3 and CBr4 followed by nitro group reduction with SnCl2 to afford anilide 3-159. 
Under the conditions of Lautens, subjection of anilide 3-159 and alkyne 3-117 to the 
reaction conditions resulted only in isolation of starting material, without the observance 
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of any cross-coupled product. A control test was performed with 1-hexyne and the 
reaction was found to proceed as described, affording the alkynylindole in excellent 
yield, indicating that the reaction was substrate specific, rather than suffering from 
irreproducibility. 
Scheme 3.35. Tandem Ullman/Sonogashira Cross Coupling 
 
 
3.2.7 Horner–Wadsworth–Emmons Route 
A new strategy was devised, whereby the indole C-2 position would first be 
joined to the pyrrolidine fragment through HWE chemistry, followed by ring closure at 
the 3-position (See Scheme 3.33). To this end, the 3-position of 2-methyl indole was 
thiolated and the nitrogen was protected as the benzenesulfonamide (Scheme 3.36). Next, 
the phosphonate was installed via radical bromination and subsequent ZnBr2-catalyzed 
Arbuzov reaction. With phosphonate 3-163 in hand, we were delighted to discover that 
the HWE reaction worked as planned, as treatment of a mixture of 3-163 and aldehyde 3-
103 with LiHMDS afforded the desired product (3-164) in 83% yield. Unfortunately, as 
the scale of the reaction was increased, a significant decrease in yield was observed (83% 
at 0.64 mmol scale, 57% at 2.8 mmol scale). Attempts to increase the yield through use of 
modified conditions (LiCl/DBU38 or NaI/DBU39) were unsuccessful and resulted in only 
decomposition of the aldehyde. Cleavage of the oxazolidinone could be achieved as 
previously described through basic, then acidic conditions. Unfortunately, due to time 
constraints, the project was suspended.  
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Scheme 3.36. HWE Route Towards Grandilodine A 
 
 
The current route bears promise, as effective coupling of indole and pyrrolidine 
fragments has been achieved. Further study is required to successfully elaborate 3-165 
and determine if the route is viable for the total synthesis of grandilodine A.  
In a forward-looking scence, the current route being investigated has been 
summarized below in Scheme 3.37. The benzenethiol protecting group and the internal 
olefin in HWE product 3-165 would be reduced using Ranney nickel and hydrogen to 
afford 3-166. Subsequent Michael addition of the secondary amine in 3-166 to phenyl 
vinyl sulfoxide followed by Pummerer rearrangement and reduction would afford the 
necessary 2-carbon bridge, forming the 8-membered ring in 3-167. A partial reduction of 
the ester present in 3-167, followed by HWE homologation would afford 3-168 which, 
upon treatment with the Corey–Kim reagent, would yield the necessary quaternary 
stereocenter. An aza-Baylis–Hillman reaction would then close on the generated imine, 
generating the azabicyclo[2.2.4]decane ring system (3-170). All that would remain would 
be functional group manipulations: oxidation of the thioether, Pummerer rearrangement 
and further oxidation to afford the methyl ester present in 3-171 and installation of the 
148 
 
 
 
carbamate on the indoline nitrogen using methyl chloroformate, affording grandilodine 
A. 
Scheme 3.37. Future Work Towards Grandilodine A 
 
3.3 Summary and Outlook 
The grandilodines are structurally and biologically fascinating natural products 
that will continue to provide inspiration for chemists to develop new strategies and 
methods for their effective formation. Enclosed herein we have described multiple routes 
toward the synthesis of the grandilodine A. We have developed an effective procedure for 
formation of a variety of pyrrolidine fragments, which may be of use for future synthesis 
of the natural product. The most recently explored route bears promise; however, many 
synthetic transformations remain to be completed. 
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3.4 Experimental 
3.4.1 General Experimental Details 
All reactions were run under an argon atmosphere. Flasks were oven dried and 
cooled in a dessicator prior to use. Solvents and reagents were purified by standard 
methods.40 Dichloromethane and toluene were purified by passing the solvent through 
activated alumina columns. All other chemicals were of reagent quality and used as 
obtained from commercial sources unless otherwise noted. The progress of reactions was 
monitored by thin layer chromatography performed on F254 silica gel plates. The plates 
were visualized by UV light (254 nm) or by staining with ceric ammonium molybdate,41 
or KMnO4. Column chromatography was performed with Silica Flash P60 60 Å silica gel 
from Silicycle according to the Still method.42 
The 1H and 13C NMR data were obtained on 400 or 600 MHz spectrometers. All 
spectra were obtained in deuterated chloroform and were referenced to the residual 
chloroform at δ 7.25 ppm for 1H spectra and the center peak of the triplet at δ 77.0 for 13C 
spectra. EI mass spectra were obtained on a Finnigan MAT 8200 spectrometer at an 
ionizing voltage of 70 eV. 
3.4.2 Experimental Details 
2-oxindole (3-64) 
Isatin (15 g, 102 mmol, 1 equiv) was added to hydrazine hydrate (60 mL) 
and the solution was heated to reflux. After 4 h the reaction mixture was 
cooled to room temperature, poured into an ice/water mixture and acidified with 6 M 
HCl. After sitting at room temperature for 2 days the resulting brown-orange solids were 
collected by vacuum filtration, washed with water, and dried under vacuum to afford 2-
oxindole as a brown-orange solid (8.85 g, 65%). 1H NMR (400 MHz, CDCl3)  8.64 (br. 
s., 1 H), 7.16 - 7.25 (m, 2 H), 6.96 - 7.05 (m, 1 H), 6.88 (d, J = 8.2 Hz, 1 H), 3.54 (s, 2 
H); 13C NMR (101 MHz, CDCl3) δ 184.33, 139.87, 136.24, 127.60, 122.53, 122.39, 
109.94, 44.70, 24.27 . 1H and 13C NMR spectra were in agreement with previously 
reported data.43  
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3,3-dimethyl-2-oxindole (3-65) 
To a solution of 2-oxindole (1.5 g, 11.3 mmol, 1 equiv) and LiCl (1.18 g, 
27.9 mmol, 2.47 equiv) in THF (50 mL) at 0 °C was added nBuLi (2.35 M, 
10 mL, 23.7 mmol, 2.1 equiv). After 20 min MeI (1.40 mL, 22.5 mmol, 2 
equiv) was added and the reaction mixture was allowed to warm to room temperature. 
After 16 h the reaction mixture was diluted with ½ saturated NH4Cl and Et2O and the 
layers were separated. The aqueous layer was extracted with Et2O (3 x 20 mL), the 
combined organic layers were washed with brine, dried over MgSO4, filtered through 
celite, and concentrated in vacuo. The residue was then purified by flash column 
chromatography (2:1 hexanes/EtOAc) to afford the title compound as a waxy white solid 
(830 mg, 46%). Rf 0.37 (2:1 hexanes/EtOAc); 1H NMR (600 MHz, CDCl3)  9.74 (br. s., 
1 H), 7.15 - 7.23 (m, 2 H), 7.04 (t, J = 7.9 Hz, 1 H), 7.00 (d, J = 7.6 Hz, 1 H), 1.43 (s, 6 
H); 13C NMR (151 MHz, CDCl3)  184.7, 140.0, 136.2, 127.6, 122.4, 122.3, 110.1, 44.7, 
24.2; LRMS m/z 161.2 (calcd for C10H11NO, 161.0841). 
 
Compound 3-67 
To a solution of oxindole 2-65 (65 mg, 0.5 mmol, 1.0 equiv) and 2,6-
lutidine (93 μL, 0.80 mmol, 1.5 equiv) in CH2Cl2  (5 mL) at 0 °C was added 
oxalyl chloride (43 μL, 0.5 mmol, 1 equiv). After 15 min the reaction mixture was diluted 
with Et2O and filtered and concentrated in vacuo to afford the iminochloride as a 
moisture sensitive yellow oil (90 mg, quant.) that was used without further purification. 
1H NMR (400 MHz, CDCl3) 8.10 (d, J = 7.8 Hz, 1 H), 7.29 - 7.43 (m, 3 H), 1.53 (s, 6 
H. 
 
Compound 3-68 
To a solution of 3,3-dimethyl-2-oxindole (3-65, 559 mg, 3.47 mmol, 1.0 
equiv) in CH2Cl2 (10 mL)was added Boc2O (0.957 mL, 4.2 mmol, 1.3 
equiv). After 18 h the solvent was removed in vacuo and the residue was 
purified by column chromatography to afford compound 3-68 as a waxy white solid (816 
mg, 90% ). Rf 0.38 (5:1 hexanes/EtOAc); 1H NMR (400 MHz, CDCl3)  7.85 (d, J = 8.2 
Hz, 1 H), 7.27 - 7.31 (m, 1 H), 7.14 - 7.24 (m, 2 H), 1.66 (s, 9 H), 1.43 (s, 6 H); 13C NMR 
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(101 MHz, CDCl3)  179.8, 149.5, 138.3, 134.6, 127.9, 124.5, 122.2, 115.0, 84.2, 44.5, 
28.1, 25.3; HRMS m/z 261.1369 (calcd for C15H19NO3, 261.1365). 
 
Compound 3-69 
 To a solution of 3-68 (125 mg, 0.47 mmol, 1.0 equiv) in THF (5 mL) was 
added vinyl magnesium bromide (0.72 M in Et2O, 2 mL, 1.42 mmol, 3.0 
equiv). After 30 min the reaction mixture was diluted with ½ saturated 
NH4Cl and Et2O and the layers were separated. The aqueous layer was extracted with 
Et2O (2 x 10 mL) and the combined organic layers were washed with brine, dried over 
MgSO4, filtered through celite, and concentrated in vacuo. The residue was then purified 
by flash column chromatography (10:1hexanes/EtOAc) to afford the title compound as a 
colorless oil (68 mg, 50%). Rf 0.63 (5:1 hexanes/EtOAc); 1H NMR (400 MHz, CDCl3)  
7.58 (br. s., 1 H), 7.15 - 7.22 (m, 1 H), 7.10 - 7.15 (m, 1 H), 6.98 - 7.06 (m, 1 H), 5.98 
(dd, J = 10.6, 17.2 Hz, 1 H), 5.40 (dd, J = 1.2, 17.2 Hz, 1 H), 5.25 (dd, J = 1.0, 10.7 Hz, 1 
H), 1.60 (s, 9 H), 1.30 (s, 3 H), 1.19 (s, 3 H); 13C NMR (101 MHz, CDCl3)  153.2, 
139.2, 138.6, 138.4, 127.6, 123.1, 122.1, 114.5, 114.4, 97.5, 82.6, 47.4, 28.4, 24.4, 23.8; 
HRMS m/z 289.1683 (calcd for C15H19NO3, 289.1678). 
 
Compound 3-63 
 To a solution of 2-oxindole (6.66 g, 50 mmol, 1.0 equiv) and Et3N (18.2 
mL, 130 mmol, 3.0 equiv) in THF (100 mL) at 0 °C was added methyl 
chloroformate (9.6 mL, 125 mmol, 2.5 equiv) dropwise. The reaction 
mixture was allowed to warm to room temperature and after 30 min the solvent was 
removed in vacuo. The residue was dissolved in CH2Cl2 (100 mL) and washed with ½ 
saturated NaHCO3 (50 mL), the aqueous layer was extracted with CH2Cl2 (50 mL) and 
the combined organic layers were dried over MgSO4, filtered through celite and the 
solvent was removed in vacuo to afford the N,O-bismethylformate product (3-76, 12.0 g, 
96%) that was used without further purification. To the N,O-bismethyl formate (10.88 g, 
43.7 mmol, 1.0 equiv) in PhMe (150 mL) was added DMAP (5.33 g, 43.6 mmol, 1.0 
equiv). After 30 min CH2Cl2 (50 mL) was added, followed by 1 M HCl (50 mL) and the 
layers were separated. The aqueous layer was extracted with CH2Cl2 (3 x 50 mL) and the 
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organic layers were combined, dried over MgSO4, filtered through celite and the solvent 
was removed in vacuo. The residue was purified by column chromatography (2:1 
hexanes/EtOAc) to afford the title compound (1.88 g, 17%) as a waxy blue solid as a 
1.2:1 mixture of keto and enol forms. Rf 0.34 (1:1 hexanes/EtOAc);  
Keto form: 1H NMR (600 MHz, CDCl3)  7.93 (d, J = 8.2 Hz, 1 H), 7.36 - 7.40 (m, 1 H), 
0 7.19 - 7.24 (m, 2 H), 4.57 (s, 1 H), 4.02 (s, 3 H), 3.78 (s, 3 H);  
Enol form: 1H NMR (600 MHz, CDCl3)  8.00 (d, J = 7.6 Hz, 1 H), 7.75 (d, J = 7.6 Hz, 1 
H), 7.36 - 7.40 (m, 1 H), 7.26 - 7.29 (m, 1 H), 4.10 (s, 3 H), 3.99 (s, 3 H). 
Due to the interconverison of the two compounds, 13C spectra could not be correlated to 
either of the specific compounds.13C NMR (101 MHz, CDCl3)  168.9, 168.2, 166.4, 
160.0, 151.0, 140.1, 129.9, 129.4, 128.1, 124.9, 124.4, 124.2, 124.0, 123.0, 122.0, 119.2, 
115.4, 115.1, 114.6, 88.0, 54.3, 54.0, 53.2, 52.7, 51.6; HRMS m/z 249.0634 (calcd for 
C12H11NO5, 249.0637). 
 
Compound 3-81 
 To a solution of indole (11.7 g, 100 mmol, 1.0 equiv) in Et2O (200 mL) 
at 0 °C was added oxalyl chloride (10.3 mL, 120 mmol, 1.2 equiv) 
dropwise and the reaction was warmed to room temperature. After 1 h 
ethanol (19.1 mL, 500 mmol, 5.0 equiv) was added to the reaction mixture. After 16 h the 
reaction mixture was diluted with H2O (100 mL) and the solids were isolated by vacuum 
filtration. The solids were washed with H2O (50 mL), cold Et2O (50 mL) and then dried 
under vacuum to afford the product as a tan to pale pink powder (19.2 g, 88%). 1H NMR 
(400 MHz, (CD3)2SO)  12.40 (br. s., 1 H), 8.42 (d, J = 3.1 Hz, 1 H), 8.13 - 8.17 (m, 1 
H), 7.46 - 7.58 (m, 1 H), 7.15 - 7.32 (m, 2 H), 4.34 (q, J = 7.0 Hz, 2 H), 1.31 (t, J = 7.0 
Hz, 3 H); 13C NMR (101 MHz, (CD3)2SO)  179.5, 164.0, 138.7, 137.1, 125.9, 124.3, 
123.3, 121.6, 113.2, 112.8, 62.0, 14.4.  
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Compound 3-82 
 To a slurry of LiAlH4 (2.62 g, 69 mmol, 3.0 equiv) in THF (50 mL) at 0 
°C was added the glyoxylate (5.0 g, 23 mmol, 1.0 equiv) portionwise. 
Upon completion of the glyoxylate addition, the reaction mixture was 
warmed to room temperature for 1 h, then heated to reflux. After 2 h at reflux the reaction 
mixture was cooled to 0 °C and diluted with diethyl ether (100 mL) and H2O (2.62 mL) 
was added dropwise, followed by 15% aqueous NaOH (2.62 mL), and H2O (7.86 mL). 
The reaction mixture was warmed to room temperature and after 15 min the solids were 
removed by filtration. After concentration in vacuo the product was obtained as a 
colorless oil that slowly solidified on standing (3.52 g, 95%) that was used without 
further purification. 1H NMR (400 MHz, CDCl3)  8.28 (br. s., 1 H), 7.63 (d, J = 7.8 Hz, 
1 H), 7.31 - 7.37 (m, 1 H), 7.23 (t, J = 6.8 Hz, 1 H), 7.13 - 7.19 (m, 1 H), 6.97 (d, J = 2.3 
Hz, 1 H), 3.89 (t, J = 6.1 Hz, 2 H), 3.02 (t, J = 6.4 Hz, 2 H), 2.18 (br. s., 1 H); 13C NMR 
(101 MHz, CDCl3)  136.3, 127.2, 122.6, 121.9, 119.2, 118.6, 111.9, 111.2, 62.4, 28.5. 
1H and 13C NMR spectra were in agreement with previously reported data.44 
 
Compound 3-83 
 To a solution of the indole (2.54 g, 15.8 mmol, 1.0 equiv) in DMSO (8 
mL) in a room temperature water bath was added conc. HCl (11 mL) 
dropwise. After 3 h the dark mixture was poured into an ice/water mixture 
(80 mL) and the pH was adjusted to ~7 by addition of a conc. NaOH solution. The 
aqueous solution was extracted with EtOAc (2 x 30 mL) and the combined organic layers 
were washed with brine (2 x 30 mL), dried over MgSO4, filtered and concentrated in 
vacuo to afford the title compound as a orange semisolid (2.06 g, 74%) that was used 
without further purification. 1H NMR (400 MHz, CDCl3)  8.74 (br. s., 1 H), 7.19 - 7.25 
(m, 2 H), 7.03 - 7.08 (m, 1 H), 6.91 (d, J = 7.4 Hz, 1 H), 3.91 (q, J = 5.1 Hz, 2 H), 3.63 
(dd, J = 4.9, 8.4 Hz, 1 H), 3.28 (br. s., 1 H), 2.21 - 2.31 (m, 1 H), 2.06 - 2.14 (m, 1 H); 13C 
NMR (101 MHz, CDCl3)  181.3, 141.2, 129.4, 128.1, 124.0, 122.6, 109.9, 60.8, 44.8, 
33.1; 1H and 13C NMR spectra were in agreement with previously reported data.45 
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Compound 3-84 
 To a solution of alcohol 3-83 (16.7 g, 94.4 mmol, 1.0 equiv) and 
imidazole (12.6 g, 188.8 mmol, 2.0 equiv) in CH2Cl2 (100 mL) was 
added TBSCl (17.07 g, 113.3 mmol, 1.2 equiv). After complete 
consumption of the starting material (as indicated by TLC) H2O (100 mL) was added and 
the layers were separated. The aqueous layer was extracted with CH2Cl2 (2 x 40 mL) and 
the combined organic layers were dried over MgSO4, filtered, and concentrated in vacuo. 
The residue was purified by flash column chromatography (3:1 hex/EtOAc) to afford the 
title compound as a pale yellow oil (23.6 g, 86%). Rf 0.30 (2:1 hexanes/EtOAc); 1H NMR 
(400 MHz, CDCl3)  9.27 (s, 1 H), 7.24 (d, J = 7.4 Hz, 1 H), 7.16 - 7.23 (m, 1 H), 6.98 - 
7.04 (m, 1 H), 6.91 (d, J = 7.4 Hz, 1 H), 3.74 - 3.87 (m, 2 H), 3.62 (t, J = 6.6 Hz, 1 H), 
2.17 - 2.28 (m, 1 H), 2.10 (dq, J = 6.7, 13.6 Hz, 1 H), 0.86 (s, 9 H), 0.01 (s, 3 H), 0.00 (s, 
3 H); 13C NMR (101 MHz, CDCl3)  181.2, 141.7, 129.5, 127.7, 124.3, 122.0, 109.8, 
59.7, 42.9, 33.2, 25.9, 18.2, -5.5, -5.5; LRMS m/z 291.3 (calc’d for C16H25NO2Si, 
291.1655). 
 
Compound 3-86 
 To a solution of oxindole 3-84 (2.55 g, 8.75 mmol, 1.0 equiv) in THF 
(25 mL) at - 20 °C was added LiHMDS (1.0 M in THF, 9.62 mL, 9.62 
mmol, 1.1 equiv). After 20 min acyl imidazole 3-85 (1.21 g, 9.62 mmol, 
1.1 equiv) in THF (8 mL) was added dropwise and the reaction mixture was allowed to 
warm to 0 °C. After 3 h at 0 °C acetic acid (2.2 mL) in THF (8 mL) was added, the 
reaction mixture was diluted with water (15 mL), EtOAc (15 mL) and the layers were 
separated. The aqueous layer was extracted with EtOAc (2 x 20 mL) and the combined 
organic layers were washed with brine, dried over MgSO4, filtered through celite and 
concentrated in vacuo. The residue was purified by flash column chromatography (5:1 
hex/EtOAc) to afford the title compound as a pale yellow oil (2.00 g, 65%). Rf 0.27 (5:1 
hex/EtOAc); 1H NMR (400 MHz, CDCl3)  7.94 (d, J = 7.8 Hz, 1 H), 7.29 - 7.35 (td, J = 
0.8, 7.4 Hz, 1 H), 7.25 (d, J = 6.6 Hz, 1 H), 7.15 - 7.21 (td, J = 0.8, 7.4 Hz, 1 H), 4.00 (s, 
3 H), 3.67 - 3.78 (m, 3 H), 2.23 - 2.33 (m, 1 H), 2.13 - 2.23 (m, 1 H), 0.82 (s, 9 H), -0.04 
(s, 3 H), -0.07 (s, 2 H); 13C NMR (101 MHz, CDCl3)  176.0, 151.7, 139.9, 128.1, 127.5, 
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124.4, 123.8, 115.1, 59.2, 53.6, 42.8, 33.6, 25.8, 18.2, -5.7, -5.7; HRMS m/z 349.1654 
(calc’d for C18H27NO4Si, 349.1709). 
 
Compound 3-87 
 To a solution of oxindole 3-86 (1.09 g, 3.1 mmol, 1.0 equiv), 
organocatalyst 3-79 (50 mg, 0.155 mmol, 5 mol %) in CH2Cl2 (25 mL) 
was added paraformaldehyde (280 mg, 9.3 mmol, 3.0 equiv). After 18 h 
the solvent was removed in vacuo and the residue was purified by flash 
column chromatography (1:1 hex/EtOAc) to afford the title compound as a white foam 
(1.11 g, 96%, 86% ee by Mosher’s ester). Rf 0.34 (1:1 hex/EtOAc); 1H NMR (400 MHz, 
CDCl3)  7.99 (d, J = 8.2 Hz, 1 H), 7.36 (ddd, J = 1.8, 7.0, 8.4 Hz, 1 H), 7.19 - 7.27 (m, 2 
H), 3.97 (s, 3 H), 3.77 - 3.88 (m, 2 H), 3.57 (ddd, J = 3.7, 5.2, 10.3 Hz, 1 H), 3.43 (td, J = 
3.9, 10.4 Hz, 1 H), 2.39 - 2.49 (m, 2 H), 1.95 (dt, J = 3.9, 14.2 Hz, 1 H), 0.75 (s, 9 H), -
0.14 (s, 3 H), -0.17 (s, 3 H); 13C NMR (101 MHz, CDCl3)  177.4, 151.5, 140.0, 128.7, 
128.6, 124.6, 123.2, 115.3, 68.4, 58.9, 53.6, 53.1, 36.0, 25.7, 18.1, -6.0 (x 2); HRMS m/z 
380.1891 (calc’d for C19H29NO5Si+H+, 380.1888). 
 
Compound 3-88 
 To a solution of oxindole 3-87 (200 mg, 0.527 mmol, 1.0 equiv) and 
paramethoxybenzyl (300 mg, 1.05 mmol, 2.0 equiv) in CH2Cl2 (5 mL) 
was added 10•CSA (6.1 mg, 0.026 mmol, 5 mol %). Following complete 
consumption of the starting material as indicated by TLC, the reaction 
mixture was diluted with CH2Cl2 (10 mL) and ½ saturated NaHCO3 (5 mL) and the 
layers were separated. The aqueous layer was extracted with CH2Cl2 (2 x 10 mL) and the 
combined organic layers were dried over MgSO4, filtered through celite and concentrated 
in vacuo. The residue was then purified by flash column chromatography (5:1 
hex/EtOAc) to afford the title compound as a pale yellow oil (263 mg, 99%). Rf 0.29 (3:1 
hex/EtOAc); 1H NMR (600 MHz, CDCl3)  7.99 (d, J = 8.2 Hz, 1 H), 7.32 - 7.36 (m, 1 
H), 7.15 - 7.21 (m, 2 H), 7.02 (d, J = 8.8 Hz, 2 H), 6.80 (d, J = 8.8 Hz, 2 H), 4.37 (d, J = 
12.3 Hz, 1 H), 4.27 (d, J = 11.7 Hz, 1 H), 3.99 (s, 3 H), 3.80 (s, 3 H), 3.61 - 3.67 (m, 2 
H), 3.48 (ddd, J = 3.5, 6.0, 9.8 Hz, 1 H), 3.28 (td, J = 4.7, 10.2 Hz, 1 H), 2.28 (ddd, J = 
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5.9, 10.2, 13.8 Hz, 1 H), 1.98 (dt, J = 4.1, 14.1 Hz, 1 H), 0.72 (s, 9 H), -0.19 (s, 3 H), -
0.22 (s, 3 H); 13C NMR (101 MHz,CDCl3)  176.7, 159.0, 151.7, 140.2, 129.8, 129.2, 
128.9, 128.2, 124.2, 123.4, 115.1, 113.6, 74.9, 72.9, 59.0, 55.2, 53.5, 52.4, 36.1, 25.7, 
18.1, -6.0, -6.1; HRMS m/z 499.2378 (calc’d for C27H37NO6Si, 499.2390). 
 
Compound 3-89 
 To a solution of Moc protected oxindole 3-88 (131 mg, 0.262 mmol, 
1.0 equiv) in MeOH (2 mL) was added NaOMe (25 wt % in MeOH, 
0.29 mL, 0.29 mmol, 1.1 equiv). After 30 min, the reaction mixture was 
diluted with ½ sat NH4Cl (2 mL), EtOAc (5 mL) and the layers were 
separated. The aqueous layer was extracted with EtOAc (2 x 5 mL) and the combined 
organic layers were washed with brine, dried over MgSO4, filtered, and concentrated in 
vacuo to afford the free N-H oxindole (116 mg, 99%) as a colorless syrup that was used 
without further purification. Rf 0.26 (3:1 hexanes/EtOAc); 1H NMR (600 MHz, CDCl3)  
8.75 (br. s., 1 H), 7.20 - 7.24 (m, 2 H), 7.07 (d, J = 8.8 Hz, 2 H), 7.03 (t, J = 7.0 Hz, 1 H), 
6.91 (d, J = 7.6 Hz, 1 H), 6.78 - 6.83 (m, 2 H), 4.40 (d, J = 11.7 Hz, 1 H), 4.33 (d, J = 
11.7 Hz, 1 H), 3.77 (s, 3 H), 3.70 (d, J = 9.4 Hz, 1 H), 3.64 (d, J = 8.8 Hz, 1 H), 3.43 (dd, 
J = 5.9, 7.0 Hz, 2 H), 2.14 - 2.22 (m, 1 H), 2.06 - 2.12 (m, 1 H), 0.78 (s, 9 H), -0.12 (s, 2 
H), -0.13 (s, 3 H); 13C NMR (151 MHz, CDCl3)  180.6, 159.0, 141.4, 131.1, 130.1, 
128.9, 127.8, 124.1, 122.0, 113.6, 109.6, 74.2, 73.0, 59.1, 55.2, 52.6, 35.8, 25.8, 18.1, -
5.7, -5.8; HRMS m/z 441.2331 (calc’d for C25H35NO4Si, 441.2335). 
 
Compound 3-90 
To a solution of oxindole 3-89 (53 mg, 0.120 mmol, 1.0 equiv) in THF () 
3 mL) at -78 °C was added LiHMDS (0.91 M, 198 μL, 0.18 mmol, 1.5 
equiv). After 30 min Boc2O (55 μL, 0.24 mmol, 2.0 equiv) and the 
reaction mixture was allowed to warm to room temperature. After 1 h at 
room temperature the reaction mixture was diluted with a ½ saturated NH4Cl solution (3 
mL) and EtOAc (5 mL). The layers were separated and the aqueous layer was extracted 
with EtOAc (2 x 5 mL) and the organic layers were combined, washed with brine, dried 
over MgSO4, filtered through celite and concentrated in vacuo. The residue was purified 
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by column chromatography (5:1 hexanes/EtOAc) to afford the title compound as a 
colorless oil (45 mg, 90%). Rf 0.18 (5:1 hexanes/EtOAc); 1H NMR (400 MHz, CDCl3-d) 
 8.08 (d, J = 8.2 Hz, 1 H), 7.51 (td, J = 1.6, 7.8 Hz, 1 H), 7.38 - 7.43 (m, 1 H), 7.32 - 
7.38 (m, 1 H), 7.23 - 7.28 (m, 2 H), 6.99 - 7.04 (m, 2 H), 4.58 (d, J = 12.1 Hz, 1 H), 4.49 
(d, J = 12.1 Hz, 1 H), 3.99 (s, 3 H), 3.79 - 3.86 (m, 2 H), 3.68 (ddd, J = 3.5, 6.2, 10.3 Hz, 
1 H), 3.50 (td, J = 4.9, 10.1 Hz, 1 H), 2.47 (ddd, J = 6.1, 9.8, 13.9 Hz, 1 H), 2.22 (dt, J = 
4.2, 13.8 Hz, 1 H), 1.84 (s, 9 H), 0.93 (s, 9 H), 0.02 (s, 3 H), 0.00 (s, 3 H); 13C NMR (101 
MHz, CDCl3)  176.8, 159.0, 149.4, 140.4, 130.0, 129.2, 128.9, 128.0, 123.7, 123.6, 
114.9, 113.6, 83.6, 75.0, 72.9, 59.0, 55.2, 52.3, 35.9, 28.1, 25.8, 18.2, -5.9, -5.9. 
 
Compound 3-91 
To a solution of oxindole 3-90 (45 mg, 0.083 mmol, 1.0 equiv) in THF (3 
mL) at -78 °C was added vinyl magnesium bromide (0.72 M solution in 
Et2O, 0.35 mL, 0.25 mmol, 3.0 equiv) and, after 15 min, the reaction 
mixture was allowed to warm to room temperature. After 2 h at room 
temperature the reaction mixture was diluted with ½ saturated NH4Cl (3 mL) and Et2O (5 
mL) and the layers were separated. The aqueous layer was extracted with Et2O (2 x 5 
mL) and the combined organic layers were washed with brine, dried over MgSO4, filtered 
through celite and the solvent was removed in vacuo. The residue was purified by column 
chromatography (7:1 hexanes/EtOAc) to afford the product as a pale yellow oil (18 mg, 
50%) as an inseparable mixture of two diastereomers. Rf 0.46 (6:1 hexanes/EtOAc); See 
spectra for 1H NMR and 13C NMR; LRMS m/z 569 (calc’d for C32H47NO6Si, 569.3173).  
 
Compound 3-92 
To a solution of 3-90 (50 mg, 0.092 mmol, 1.0 equiv) in EtOH (1.5 mL) 
was added 10•CSA. After 1 h the reaction mixture was diluted with ½ 
saturated NaHCO3 (2 mL) and CH2Cl2 (5 mL) and the layers were 
separated. The aqueous layer was extracted with CH2Cl2 (2 x 5 mL) and the 
organic layers were combined and dried over MgSO4, filtered through celite and 
concentrated in vacuo. The residue was purified by flash column chromatography (2:1 
hexanes/EtOAc) to afford the title compound as a sticky syrup (39 mg, quant.); Rf 0.52 
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(1:2 hexanes/EtOAc); 1H NMR (600 MHz, CDCl3)  8.23 (br. s., 1 H), 7.73 (d, J = 7.6 
Hz, 1 H), 7.28 - 7.35 (m, 2 H), 7.24 (d, J = 8.8 Hz, 2 H), 7.10 (t, J = 7.6 Hz, 1 H), 6.87 - 
6.93 (m, 2 H), 4.49 - 4.57 (m, 2 H), 4.35 (td, J = 4.7, 8.5 Hz, 1 H), 4.08 - 4.16 (m, 1 H), 
3.88 - 3.96 (m, 2 H), 3.82 (s, 3 H), 2.85 (ddd, J = 4.1, 7.0, 13.5 Hz, 1 H), 2.60 (dt, J = 8.2, 
12.9 Hz, 1 H), 1.48 (s, 9 H); 13C NMR (101 MHz, CDCl3)  178.6, 159.5, 153.8, 136.6, 
129.6, 128.9, 128.8, 127.5, 126.6, 124.9, 113.9, 80.0, 74.7, 73.6, 66.5, 55.2, 52.3, 33.3, 
28.4, 28.2; HRMS m/z 427.1990 (calc’d for C24H29NO6, 427.1995). 
 
Compound 3-93 
 To a solution of free N-H oxindole 3-89 (2.018 g, 4.57 mmol, 1.0 equiv) 
in EtOH (10 mL) was added 10•CSA (106 mg, 0.457 mmol, 10 mol %). 
After 1 h the reaction mixture was diluted with CH2Cl2 (20 mL) and a ½ 
saturated solution of NaHCO3 (5 mL) and the layers were separated. The 
aqueous layer was extracted with CH2Cl2 (2 x 10 mL) and the combined organic layers 
were dried over MgSO4, filtered through celite and concentrated in vacuo. The residue 
was purified by flash column chromatography (100% EtOAc) to afford the title 
compound as a sticky syrup (1.49 g, quant.); Rf 0.35 (100% EtOAc); 1H NMR (600 MHz, 
CDCl3)  7.21 - 7.26 (m, 2 H), 7.08 - 7.12 (m, 2 H), 7.03 - 7.08 (m, 1 H), 6.90 (d, J = 7.6 
Hz, 1 H), 6.79 - 6.86 (m, 2 H), 4.42 (d, J = 12.3 Hz, 1 H), 4.35 (d, J = 11.7 Hz, 1 H), 3.79 
(s, 3 H), 3.73 (d, J = 8.8 Hz, 1 H), 3.65 (d, J = 8.8 Hz, 1 H), 3.61 (br. s., 1 H), 3.49 (br. s., 
1 H), 2.17 - 2.23 (m, 1 H), 2.10 (dt, J = 5.9, 14.1 Hz, 1 H), 1.58 - 1.67 (m, 1 H); 13C 
NMR (101 MHz, CDCl3)  180.9, 159.1, 140.8, 131.3, 129.8, 129.0, 128.2, 124.2, 122.4, 
113.7, 109.8, 73.5, 73.1, 59.0, 55.2, 52.6, 36.1; HRMS m/z 327.1474 (calc’d for 
C19H21NO4, 327.1471). 
 
Compound 3-94 
 To a solution of alcohol 3-93 (423 mg, 1.3 mmol, 1.0 equiv) in EtOAc 
(10 mL) was added IBX (1.09 g, 3.9 mmol, 3.0 equiv) and the resulting 
reaction mixture was heated to reflux for 3 h. The reaction mixture was 
then cooled to 0 °C, filtered, and the solids were rinsed with cold EtOAc 
(10 mL). The filtrates were combined and concentrated in vacuo to afford the aldehyde as 
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an orange gum (423 mg, quant.) that was used without further purification. Rf 0.35 (1:2 
hexanes/EtOAc); 1H NMR (400 MHz, CDCl3)  9.55 (d, J = 0.8 Hz, 1 H), 8.11 (s, 1 H), 
7.20 - 7.27 (m, 2 H), 7.08 - 7.14 (m, 2 H), 6.98 - 7.05 (m, 1 H), 6.91 (d, J = 7.4 Hz, 1 H), 
6.80 - 6.87 (m, 2 H), 4.33 - 4.46 (m, 2 H), 3.79 (s, 3 H), 3.70 (d, J = 8.6 Hz, 1 H), 3.53 (d, 
J = 9.0 Hz, 1 H), 3.17 (dd, J = 18.0, 1.6 Hz, 1 H), 2.9 (dd, J = 18.0, 0.8 Hz, 1 H); 13C 
NMR (101 MHz, CDCl3)  198.4, 178.8, 159.2, 140.8, 130.5, 129.6, 129.1, 128.5, 124.1, 
122.5, 113.7, 109.8, 73.3, 73.2, 55.2, 50.4, 46.8; LRMS m/z 326.2 (calc’d for C19H19NO4, 
325.1314). 
 
Compound 3-6 
 A mixture of L-(-) S-proline (11.52 g, 100 mmol, 1.0 equiv), chloral 
hydrate (19.84 g, 120 mmol, 1.2 equiv) and 4 Å molecular sieves in 
acetonitrile (200 mL) was heated to 90 °C. After 2.5 h the mixture was 
cooled to room temperature, filtered through a celite pad and the celite pad was rinsed 
with CH2Cl2 (100 mL). The solution was concentrated in vacuo and the residue was taken 
up in diethyl ether (125 mL) and filtered through a celite pad. The solution was 
concentrated in vacuo until solids began to form, at which point diethyl ether was added 
until the solids remained in solution at 40 °C. The orange solution was cooled to room 
temperature, then 0 °C to fully precipitate the product. The crystals were collected by 
vacuum filtration, washed with cold diethyl ether, and dried under vacuum to afford the 
title compound (15.15 g, 60%) as pale orange crystals. 1H NMR (400 MHz, CDCl3)  
5.17 (s, 1 H), 4.12 (dd, J = 4.7, 8.6 Hz, 1 H), 3.43 (ddd, J = 5.9, 7.8, 10.9 Hz, 1 H), 3.13 
(dt, J = 5.9, 11.2 Hz, 1 H), 2.18 - 2.29 (m, 1 H), 2.07 - 2.16 (m, 1 H), 1.89 - 1.99 (m, 1 
H), 1.69 - 1.81 (m, 1 H); 13C NMR (101 MHz, CDCl3)  175.4, 103.6, 62.4, 57.9, 41.8, 
29.9, 25.3. 1H and 13C NMR spectra were in agreement with previously reported data.46 
 
Compound 3-103 
 To a freshly prepared solution of LDA (15 mmol, 1.5 equiv) in THF (50 
mL) at -78 °C was added oxazolidine 3-6 (2.55 g, 10 mmol, 1.0 equiv) as a 
solid. After 30 min at -78 °C methyl formate (2.45 mL, 40 mmol, 4.0 equiv) 
was added over 5 min and after 20 min the reaction mixture was warmed to -40 °C. After 
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30 min at -40 °C a ½ saturated solution of NH4Cl (30 mL) was quickly added and the 
reaction mixture was warmed to room temperature. The aqueous layer was extracted with 
Et2O (3 x 30 mL), the combined organic layers were washed with brine, dried over 
MgSO4, filtered through celite, and concentrated in vacuo. The residue was then purified 
by flash column chromatography (6:1 to 3:1 hex/EtOAc) to afford the title compound as a 
waxy white solid (1.90 g, 70%). Rf 0.24 (4:1 hexanes/EtOAc); 1H NMR (400 MHz, 
CDCl3)  9.60 (s, 1 H), 5.20 (s, 1 H), 3.54 (ddd, J = 6.3, 7.8, 11.3 Hz, 1 H), 3.34 (dt, J = 
6.0, 11.5 Hz, 1 H), 2.26 - 2.43 (m, 2 H), 1.92 - 2.02 (m, 1 H), 1.79 - 1.92 (m, 1 H); 13C 
NMR (101 MHz, CDCl3)  193.5, 169.3, 102.3, 99.9, 78.1, 58.9, 33.9, 25.4. 1H and 13C 
NMR spectra were in agreement with previously reported data.47 
 
Compound 3-104 
 To a solution of tBuOK (247 mg, 2.2 mmol, 1.2 equiv) in THF (15 mL) 
was added Ph3PMeI (890 mg, 2.2 mmol, 1.2 equiv). After 30 min the bright 
yellow mixture was cooled to -78 °C and aldehyde 3-103 (500 mg, 1.83 
mmol, 1.0 equiv) was added as a solid. After 30 min the reaction mixture was slowly 
warmed to 0 °C and, after 1 h, was filtered through a SiO2/celite bilayer pad, rinsed with 
Et2O (50 mL) and the filtrate was concentrated in vacuo. The residue was purified by 
flash column chromatography (5:1 hex/EtOAc) to afford the title compound as a pale 
yellow to orange oil (379 mg, 76%). Rf 0.59 (4:1 hexanes/EtOAc); 1H NMR (400 MHz, 
CDCl3)  6.00 (dd, J = 10.4, 17.0 Hz, 1 H), 5.51 (dd, J = 1.2, 16.8 Hz, 1 H), 5.22 (dd, J = 
1.2, 10.6 Hz, 1 H), 5.07 (s, 1 H), 3.46 (dt, J = 6.4, 11.0 Hz, 1 H), 3.19 (dt, J = 6.3, 11.2 
Hz, 1 H), 2.17 (dt, J = 7.8, 12.5 Hz, 1 H), 1.97 - 2.07 (m, 1 H), 1.88 - 1.97 (m, 1 H), 1.80 
- 1.88 (m, 1 H); 13C NMR (101 MHz, CDCl3)  174.0, 135.7, 116.1, 102.6, 73.5, 58.3, 
41.8, 38.3, 24.8. 1H and 13C NMR spectra were in agreement with previously reported 
data.47 
 
Compound 3-106 
 A solution of NaOMe in MeOH (25 wt %, 2 mL, 8.8 mmol, 0.5 equiv) was 
added dropwise to a solution of oxazolidinone 3-104 (4.173 g, 15.4 mmol, 
1.0 equiv) in MeOH (40 mL) at room temperature. After 30 min and 
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complete consumption of the starting material by TLC (Rf 0.48, 5:1 hexanes/EtOAc) the 
solution was cooled to 0 °C and acetyl chloride (22 mL, 308 mmol, 20 equiv) was added 
dropwise. The solution was heated to reflux until only baseline material was observed by 
TLC (1:1 hexanes/EtOAc) at which time the solution was cooled to room temperature 
and the solvent was removed in vacuo. The residue was diluted with anhydrous CH2Cl2 
(50 mL) and iPr2NEt (8.06 mL, 46.2 mmol, 3 equiv) and Boc2O (10.6 mL, 46.2 mmol, 3 
equiv) were added sequentially. After 16 h the volatiles were removed in vacuo and the 
residue was purified by flash column chromatography (3:1 hexanes/EtOAc) to afford the 
title compound as a colorless oil (1.44 g, 76%) as a 2.4:1 mixture of two rotamers. Rf 
0.32 (3:1 hexanes/EtOAc).  
Major Rotamer: H NMR (400 MHz, CDCl3) 6.31 (dd, J = 10.6, 17.2 Hz, 1 H), 5.15 (dd, 
J = 10.6, 0.8, 1H), 5.03 (dd, J = 0.8, 17.2, 1 H), 3.73 (s, 3 H), 3.62 - 3.68 (m, 1 H), 3.52 - 
3.60 (m, 1 H), 2.12 - 2.25 (m, 1 H), 1.95 - 2.03 (m, 1 H), 1.76 - 1.92 (m, 2 H), 1.35 (s, 9 
H); 13C NMR (101 MHz, CDCl3)  173.7, 153.4, 137.1, 113.0, 79.9, 69.3, 52.2, 47.8, 
39.1,  28.1, 21.8. 
Minor Rotamer: H NMR (400 MHz, CDCl3)6.33 (dd, J = 10.6, 17.2 Hz, 1 H), 5.16 (dd, 
J = 10.6,  0.8, 1 H), 5.05 (dd, J = 0.8, 17.2, 1 H), 3.74 (s, 3H), 3.62 - 3.68 (m, 1 H), 3.52 - 
3.60 (m, 1 H), 2.12 - 2.25 (m, 1 H), 1.95 - 2.03 (m, 1 H), 1.76 - 1.92 (m, 2 H), 1.44 (s, 9 
H); 13C NMR (101 MHz, CDCl3) 173.5, 153.5, 136.3, 113.1, 79.7, 69.4, 52.4, 48.0, 
37.9, 28.4, 22.7.  
HRMS m/z 255.1471 (calcd for C13H21NO4, 255.1471). 
 
Compound 3-107 
A solution of DIBAL (1.0 M in hexanes, 3.43 mL, 3.43 mmol, 2.5 equiv) was 
added to a solution of ester 3-106 (350 mg, 1.37 mmol, 1.0 equiv) in CH2Cl2 
(10 mL) and, after 1 h, 1 M HCl (5 mL) was added. The reaction mixture was 
diluted with H2O (10 mL) and the layers were separated. The aqueous layer was extracted 
with CH2Cl2 (3 x 10 mL) and the combined organic layers were dried over MgSO4, 
filtered through celite and concentrated in vacuo to afford the product as a colorless oil 
(300 mg, 96%) that was used without further purification. Rf 0.33 (1:1 hexanes/EtOAc); 
1H NMR (400 MHz, CDCl3)  5.88 (dd, J = 10.6, 17.2 Hz, 1 H), 5.51 (dd, J = 1.6, 10.6 
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Hz, 1 H), 5.22 (d, J = 10.6 Hz, 1 H), 4.97 (d, J = 17.2 Hz, 1 H), 3.77 - 3.84 (m, 1 H), 3.68 
- 3.74 (m, 1 H), 3.52 - 3.61 (m, 1 H), 3.33 - 3.43 (m, 1 H), 1.61 - 1.84 (m, 4 H), 1.47 (s, 9 
H); 13C NMR (101 MHz, CDCl3)  156.0, 138.0, 114.0, 80.2, 70.1, 68.9, 49.0, 36.1, 28.4, 
20.7; HRMS m/z 228.1608 (calcd for C12H21NO3+H+, 228.1594). 
 
Compound 3-108 
To a solution of alcohol 3-107 (1.86 g, 8.19 mmol, 1.0 equiv) and imidazole 
(1.115 g, 16.38 mmol, 2.0 equiv) in CH2Cl2 (50 mL) was added TBSCl (1.48 g, 
9.82 mmol, 1.2 equiv). After complete consumption of the starting material as 
indicated by TLC, the reaction mixture was diluted with CH2Cl2 (20 mL) and a ½ 
saturated NaHCO3 solution (20 mL) and the layers were separated. The aqueous layer 
was extracted with CH2Cl2 (3 x 10 mL) and the combined organic layers were dried over 
MgSO4, filtered and concentrated in vacuo. The residue was then purified by flash 
column chromatography (10:1 hexanes/EtOAc) to afford the product as a colorless oil 
(2.66 g, 95%) as a mixture of greater than two rotamers. Rf 0.52 (5:1 hexanes/EtOAc); 1H 
NMR (400 MHz, CDCl3)  5.46 - 5.70 (m, 1 H), 4.53 - 4.76 (m, 2 H), 3.77 (d, J = 9.4 Hz, 
1 H), 3.47 (d, J = 9.4 Hz, 1 H), 3.25 - 3.37 (m, 1 H), 3.19 - 3.25 (m, 1 H), 3.10 - 3.17 (m, 
1 H), 2.88 - 3.05 (m, 1 H), 1.78 - 1.88 (m, 1 H), 1.23 - 1.47 (m, 3 H), 1.04 (d, J = 5.9 Hz, 
9 H), 0.47 - 0.54 (m, 9 H), -0.29 (s, 1 H), -0.37 - -0.32 (m, 5 H); 13C NMR (101 MHz, 
CDCl3)  154.3, 153.4, 140.1, 139.4, 112.7, 112.4, 79.3, 78.6, 68.1, 67.4, 66.2, 64.9, 49.2, 
49.0, 37.0, 35.3, 28.5, 28.5, 25.8, 25.7, 21.7, 21.2, 18.1, 18.1, -3.6, -5.4, -5.5, -5.6; HRMS 
m/z 341.2386 (calcd for C18H35NO3Si, 341.2386). 
 
Compound 3-109 
To a solution of protected alcohol 3-108 (1.544 g, 4.5 mmol, 1.0 equiv) and 2,6-
lutidine (2.63 mL, 22.5 mmol, 5.0 equiv) in CH2Cl2 (15 mL) at 0 °C was added 
TMSOTf (3.27 mL, 18.1 mmol, 4.0 equiv). Following complete consumption of 
the starting material by TLC, a ½ saturated solution of NH4Cl (5 mL) was added. Once 
gas evolution had ceased, a ½ saturated NaHCO3 solution (10 mL) was added and the 
layers were separated. The aqueous layer was extracted with CH2Cl2 (3 x 15 mL) and the 
combined organic layers were dried over MgSO4, filtered through celite, and 
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concentrated in vacuo. Residual 2,6-lutidine was removed under vacuum to afford the 
free secondary amine as a pale brown oil (0.911 g, 84%) that was used without further 
purification.  1H NMR (600 MHz, CDCl3)  5.83 (dd, J = 10.8, 17.3 Hz, 1 H), 5.20 (d, J 
= 17.6 Hz, 1 H), 5.07 (d, J = 10.5 Hz, 1 H), 3.47 (s, 2 H), 2.99 (d, J = 7.0 Hz, 1 H), 2.84 - 
2.95 (m, 1 H), 2.18 (br. s., 1 H), 1.75 (br. d, J = 6.4 Hz, 2 H), 1.57 - 1.70 (m, 1 H), 1.26 
(br. s., 1 H), 0.89 (s, 9 H), 0.05 (s, 6 H); 13C NMR (101 MHz, CDCl3)  142.7, 113.0, 
67.5, 67.4, 46.1, 32.3, 25.9, 25.6, 18.3, -5.5; HRMS m/z 241.1859 (calcd for C13H27NOSi, 
241.1862). 
 
Compound 3-111 
To a solution of alcohol 3-107 (300 mg, 1.32 mmol, 1.0 equiv), 
diisopropylethylamine (1.61 mL, 9.24 mmol, 7.0 equiv), and DMSO (468 
μL, 6.60 mmol, 5.0 equiv) in CH2Cl2 (10 mL) at 0 °C was added 
SO3•pyridine complex (632 mg, 3.97 mmol, 3.0 equiv) as a solid. After complete 
consumption of the starting material as indicated by TLC (2 h) the reaction mixture was 
diluted with CH2Cl2 (10 mL) and a ½ saturated NaHCO3 solution (10 mL). The layers 
were separated and the aqueous layer was extracted with CH2Cl2 (3 x 10 mL). The 
combined organic layers were dried over MgSO4, filtered, and concentrated in vacuo to 
afford the product as a pale yellow oil (276 mg, 93%) that was used without further 
purification. To a solution of trimethyl phosphonoacetate (314 μL, 2.18 mmol, 1.5 equiv) 
in THF (10 mL) at 0 °C was added nBuLi (2.35 M, 0.86 mL, 2.03 mmol, 1.4 equiv). 
After 10 min at 0 °C the above synthesized aldehyde 3-110 (326 mg, 1.45 mmol, 1.0 
equiv) in THF (5 mL) was added and the reaction was warmed to room temperature. 
After 16 h the reaction mixture was diluted with a ½ saturated solution of NH4Cl (10 mL) 
and Et2O (10 mL) and the layers were separated. The aqueous layer was extracted with 
Et2O (2 x 15 mL) and the combined organic layers were washed with brine, dried over 
MgSO4, filtered through celite and concentrated in vacuo. The residue was then purified 
by flash column chromatography (4:1 hexanes/EtOAc) to afford the product as a pale 
yellow oil (330 mg, 81%) as a 1.8 to 1 mixture of rotamers. Rf 0.56(5:1 hexanes/EtOAc). 
Major Rotamer: 1H NMR (400 MHz, CDCl3)  7.06 (d, J = 16.0 Hz, 1 H), 5.95 (dd, J = 
10.7, 17.4 Hz, 1 H), 5.79 (dd, J = 15.6 Hz, 1 H), 5.14 - 5.25 (m, 1 H), 5.01 - 5.14 (m, 1 
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H), 3.75 (s, 3 H), 3.42 - 3.60 (m, 2 H), 1.88 - 2.03 (m, 2 H), 1.74 - 1.86 (m, 2 H), 1.36 (s, 
9 H); 13C NMR (101 MHz, CDCl3)  167.0, 153.9, 151.8, 138.9, 119.0, 114.1, 80.1, 66.8, 
51.6, 47.8, 39.9, 28.3, 21.5. 
Minor Rotamer: 1H NMR (400 MHz, CDCl3)  7.13 (d, J = 16.0 Hz, 1 H), 6.08 (dd, J = 
10.7, 17.4 Hz, 1 H), 5.80 (d, J  = 15.6 Hz, 1 H), 5.14 - 5.25 (m, 1 H), 5.01 - 5.14 (m, 1 
H), 3.72 (s, 3 H), 3.42 - 3.60 (m, 2 H), 1.88 - 2.03 (m, 2 H), 1.74 - 1.86 (m, 2 H), 1.45 (s, 
9 H); 13C NMR (101 MHz, CDCl3)  167.0, 153.9, 150.8, 138.7, 119.3, 114.1, 79.5, 67.1, 
51.6, 47.9, 38.9, 28.5, 22.2. 
HRMS m/z 282.1693 (calcd for C15H23NO4+H+, 282.1705). 
 
Compound 3-62 
 To a solution of α,β unsaturated ester 3-111 (20 mg, 0.071 mmol, 1.0 equiv) 
and poly(methylhydrogensiloxane) (60 μL, 1.065 mmol, 15 equiv) in THF 
(2 mL) at 0 ° C was added a solution of Stryker’s reagent (7 mg, 0.004 
mmol, 5 mol %) in THF (1 mL) and the reaction mixture was warmed to room 
temperature. After 18 h the reaction mixture the septum and argon balloon was removed 
and H2O (5 mL) was added. After 30 min the reaction mixture was filtered through celite, 
diluted with EtOAc (5 mL), and the layers were separated. The aqueous layer was 
extracted with Et2O (2 x 10 mL) and the combined organic layers were washed with 
brine, dried over MgSO4, filtered through celite and concentrated in vacuo. The residue 
was then purified by flash column chromatography (4:1 hexanes/EtOAc) to afford the 
product as a pale yellow oil (18.5 mg, 93%) as a 1.4:1 mixture of two rotamers. Rf 0.36 
(3:1 hexanes/EtOAc). 
Major Rotamer: 1H NMR (400 MHz, CDCl3)  5.84 (dd, J = 10.6, 17.2 Hz, 1 H), 5.02 (d, 
J = 10.9 Hz, 1 H), 4.94 (d, J = 17.2 Hz, 1 H), 3.68 (s, 3 H), 3.63 - 3.66 (m, 1 H), 3.25 - 
3.39 (m, 1 H), 2.32 - 2.46 (m, 1 H), 2.16 - 2.32 (m, 2 H), 1.97 - 2.06 (m, 1 H), 1.78 - 1.97 
(m, 2 H), 1.64 - 1.78 (m, 2 H), 1.44 (s, 9 H); 13C NMR (101 MHz, CDCl3)  174.1, 141.7, 
111.7, 79.7, 65.7, 48.7, 37.3, 32.1, 31.4, 29.0, 28.4, 20.8. 
Minor Rotamer: 1H NMR (400 MHz, CDCl3)  5.98 (dd, J = 10.6, 17.2 Hz, 1 H), 5.06 (d, 
J = 10.9 Hz, 1 H), 4.96 (d, J = 17.2 Hz, 1 H), 3.66 (s, 3 H), 3. 49 - 3.56 (m, 1 H), 3.25 - 
3.39 (m, 1 H), 2.32 - 2.46 (m, 1 H), 2.16 - 2.32 (m, 3 H), 1.78 - 1.97 (m, 2 H), 1.64 - 1.78 
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(m, 2 H), 1.44 (s, 9 H); 13C NMR (101 MHz, CDCl3)  174.1, 140.7, 112.0, 79.7, 66.2, 
65.7, 51.6, 36.0, 32.1, 31.4, 29.4, 28.5, 21.4. 
HRMS m/z 283.1775 (calcd for C15H25NO4, 283.1784). 
 
Compound 3-112 
 To a solution of PPh3 (6.86 g, 26.2 mmol, 4 equiv) in CH2Cl2 (40 mL) at 0 
°C was added CBr4 (4.34 g, 13.08 mmol, 2 equiv) portion-wise. After 30 
min a solution of aldehyde 3-103 (1.782 g, 6.54 mmol, 1.0 equiv) in 
CH2Cl2 (10 mL) was added slowly and the reaction mixture was allowed to warm to 
room temperature. After 1 h the reaction mixture was diluted with CH2Cl2 (50 mL) and 
water (50 mL) and the layers were separated. The aqueous layer was extracted with 
CH2Cl2 (2 x 50 mL) and the combined organic layers were dried over MgSO4, filtered 
through celite, and concentrated in vacuo. The resulting oil was purified by flash column 
chromatography (9:1 hexanes/EtOAc) to afford the title compound as a brown oil (2.65 g, 
95%). Rf 0.46 (2:1 hexanes/EtOAc); 1H NMR (400 MHz, CDCl3)  6.90 (s, 1 H), 5.14 (s, 
1 H), 3.64 (ddd, J = 6.1, 8.6, 11.5 Hz, 1 H), 3.25 (ddd, J = 4.5, 6.6, 11.5 Hz, 1 H), 2.35 - 
2.44 (m, 1 H), 2.22 - 2.33 (m, 1 H), 1.99 - 2.09 (m, 1 H), 1.70 - 1.83 (m, 1 H); 13C NMR 
(101 MHz, CDCl3)  173.3, 135.9, 103.1, 99.9, 90.5, 74.2, 59.0, 39.0, 25.5; HRMS m/z 
425.8055 (calcd for C9H8Br2Cl3NO2+H+, 425.8066). 
 
Compound 3-113 
 A solution of NaOMe in MeOH (25 wt %, 1 mL, 4.4 mmol, 1.0 equiv) was 
added dropwise to a solution of oxazolidinone 3-112 (1.9 g, 4.4 mmol, 1.0 
equiv) in MeOH (20 mL) at room temperature. After 30 min and complete 
consumption of the starting material by TLC (Rf 0.30, 3:1 hexanes/EtOAc) the solution 
was cooled to 0 °C and acetyl chloride (6.97 mL, 88.7 mmol, 20 equiv) was added 
dropwise. The solution was heated to reflux until only baseline material was observed by 
TLC (1:1 hexanes/EtOAc) at which time the solution was cooled to room temperature 
and the solvent was removed in vacuo. The residue was diluted with anhydrous CH2Cl2 
(50 mL) and iPr2NEt (2.30 mL, 13.2 mmol, 3 equiv) and Boc2O (2.60 mL, 13.2 mmol, 3 
equiv) were added sequentially. After 16 h the volatiles were removed in vacuo and the 
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residue was purified by flash column chromatography (7:1 hexanes/EtOAc) to afford the 
title compound as a colorless oil (1.56 g, 86%) as a 3:1 mixture of two rotamers. Rf 0.32 
(3:1 hexanes/EtOAc). 
Major Rotamer: 1H NMR (400 MHz, CDCl3)  7.38 (s, 1 H), 3.76 (s, 3 H), 3.71 - 3.76 
(m, 1 H), 3.51 - 3.65 (m, 1 H), 2.29 - 2.40 (m, 1 H), 2.18 - 2.26 (m, 1 H), 1.93 - 2.02 (m, 
2 H), 1.40 (s, 9 H); 13C NMR (101 MHz, CDCl3)  172.9, 152.6, 137.2, 87.4, 80.4, 69.6, 
52.9, 47.8, 39.2, 28.2, 23.1. 
Minor Rotamer: 1H NMR (400 MHz, CDCl3)  7.34 (s, 1 H), 3.77 (s, 3 H), 3.71 - 3.76 
(m, 1 H), 3.51 - 3.65 (m, 1 H), 2.29 - 2.40 (m, 1 H), 2.18 - 2.26 (m, 1 H), 1.93 - 2.02 (m, 
2 H), 1.46 (s, 9 H); 13C NMR (101 MHz, CDCl3)  172.9, 152.6, 136.6, 87.3, 80.1, 69.7, 
52.9, 48.0, 38.2, 28.3, 23.8. 
HRMS m/z 411.9753 (calcd for C13H19Br2NO4+H+, 411.9759). 
 
Compound 3-114 
A solution of DIBAL (1.0 M in hexanes, 7.1 mL, 7.1 mmol, 3.5 equiv) was 
added to a solution of ester 3-113 (869 mg, 2.03 mmol, 1.0 equiv) in CH2Cl2 
(15 mL) and, after 1 h, the reaction mixture was diluted with Et2O (30 mL). 
Water (0.28 mL) was added dropwise, followed by a 10% NaOH(aq) solution (0.28 mL) 
followed by additional water (0.7 mL). MgSO4 was added and the reaction mixture was 
filtered through celite and the solvent was removed in vacuo to afford the title compound 
as a colorless oil as a 2.7:1 mixture of two rotamers that was used without further 
purification (704 mg, 90%). Rf 0.33 (1:1 hexanes/EtOAc). 
Major Rotamer: 1H NMR (400 MHz, CDCl3)  6.79 (s, 1 H), 5.19 (dd, J = 2.0, 9.4 Hz, 1 
H), 3.65 - 3.83 (m, 2 H), 3.49 - 3.62 (m, 1 H), 3.36 - 3.46 (m, 1 H), 2.78 (br. s, 1 H), 2.08 
- 2.17 (m, 1 H), 1.72 - 1.95 (m, 3 H), 1.46 (s, 9 H); 13C NMR (101 MHz, CDCl3)  155.6, 
138.7, 87.4, 80.7, 69.8, 66.1, 49.0, 36.2, 28.4, 22.5.  
Minor Rotamer: 1H NMR (400 MHz, CDCl3)  6.86 (s, 1 H), 5.19 (dd, J = 2.0, 9.4 Hz, 1 
H), 3.65 - 3.83 (m, 2 H), 3.49 - 3.62 (m, 1 H), 3.36 - 3.46 (m, 1 H), 2.78 (br. s, 1 H), 2.18 
- 2.26 (m, 1 H), 1.72 - 1.95 (m, 3 H), 1.49 (s, 9 H); 13C NMR (101 MHz, CDCl3)  153.2, 
139.4, 87.7, 80.3, 69.8, 67.6, 48.5, 35.2, 28.4, 22.2. 
HRMS m/z 383.9816 (calcd for C12H19Br2NO3+H+, 383.9810). 
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Compound 3-115 
To a solution of alcohol 3-114 (704 mg, 1.83 mmol, 1.0 equiv) and 
imidazole (276 mg, 4.06 mmol, 2.2 equiv) in CH2Cl2 (5 mL) was added 
TBSCl (367 mg, 2.44 mmol, 1.3 equiv). After complete consumption of the 
starting material as indicated by TLC, the reaction mixture was diluted with CH2Cl2 (5 
mL) and a ½ saturated NaHCO3 solution (10 mL) and the layers were separated. The 
aqueous layer was extracted with CH2Cl2 (2 x 10 mL) and the combined organic layers 
were dried over MgSO4, filtered and concentrated in vacuo. The residue was then 
purified by flash column chromatography (10:1 hexanes/EtOAc) to afford the product as 
a colorless oil (784 mg, 86%) as a 2:1 mixture of two rotamers. 
Major Rotamer: 1H NMR (600 MHz, CDCl3)  6.79 (s, 1 H), 3.71 - 3.75 (m, 1 H), 3.49 - 
3.57 (m, 2 H), 3.48 (d, J = 8.8 Hz, 1 H), 3.40 - 3.46 (m, 1 H), 2.24 - 2.30 (m, 1 H), 2.06 - 
2.18 (m, 1 H), 1.83 - 1.91 (m, 2 H), 1.47 (s, 0 H), 0.89 (s, 9 H), 0.06 (s, 3 H), 0.05 (s, 3 
H); 13C NMR (101 MHz, CDCl3)  169.8, 153.2, 139.8, 87.2, 79.7, 67.4, 65.2, 48.4, 34.8, 
28.5, 25.8, 22.0, 18.2, -5.4, -5.5. 
Minor Rotamer: 1H NMR (600 MHz, CDCl3)  6.83 (s, 1 H), 3.77 - 3.81 (m, 2 H), 3.49 - 
3.52 (m, 2 H), 3.40 - 3.46 (m, 1 H), 2.24 - 2.30 (m, 1 H), 2.06 - 2.18 (m, 1 H), 1.83 - 1.91 
(m, 1 H), 1.78 - 1.83 (m, 1 H), 1.44 (s, 9 H), 0.87 (s, 9 H), 0.04 (s, 3 H), 0.03 (s, 3 H); 13C 
NMR (101 MHz, CDCl3)  169.8, 152.8, 139.2, 86.3, 79.1, 68.2, 64.3, 48.6, 34.6, 28.5, 
25.8, 22.9, 18.1, -5.4, -5.5. 
HRMS m/z 398.0140 (calcd for C13H25Br2NOSi+H+, 398.0140) 
 
Compound 3-116 
To a solution of protected alcohol 3-115 (210 mg, 0.42 mmol, 1.0 equiv) and 
2,6-lutidine (243 μL, 2.1 mmol, 5.0 equiv) in CH2Cl2 (4 mL) at 0 °C was 
added TMSOTf (304 μL, 1.68 mmol, 4.0 equiv). Following complete 
consumption of the starting material by TLC, a ½ saturated solution of NH4Cl (5 mL) 
was added. Once gas evolution had ceased, a ½ saturated NaHCO3 solution (10 mL) was 
added and the layers were separated. The aqueous layer was extracted with CH2Cl2 (3 x 
10 mL) and the combined organic layers were dried over MgSO4, filtered through celite, 
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and concentrated in vacuo. Residual 2,6-lutidine was removed under vacuum to afford 
the free secondary amine as a pale brown oil (130 mg, 77%) that was used without 
further purification. 1H NMR (599 MHz, CDCl3)  6.76 (s, 1 H), 3.63 - 3.65 (m, 2 H), 
2.95 - 3.00 (m, 1 H), 2.89 - 2.95 (m, 1 H), 2.19 (br. s., 1 H), 1.96 - 2.03 (m, 1 H), 1.86 - 
1.93 (m, 1 H), 1.79 - 1.86 (m, 1 H), 1.69 - 1.79 (m, 1 H), 0.87 - 0.95 (m, 10 H), 0.04 - 
0.11 (m, 6 H); HRMS m/z 398.0140 (calcd for C13H25Br2NOSi+H+, 398.0140). 
 
Compound 3-117 
To a solution of dibromoolefin 3-115 (2.34 g, 4.69 mmol, 1.0 equiv) in THF 
(50 mL) at -78 °C was added nBuLi (1.88 M in hexanes, 5.5 mL, 10.3 mmol, 
2.2 equiv). After 15 min a ½ saturated solution of NH4Cl (20 mL) was added 
and the reaction mixture was warmed to room temperature. The reaction mixture was 
diluted with Et2O (20 mL) and the layers were separated. The aqueous layer was 
extracted with Et2O (2 x 20 mL) and the organic layers were combined, washed with 
brine, dried over MgSO4, filtered through celite and the solvent was removed in vacuo. 
The residue was purified by column chromatography (10:1 hexanes/EtOAc) to afford the 
title compound as a colorless oil (1.31 g, 82%) as a 1.1:1 mixture of two rotamers. Rf 
0.43 (10:1 hexanes/EtOAc). 
Major Rotamer: 1H NMR (400 MHz, CDCl3)  3.95 (d, J = 9.4 Hz, 1 H) 3.73 (d, J = 9.8 
Hz, 1 H), 3.58 - 3.69 (m, 1 H), 3.23 - 3.38 (m, 1 H), 2.35 - 2.45 (m, 1 H), 2.27 (s, 1 H), 
2.04 - 2.20 (m, 1 H), 1.80 - 1.92 (m, 2 H), 1.49 (s, 9 H), 0.88 (br. s., 9 H), 0.02 - 0.08 (m, 
6 H); 13C NMR (101 MHz, CDCl3)  153.9, 85.3, 80.0, 70.4, 66.4, 60.5, 48.3, 38.7, 28.5, 
25.8, 22.5, 18.2, -5.4, -5.5. 
Minor Rotamer: 1H NMR (400 MHz, CDCl3)  4.32 (d, J = 9.8 Hz, 1 H), 3.65 (d, J = 9.8 
Hz, 1 H) 3.49 - 3.58 (m, 1 H), 3.23 - 3.38 (m, 1 H), 2.35 - 2.45 (m, 1 H), 2.33 (s, 1 H), 
2.04 - 2.20 (m, 1 H), 1.80 - 1.92 (m, 2 H), 1.46 (s, 9 H), 0.88 (br. s., 9 H), 0.02 - 0.08 (m, 
6 H); 13C NMR (101 MHz, CDCl3)  153.0, 84.7, 79.2, 70.7, 65.0, 60.7, 48.6, 37.5, 28.5, 
25.8, 23.1, 18.2, -5.3, -5.4. 
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Compound 3-118 
To a a solution of alkyne 3-117 (177 mg, 0.52 mmol, 1.0 equiv) and 
Pd(PPh3)4 (30 mg, 0.026 mmol, 5 mol %) in THF (3 mL) was added 
nBu3SnH (154 μL, 0.57 mmol, 1.1 equiv). After 40 min the solvent was 
removed in vacuo and the residue was purified by column chromatography (20:1 
hexanes/EtOAc) to afford the title compound as a colorless oil (187 mg, 58%) as a 2.2:1 
mixture of two rotamers. Rf 0.66 (10:1 hexanes/EtOAc).  
Major Rotamer: 1H NMR (400 MHz, CDCl3)  6.04 (d, J = 19.3 Hz, 1 H), 5.87 (d, 19.3 
Hz, 1 H), 3.84 (d, J = 9.4 Hz, 1 H), 3.76 (d, J = 9.4 Hz, 1 H), 3.63 (td, J = 3.7, 7.1 Hz, 1 
H), 3.34 - 3.42 (m, 1 H), 2.20 (ddd, J = 6.8, 10.3, 12.2 Hz, 1 H), 1.78 - 1.86 (m, 1 H), 
1.69 - 1.78 (m, 1 H), 1.59 - 1.68 (m, 1 H), 1.46 - 1.54 (m, 6 H), 1.42 (s, 9 H), 1.25 - 1.37 
(m, 6 H), 0.93 - 0.99 (m, 6 H), 0.90 (s, 9 H), 0.84 - 0.89 (m, 9 H), 0.05 (s, 3 H), 0.05 (s, 3 
H); 13C NMR (101 MHz, CDCl3)  154.4, 149.2, 124.4, 79.1, 69.6, 66.5, 49.2, 37.2, 30.6, 
29.1, 28.5, 27.5, 27.3, 25.8, 21.1, 13.7, 10.0, 9.4, -5.4, -5.5. 
Minor Rotamer: 1H NMR (400 MHz, CDCl3)  6.09 (d, J = 19.3 Hz, 1 H), 5.87 (d, J = 
19.3 Hz, 1 H), 4.17 (d, J = 9.8 Hz, 1 H), 3.68 (d, J = 9.8 Hz, 1 H), 3.50 - 3.57 (m, 1 H), 
3.27 - 3.33 (m, 1 H), 2.20 (ddd, J = 6.8, 10.3, 12.2 Hz, 1 H), 1.78 - 1.86 (m, 1 H), 1.69 - 
1.78 (m, 1 H), 1.59 - 1.68 (m, 1 H), 1.46 - 1.54 (m, 6 H), 1.44 (s, 9 H), 1.25 - 1.37 (m, 6 
H), 0.93 - 0.99 (m, 6 H), 0.92 (s, 9 H), 0.84 - 0.89 (m, 9 H), 0.04 (s, 3 H), 0.03 (s, 3 H); 
13C NMR (101 MHz, CDCl3)  154.4, 148.3, 124.7, 78.3, 70.3, 65.1, 49.2, 35.2, 30.6, 
29.1, 28.5, 27.5, 27.2, 25.8, 21.7, 13.7, 10.0, 9.5, -5.4, -5.5. 
 
Compound 3-120 
 To a solution of aldehyde 3-95 (423 mg, 1.3 mmol, 1.0 equiv) in 
CH2Cl2 (5 mL) was added amine 3-109 (314 mg, 1.3 mmol, 1.0 
equiv). After 10 min NaBH(OAc)3 (551 mg, 2.6 mmol, 2.0 equiv) was 
added in one portion. After 2 h the reaction mixture was diluted with 
½ saturated NaHCO3 (5 mL) and CH2Cl2 (5 mL) and the layers were separated. The 
aqueous layer was extracted with CH2Cl2 (2 x 5 mL) and the combined organic layers 
were dried over MgSO4, filtered through celite and concentrated in vacuo to afford the 
title compound as a pale brown oil (716 mg, 99%) that was used without further 
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purification. Rf 0.46 (1:1 hexanes/EtOAc); 1H NMR (400 MHz, CDCl3)  8.19 (s, 1 H), 
7.17 - 7.24 (m, 2 H), 7.04 - 7.09 (m, 2 H), 6.99 - 7.04 (m, 1 H), 6.87 (d, J = 7.8 Hz, 1 H), 
6.78 - 6.82 (m, 2 H), 5.36 (dd, J = 10.9, 17.6 Hz, 1 H), 4.88 (dd, J = 1.6, 18.0 Hz, 1 H), 
4.82 (dd, J = 1.6, 10.9 Hz, 1 H), 4.39 (d, J = 12.1 Hz, 1 H), 4.31 (d, J = 12.1 Hz, 1 H), 
3.78 (s, 3 H), 3.60 - 3.66 (m, 2 H), 3.33 - 3.40 (m, 2 H), 2.88 - 2.96 (m, 1 H), 2.60 - 2.68 
(m, 1 H), 2.36 - 2.45 (m, 1 H), 2.15 - 2.24 (m, 1 H), 2.07 - 2.14 (m, 1 H), 1.98 - 2.07 (m, 
1 H), 1.77 - 1.86 (m, 1 H), 1.57 - 1.74 (m, 3 H), 0.80 (s, 9 H), -0.07 (s, 3 H), -0.10 (s, 3 
H); 13C NMR (101 MHz, CDCl3)  180.1, 159.0, 141.4, 141.0, 131.3, 130.1, 128.9, 
127.7, 123.9, 122.1, 113.6, 113.2, 109.5, 74.5, 72.9, 67.3, 66.1, 55.2, 53.2, 51.6, 43.9, 
34.5, 32.7, 25.8, 21.8, 18.0, -5.7; HRMS m/z 551.3327 (calcd for C32H46N2O4Si+H+, 
551.3305). 
 
Compound 3-121 
To a solution of oxindole 3-120 (716 mg, 1.3 mmol, 1.0 equiv) in 
CH2Cl2 (10 mL) was added Boc2O (448 μL, 1.95 mmol, 1.3 equiv) and 
DMAP (16 mg, 0.13 mmol, 10 mol %) sequentially. After 16 h the 
reaction mixture was concentrated in vacuo and residue was purified 
by flash column chromatography (5:1 hex/EtOAc) to afford the title compound as a pale 
yellow oil (814 g, 99%). Rf 0.26 (5:1 hexanes/EtOAc); 1H NMR (400 MHz, CDCl3)  
7.85 (d, J = 8.2 Hz, 1 H), 7.30 (td, J = 1.8, 7.7 Hz, 1 H), 7.10 - 7.19 (m, 2 H), 7.02 - 7.07 
(m, 2 H), 6.78 - 6.83 (m, 2 H), 4.90 (dd, J = 10.9, 17.6 Hz, 1 H), 4.66 (dd, J = 1.6, 17.6 
Hz, 1 H), 4.57 (dd, J = 1.6, 10.9 Hz, 1 H), 4.37 (d, J = 12.1 Hz, 1 H), 4.27 (d, J = 12.1 
Hz, 1 H), 3.79 (s, 3 H), 3.57 (s, 2 H), 3.28 - 3.41 (m, 2 H), 2.99 - 3.06 (m, 1 H), 2.42 (q, J 
= 7.8 Hz, 1 H), 2.34 (dd, J = 6.1, 11.9 Hz, 1 H), 2.15 - 2.28 (m, 2 H), 1.92 - 2.00 (m, 1 
H), 1.75 - 1.85 (m, 1 H), 1.65 - 1.74 (m, 2 H), 1.64 (s, 9 H), 1.49 - 1.59 (m, 1 H), 0.81 (s, 
9 H), -0.06 (s, 3 H), -0.07 (s, 3 H); 13C NMR (101 MHz, CDCl3)  175.9, 159.0, 149.5, 
141.4, 141.0, 130.1, 129.4, 128.9, 127.8, 123.7, 123.5, 115.1, 113.6, 112.6, 83.3, 75.5, 
72.9, 67.0, 64.7, 55.2, 52.7, 50.4, 43.6, 33.9, 32.5, 28.1, 25.8, 21.8, 18.0, -5.7; HRMS m/z 
651.3853 (calcd for C37H54N2O6Si+H+, 651.3825).  
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Compound 3-123 
To a solution of oxindole 3-121 (538 mg, 0.827 mmol, 1.0 
equiv) in Et2O (10 mL) was added vinyl magnesium bromide 
(1.0 M in Et2O, 1.65 mL, 1.65 mmol, 2.0 equiv). After 30 min 
the reaction mixture was diluted with ½ saturated NH4Cl (10 
mL) and Et2O (10 mL) and the layers were separated. The aqueous layer was extracted 
with Et2O (2 x 10 mL) and the organic layers were combined, weashed with brine, dried 
over MgSO4, filtered through celite and concentrated in vacuo. The residue was purified 
by column chromatography (3:1 hexanes/EtOAc to 100% EtOAc) to afford the title 
compound as a pale yellow oil (414 mg, 74%) as a 1.2:1 mixture of two diastereomers. Rf 
0.23 (3:1 hexanes/EtOAc). 
Isolated pure diastereomer (for diastereomeric mixture, see 1H spectrum). 
1H NMR (400 MHz, CDCl3)  7.56 (br. s., 1 H), 7.17 - 7.26 (m, 2 H), 7.11 - 7.17 (m, 2 
H), 6.96 - 7.03 (m, 1 H), 6.80 - 6.85 (m, 2 H), 5.94 (dd, J = 10.4, 17.0 Hz, 1 H), 5.77 (dd, 
J = 10.9, 17.6 Hz, 1 H), 5.43 (d, J = 17.2 Hz, 1 H), 5.25 (d, J = 11.3 Hz, 1 H), 5.11 (dd, J 
= 1.6, 17.6 Hz, 1 H), 5.07 (dd, J = 1.6, 10.9 Hz, 1 H), 4.27 - 4.38 (m, 2 H), 3.87 (d, J = 
9.4 Hz, 1 H), 3.76 - 3.82 (m, 1 H), 3.80 (s, 3 H),  3.50 - 3.59 (m, 2 H), 3.48 (d, J = 9.8 
Hz, 1 H), 2.83 - 2.91 (m, 1 H), 2.75 - 2.83 (m, 1 H), 2.51 - 2.67 (m, 2 H), 2.16 - 2.27 (m, 
1 H), 1.87 - 1.98 (m, 1 H), 1.72 - 1.81 (m, 3 H), 1.64 - 1.72 (m, 1 H), 1.58 (s, 9 H), 0.89 
(s, 9 H), 0.02 - 0.09 (m, 6 H); 13C NMR (101 MHz, CDCl3)  158.8, 141.1, 136.7, 133.9, 
130.8, 128.8, 127.8, 125.4, 122.6, 115.3, 114.2, 113.6, 113.5, 98.1, 82.6, 72.9, 70.1, 67.9, 
66.6, 55.2, 53.1, 52.1, 43.6, 34.6, 30.7, 28.5, 25.9, 21.8, 18.2, -5.5, -5.6; HRMS m/z 
679.4147 (calcd for C39H58N2O6Si+H+, 679.4142). 
 
Compound 3-125 
To a solution of aldehyde 3-95 (170 mg, 0.52 mmol, 1.0 equiv) in 
CH2Cl2 (5 mL) was added amine 3-116 (201 mg, 0.504 mmol, 1.0 
equiv). After 10 min NaBH(OAc)3 (221 mg, 1.05 mmol, 2.0 equiv) 
was added in one portion. After 2 h the reaction mixture was diluted 
with ½ saturated NaHCO3 (5 mL) and CH2Cl2 (5 mL) and the layers were separated. The 
aqueous layer was extracted with CH2Cl2 (2 x 5 mL) and the combined organic layers 
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were dried over MgSO4, filtered through celite and concentrated in vacuo to a pale brown 
oil. CH2Cl2 (5 mL), Boc2O (179 μL, 0.78 mmol, 1.5 equiv), and DMAP (6 mg, 0.05 
mmol, 0.1 equiv) were added and, after 16 h the solvent was removed in vacuo and the 
reside was purified by column chromatography (5:1 hexanes/EtOAc) to afford the title 
compound as a light yellow oil (300 mg, 71%). Rf 0.46 (5:1 hexanes/EtOAc) ; 1H NMR 
(400 MHz, CDCl3)  7.92 (d, J = 7.8 Hz, 1 H), 7.30 - 7.38 (m, 1 H), 7.14 - 7.24 (m, 2 H), 
7.06 (d, J = 8.6 Hz, 2 H), 6.78 - 6.87 (m, 2 H), 5.48 (s, 1 H), 4.25 - 4.40 (m, 2 H), 3.75 - 
3.82 (m, 3 H), 3.57 (s, 2 H), 3.47 - 3.56 (m, 2 H), 3.07 (td, J = 2.1, 8.1 Hz, 1 H), 2.33 - 
2.48 (m, 2 H), 2.19 - 2.33 (m, 2 H), 1.88 - 2.04 (m, 3 H), 1.66 (s, 9 H), 0.79 (s, 9 H), -
0.05 (s, 3 H), -0.06 (s, 3 H); 13C NMR (101 MHz, CDCl3)  175.9, 159.0, 149.1, 143.0, 
140.4, 130.0, 128.9, 128.9, 128.8, 123.9, 123.4, 115.8, 113.6, 85.9, 83.5, 75.5, 73.0, 69.9, 
63.3, 55.2, 52.5, 49.3, 44.4, 33.4, 32.0, 28.1, 25.7, 21.8, 17.9, -5.7; HRMS m/z 807.2080 
(calcd for C37H52Br2N2O6Si+H+, 807.2040). 
 
Compound 3-127 
To a solution of dibromoolefin 3-125 (42 mg, 0.052 mmol, 1.0 
equiv) in THF (5 mL) at -78 °C was added nBuLi (2.45 M in 
hexanes, 43 μL, 0.104 mmol, 2.0 equiv). After 30 min the reaction 
mixture was diluted with ½ saturated NH4Cl (5 mL) and Et2O (10 
mL) warmed to room temperature. The layers were separated and the aqueous layer was 
extracted with Et2O (2 x 10 mL) and the organic layers were combined, washed with 
brine, dried over MgSO4, filtered through celite and concentrated in vacuo.  The reside 
was purified by column chromatography (5:1 hexanes/EtOAc) to afford the title 
compound as a light yellow oil (10 mg, 30%). Rf 0.36 (4:1 hexanes/EtOAc) ; 1H NMR 
(400 MHz, CDCl3)  7.84 (d, J = 8.2 Hz, 1 H), 7.29 - 7.32 (m, 1 H), 7.20 - 7.23 (m, 1 H), 
7.11 - 7.17 (m, 1 H), 7.02 - 7.07 (m, 2 H), 6.78 - 6.83 (m, 2 H), 4.38 (d, J = 12.1 Hz, 1 
H), 4.28 (d, J = 12.1 Hz, 1 H), 3.79 (s, 3 H), 3.64 (s, 2 H), 3.42 (d, J = 10.2 Hz, 1 H), 3.35 
(d, J = 9.8 Hz, 1 H), 2.68 (td, J = 4.5, 8.5 Hz, 1 H), 2.47 - 2.55 (m, 1 H), 2.40 - 2.47 (m, 1 
H), 2.13 - 2.29 (m, 2 H), 2.03 (s, 1 H), 1.93 - 2.01 (m, 1 H), 1.86 - 1.93 (m, 1 H), 1.79 - 
1.86 (m, 1 H), 1.68 - 1.77 (m, 1 H), 1.65 (m, 9 H), 0.84 (s, 9 H), -0.01 (s, 3 H), -0.02 (s, 3 
H); 13C NMR (101 MHz, CDCl3)  176.7, 159.0, 149.4, 140.5, 130.0, 129.7, 128.9, 
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128.0, 123.9, 123.3, 115.0, 113.6, 84.0, 83.6, 75.1, 72.9, 72.3, 67.8, 64.3, 55.2, 53.1, 51.8, 
45.2, 36.2, 33.6, 29.7, 28.2, 25.9, 25.7, 21.0, 18.2, -5.4; HRMS m/z 649.3684 (calcd for 
C37H52N2O6Si+H+, 649.3595). 
 
Compound 3-126 
To a solution of aldehyde 3-95 (85 mg, 0.26 mmol, 1.0 equiv) in 
CH2Cl2 (5 mL) was added amine 3-119 (138 mg, 0.26 mmol, 1.0 
equiv). After 10 min NaBH(OAc)3 (110 mg, 0.52 mmol, 2.0 
equiv) was added in one portion. After 2 h the reaction mixture 
was diluted with ½ saturated NaHCO3 (5 mL) and CH2Cl2 (5 mL) and the layers were 
separated. The aqueous layer was extracted with CH2Cl2 (2 x 5 mL) and the combined 
organic layers were dried over MgSO4, filtered through celite and concentrated in vacuo 
to a pale brown oil. CH2Cl2 (5 mL), Boc2O (90 μL, 0.39 mmol, 1.5 equiv), and DMAP (5 
mg, 0.04 mmol, 0.15 equiv) were added and, after 16 h the solvent was removed in vacuo 
and the reside was purified by column chromatography (5:1 hexanes/EtOAc) to afford the 
title compound as a light yellow oil (100 mg, 41%). Rf 0.30 (5:1 hexanes/EtOAc); 1H 
NMR (599 MHz, CDCl3)  7.84 (d, J = 8.2 Hz, 1 H), 7.27 - 7.31 (m, 1 H), 7.19 (d, J = 
6.5 Hz, 1 H), 7.10 - 7.14 (m, 1 H), 7.01 (d, J = 8.8 Hz, 2 H), 6.78 (d, J = 8.8 Hz, 2 H), 
5.80 (d, J = 19.4 Hz, 1 H), 5.62 (d, J = 19.4 Hz, 1 H), 4.35 (d, J = 12.3 Hz, 1 H), 4.25 (d, 
J = 12.3 Hz, 1 H), 3.79 - 3.82 (m, 1 H), 3.76 - 3.79 (m, 3 H), 3.58 - 3.67 (m, 3 H), 3.42 
(d, J = 10.0 Hz, 1 H), 3.36 (d, J = 10.0 Hz, 1 H), 2.73 (d, J = 8.8 Hz, 1 H), 2.57 - 2.62 (m, 
1 H), 2.30 - 2.36 (m, 1 H), 2.22 - 2.30 (m, 1 H), 2.05 - 2.12 (m, 1 H), 1.91 - 2.00 (m, 1 
H), 1.72 - 1.79 (m, 1 H), 1.60 - 1.63 (m, 2 H), 1.62 (s, 9 H), 1.39 - 1.50 (m, 6 H), 1.27 
(dq, J = 7.4, 14.9 Hz, 6 H), 0.87 (t, J = 7.6 Hz, 9 H), 0.80 - 0.82 (m, 5 H) 0.79 (s, 9 H), -
0.05 (s, 3 H), -0.08 (s, 3 H); HRMS m/z 941.4839 (calcd for C49H80N2O6SiSn+H+, 
941.4886).  
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Compound 3-9 
To a solution of tryptophol (3-132, 200 mg, 1.24 mmol, 1.0 equiv) and 
Ph3P (655 mg, 2.5 mmol, 2 equiv) in CH2Cl2 (5 mL) was added CBr4 (824 
mg, 2.5 mmol, 2 equiv). After 1 h the reaction mixture was diluted with 
water (10 mL) and the layers were separated. The aqueous layer was extracted with 
CH2Cl2 (2 x 10 mL) and the combined organic layers were dried over MgSO4, filtered 
through celite and concentrated in vacuo. The residue was purified by column 
chromatography to afford the title compound as a pale yellow oil (193 mg, 70%). Rf 0.57 
(2:1 hexanes/EtOAc); 1H NMR (400 MHz, CDCl3)  8.04 (br. s., 1 H), 7.61 (d, J = 7.8 
Hz, 1 H), 7.40 (d, J = 8.2 Hz, 1 H), 7.23 (t, J = 7.0 Hz, 1 H), 7.16 (t, J = 7.4 Hz, 1 H), 
7.11 (d, J = 2.3 Hz, 1 H), 3.66 (t, J = 7.6 Hz, 2 H), 3.36 (t, J = 7.8 Hz, 2 H); 13C NMR 
(101 MHz, CDCl3)  136.1, 126.9, 122.2, 122.2, 119.6, 118.5, 113.6, 111.3, 32.8, 29.3; 
1H and 13C NMR spectra were in agreement with previously reported data.48 
 
Compound 3-131 
A mixture of indole 3-9 (50 mg, 0.22 mmol, 1.5 equiv), amine X3-
109 (36 mg, 0.15 mmol, 1.0 equiv), K2CO3 (207 mg, 1.5 mmol, 5.0 
equiv) and NaI (45 mg, 0.3 mmol, 0.5 equiv) in DMF (1 mL) was 
heated to 150 °C in a microwave reaction. After 3 h the reaction 
mixture was cooled to 0 °C and diluted with H2O (5 mL) and EtOAc (5 mL) and the 
layers were separated. The aqueous layer was extracted with EtOAc (3 x 10 mL) and the 
combined organic layers were washed with brine, dried over MgSO4, filtered through 
celite, and concentrated in vacuo. The residue was purified by column chromatography 
(1:1 hexanes/EtOAc) to afford the title compound as a pale yellow oil (53 mg, 46%). Rf 
0.33 (1:1 hexanes/EtOAc); 1H NMR (400 MHz, CDCl3)  7.97 (br. s., 1 H), 7.62 (d, J = 
7.8 Hz, 1 H), 7.36 (d, J = 8.2 Hz, 1 H), 7.20 (t, J = 7.6 Hz, 1 H), 7.12 (t, J = 7.4 Hz, 1 H), 
7.04 (d, J = 2.3 Hz, 1 H), 5.87 (dd, J = 10.9, 18.0 Hz, 1 H), 5.08 - 5.19 (m, 2 H), 3.61 (s, 
2 H), 3.03 - 3.10 (m, 2 H), 2.85 - 3.00 (m, 4 H), 1.96 - 2.05 (m, 1 H), 1.76 - 1.92 (m, 3 
H), 0.83 - 0.93 (m, 9 H), 0.02 - 0.06 (m, 6 H); 13C NMR (101 MHz, CDCl3)  140.8, 
136.2, 127.6, 121.8, 121.3, 119.1, 119.0, 115.1, 113.7, 111.0, 67.7, 66.6, 52.3, 50.3, 34.5, 
26.0, 25.9, 21.9, 18.2, -5.5; HRMS m/z 384.2609 (calcd for C23H36N2OSi, 384.2597). 
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Compound 3-135 
To a freshly prepared solution of LDA (81.6 mmol, 1.5 equiv) in THF 
(100 mL) at -78 °C was added oxazolidine 3-6 (13.9 g, 54 mmol, 1.0 
equiv) as a solid. After 30 min at -78 °C allyl bromide (8.41 mL, 97.2 
mmol, 1.8 equiv) was added over 5 min and after 20 min the reaction mixture was 
warmed to -40 °C. After 30 min at -40 °C a ½ saturated solution of NH4Cl (40 mL) was 
quickly added and the reaction mixture was warmed to room temperature. The aqueous 
layer was extracted with CHCl3 (3 x 100 mL), the combined organic layers were dried 
over MgSO4, filtered through celite, and concentrated in vacuo to afford the title 
compound that was used without further purification (14.5 g, 94%). Rf 0.50 (3:1 
hexanes/EtOAc); 1H NMR (400 MHz, CDCl3)  5.85 - 5.96 (m, 1 H), 5.21 (s, 1 H), 5.15 - 
5.20 (m, 1 H), 4.99 (s, 1 H), 3.13 - 3.26 (m, 2 H), 2.52 - 2.68 (m, 2 H), 2.11 - 2.19 (m, 1 
H), 1.98 - 2.09 (m, 1 H), 1.82 - 1.95 (m, 1 H), 1.58 - 1.73 (m, 1 H); 13C NMR (101 MHz, 
CDCl3) 176.2, 131.9, 119.9, 102.3, 100.4, 71.3, 58.3, 41.5, 35.2, 25.2. 1H and 13C NMR 
spectra were in agreement with previously reported data.46b 
 
Compound 3-136 
To a solution of allylated oxazolidinone 3-135 (13.9 g, 48.8 mmol, 1.0 
equiv) in MeOH (100 mL) at 0 °C was added sodium metal (600 mg, 26 
mmol, 0.53 equiv). After 30 min AcCl (67 mL, 947 mmol, 19 equiv) was added dropwise 
and the reaction mixture was heated to reflux. After complete consumption of the 
intermediate formate (Rf 0.29, 2:1 EtOAc/hexanes) the reaction mixture was cooled to 
room temperature and the solvent was removed in vacuo. The residue was purified by 
column chromatography (20:1 to 10:1 CH2Cl2/MeOH) to afford the title compound (7.2 
g, 72%). 1H and 13C NMR spectra were in agreement with previously reported data.46b 
 
Compound 3-138 
 To a solution of indole-3-acetic acid (964 mg, 5.5 mmol, 1.1 
equiv) in CH2Cl2 (25 mL) was added EDCl (1.05 g, 5.5 mmol, 1.0 
equiv). After 5 min amine hydrochloride 3-136 (1.0g, 5.0 mmol, 
1.0 equiv) was added, followed by Hunig’s base (2.6 mmol, 15 mmol, 3.0 equiv). After 
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16 h at room temperature the reaction mixture was diluted with 1 M HCl (10 mL) and 
CH2Cl2 (10 mL) and the layers were separated. The aqueous layer was extracted with 
CH2Cl2 (3 x 10 mL) and the organic layers were combined, dried over MgSO4, filtered 
through celite, and concentrated in vacuo to afford the title compound as a pale brown oil 
(1.36 g, 83%) that was used without further purification. Rf 0.25 (1:1 hexanes/EtOAc); 1H 
NMR (400 MHz, CDCl3)  8.46 (br. s., 1 H), 7.59 (d, J = 7.8 Hz, 1 H), 7.34 (d, J = 8.2 
Hz, 1 H), 7.15 - 7.22 (m, 1 H), 7.08 - 7.15 (m, 2 H), 5.59 - 5.73 (m, 1 H), 5.01 - 5.12 (m, 
2 H), 3.77 (s, 2 H), 3.71 - 3.77 (m, 2 H), 3.68 (s, 3 H), 3.49 (dt, J = 7.2, 9.9 Hz, 1 H), 3.21 
(dd, J = 6.6, 14.1 Hz, 1 H), 2.67 (dd, J = 8.0, 14.3 Hz, 1 H), 2.00 - 2.13 (m, 2 H), 1.83 - 
2.00 (m, 2 H); 13C NMR (101 MHz, CDCl3)  174.4, 169.9, 136.1, 133.4, 127.3, 122.9, 
121.9, 119.3, 119.0, 118.5, 111.2, 108.5, 68.2, 52.3, 49.1, 37.8, 35.1, 32.8, 23.8; HRMS 
m/z 326.1636 (calcd for C19H22N2O3, 326.1630). 
 
Compound 3-139 
 To a solution of 3-138 (1.36 g, 4.17 mmol, 1.0 equiv) in THF (20 
mL) at 0 °C was added RED-Al (65 wt% in PhMe, 8.9 mL, 29.2 
mmol, 7.0 equiv) dropwise. After 2 h, the reaction mixture was 
heated to reflux. After 16 h the reaction mixture was cooled to room temperature and 
excess RED-Al was quenched by slowly pouring the reaction mixture into a vigorously 
stirred ½ saturated solution of Rochelle’s salt (50 mL). After 2 h the layers were 
separated and the aqueous layer was extracted with EtOAc (3 x 30 mL). The organic 
layers were combined, washed with brine, dried over MgSO4, filtered and concentrated in 
vacuo to afford the title compound as a colorless syrup (0.84 g, 70%) that was used 
without further purification. Rf 0.27 (1:2 hexanes/EtOAc, 5% Et3N); 1H NMR (400 MHz, 
CDCl3)  8.19 (br. s., 1 H), 7.61 (d, J = 7.8 Hz, 1 H), 7.37 (d, J = 7.8 Hz, 1 H), 7.21 (td, J 
= 1.4, 7.5 Hz, 1 H), 7.11 - 7.17 (m, 1 H), 7.04 (d, J = 2.0 Hz, 1 H), 5.62 - 5.75 (m, 1 H), 
5.07 - 5.11 (m, 1 H), 5.06 (s, 1 H), 3.46 - 3.57 (m, 1 H), 3.39 (d, J = 10.9 Hz, 1 H), 3.28 
(d, J = 10.9 Hz, 1 H), 2.94 - 3.12 (m, 3 H), 2.74 - 2.83 (m, 1 H), 2.69 (d, J = 8.2 Hz, 1 H), 
2.14 - 2.23 (m, 1 H), 2.05 - 2.14 (m, 1 H), 1.76 - 1.92 (m, 4 H); 13C NMR (101 MHz, 
CDCl3)  136.3, 133.5, 127.3, 122.0, 121.8, 119.4, 118.6, 118.5, 113.7, 111.3, 67.6, 63.6, 
N
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51.7, 48.9, 36.2, 31.4, 24.9, 22.0; HRMS m/z 285.1972 (calcd for C18H24N2O+H+, 
285.1961). 
 
Compound 3-140 
To a solution of oxalyl chloride (61 μ:, 0.71 mmol. 1.2 equiv) in 
CH2Cl2 (5 mL) at -78 °C was added DMSO (101 μL, 1.42 mmol, 
2.4 equiv) dropwise. After 30 min alcohol 3-139 (168 mg, 0.59 
mmol, 1.0 equiv) in CH2Cl2 (2 mL) was added and, after 1 h, Et3N (411 μL, 2.95 mmol, 5 
equiv) was added. After 15 min at -78 °C the reaction mixture was allowed to warm to 0 
°C. After 30 min at 0 °C the reaction mixture was diluted with ½ saturated NaHCO3 (5 
mL) and CH2Cl2 (5 mL) and the layers were separated. The aqueous layer was extracted 
with CH2Cl2 (2 x 5mL), the organic layers were combined, dried over MgSO4, filtered 
through celite and concentrated in vacuo. The residue was purified by flash column 
chromatography (3:1 hexanes/EtOAc, 5 % Et3N) to afford the title compound as an 
impure pale yellow oil (42 mg, 25%) that was used immediately in the next step. Rf 0.33 
(2:1 hexanes/EtOAc, 5 % Et3N); 1H NMR (599 MHz, CDCl3)  9.34 (s, 1 H), 7.98 (br. s., 
1 H), 7.58 (d, J = 7.6 Hz, 1 H), 7.36 (d, J = 8.2 Hz, 1 H), 7.20 (t, J = 7.6 Hz, 1 H), 7.10 - 
7.15 (m, 1 H), 7.01 (d, J = 2.3 Hz, 1 H), 5.73 - 5.82 (m, 1 H), 5.04 - 5.13 (m, 2 H), 3.20 - 
3.27 (m, 1 H), 2.87 - 3.05 (m, 6 H), 2.47 (dd, J = 7.0, 14.1 Hz, 1 H), 2.24 (dd, J = 7.6, 
14.1 Hz, 1 H), 1.89 - 1.99 (m, 4 H), 1.83 - 1.89 (m, 1 H). 
 
Compound 3-141 
To a mixture of NaH (60 % in mineral oil, 63 mg, 1.6 mmol, 2.5 
equiv) in THF (10 mL) was added trimethyl phosphonoacetate 
(135 μL, 0.94 mmol, 1.5 equiv). After 15 min a solution of 
aldehyde 3-140 (176 mg, 0.625 mmol, 1.0 equiv) in THF (5 mL) 
was added and after 2 h the reaction mixture was diluted with ½ saturated NH4Cl (2 mL) 
and, after 10 min, the reaction mixture was diluted with ½ saturated NaHCO3 (10 mL) 
and EtOAc (10 mL) and the layers were separated. The aqueous layer was extracted with 
EtOAc (3 x 10 mL) and the combined organic layers were washed with brine, dried over 
MgSO4, filtered through celite, and concentrated in vacuo. The residue was purified by 
N
H
N
CO2Me
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column chromatography (2:1 hexanes/EtOAc, 5% Et3N) to afford the title compound as a 
pale yellow oil (211 mg, quant.). Rf 0.26 (2:1 hexanes/EtOAc, 5% Et3N); 1H NMR (400 
MHz, CDCl3)  7.95 (br. s., 1 H), 7.59 (d, J = 7.8 Hz, 1 H), 7.37 (d, J = 7.8 Hz, 1 H), 
7.17 - 7.22 (m, 1 H), 7.09 - 7.15 (m, 1 H), 7.03 (d, J = 2.3 Hz, 1 H), 6.95 (d, J = 16.0 Hz, 
1 H), 5.85 (d, J = 16.0 Hz, 1 H), 5.73 - 5.82 (m, 1 H), 5.08 - 5.12 (m, 1 H), 5.06 (s, 1 H), 
3.72 (s, 3 H), 3.16 (ddd, J = 5.5, 7.5, 9.3 Hz, 1 H), 2.81 - 2.98 (m, 4 H), 2.60 - 2.74 (m, 1 
H), 2.38 (dd, J = 7.4, 14.0 Hz, 1 H), 2.29 (dd, J = 6.8, 13.8 Hz, 1 H), 1.81 - 1.98 (m, 3 H), 
1.72 - 1.81 (m, 1 H); 13C NMR (101 MHz, CDCl3)  167.1, 151.4, 136.2, 134.4, 127.5, 
121.9, 121.4, 119.6, 119.2, 118.8, 117.8, 114.6, 111.1, 66.1, 51.5, 51.0, 49.6, 39.0, 34.8, 
25.8, 21.2, 21.1; HRMS m/z 338.1986 (calcd for C21H26N2O2, 338.1994). 
 
Compound 3-142 
To a solution of amine hydrochloride 3-136 (1.44 g, 7.0 mmol, 1.0 equiv) 
in CH2Cl2 (20 mL) was added DMAP (10 mg), iPr2NEt (2.4 mL, 14 mmol, 
2.0 equiv) and Boc2O (1.77 mL, 7.7 mmol, 1.1 equiv) sequentially. After 
16 h the solvent was removed in vacuo and the residue was purified by column 
chromatography (5:1 hexanes/EtOAc) to afford Boc protected amine (1.44 g, 77%). To 
the above prepared amine (108 mg, 0.40 mmol, 1.0 equiv) in CH2Cl2 (3 mL) was added 
DIBAL (1.0 M in hexanes, 1.0 mL, 1.0 mmol, 2.5 equiv) dropwise. After 30 min the 
reaction mixture was poured into a ½ saturated solution of Rochelle’s salt (10 mL). The 
mixture was diluted with CH2Cl2 (10 mL) and the layers were separated. The aqueous 
layer was extracted with CH2Cl2 (2 x 10 mL) and the organic layers were combined, 
drived over MgSO4, filtered through celite and concentrated in vacuo to afford an alcohol 
(97 mg, quant.) that was used without further purification. To a solution of the above 
prepared alcohol (97 mg, 0.40 mmol, 1.0 equiv), diisopropylethylamine (660 μL, 2.8 
mmol, 7.0 equiv), and DMSO (142 μL, 2.0 mmol, 5.0 equiv) in CH2Cl2 (5 mL) at 0 °C 
was added SO3•pyridine complex (191 mg, 1.2 mmol, 3.0 equiv) as a solid. After 
complete consumption of the starting material as indicated by TLC the reaction mixture 
was diluted with CH2Cl2 (10 mL) and a ½ saturated NaHCO3 solution (10 mL). The 
layers were separated and the aqueous layer was extracted with CH2Cl2 (3 x 10 mL). The 
combined organic layers were dried over MgSO4, filtered, and concentrated in vacuo to 
N
CO2Me
Boc
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afford the product as a pale yellow oil that was used without further purification. To a 
slurry of NaH (60% in mineral oil, 24 mg, 06 mmol, 1.5 equiv) in THF (5 mL) at 0 °C 
was added trimethyl phosphonoacetate (64 μL, 0.44 mmol, 1.1 equiv). After 10 min at 0 
°C the above synthesized aldehyde in THF (5 mL) was added and the reaction was 
warmed to room temperature. After 16 h the reaction mixture was diluted with a ½ 
saturated solution of NH4Cl (10 mL) and Et2O (10 mL) and the layers were separated. 
The aqueous layer was extracted with Et2O (2 x 10 mL) and the combined organic layers 
were washed with brine, dried over MgSO4, filtered through celite and concentrated in 
vacuo. The residue was then purified by flash column chromatography (5:1 
hexanes/EtOAc) to afford the product as a pale yellow oil (70 mg, 59% over 2 steps) as a 
1.3 to 1 mixture of two rotamers. Rf 0.30 (5:1 hexanes/EtOAc). 
Major Rotamer: 1H NMR (400 MHz, CDCl3)  6.96 (d, J  = 15.6 Hz, 1 H), 5.63 - 5.80 
(m, 2 H), 5.10 - 5.20 (m, 2 H), 3.74 (s, 3 H), 3.61 - 3.69 (m, 1 H), 3.23 - 3.38 (m, 1 H), 
2.83 (dd, J = 6.3, 13.7 Hz, 1 H), 2.44 (dd, J = 8.2, 13.7 Hz, 1 H), 1.99 - 2.15 (m, 1 H), 
1.78 - 1.86 (m, 1 H), 1.62 - 1.78 (m, 2 H), 1.42 (s, 9 H); 13C NMR (101 MHz, CDCl3)  
167.1, 153.8, 152.2, 132.8, 119.3, 118.2, 80.0, 64.9, 51.6, 48.7, 41.1, 37.7, 28.4, 21.1. 
Minor Rotamer: 1H NMR (400 MHz, CDCl3)  7.00 (d, J  = 15.6 Hz, 1 H), 5.63 - 5.80 
(m, 2 H), 5.10 - 5.20 (m, 2 H), 3.71 (s, 3 H), 3.54 (ddd, J = 3.1, 7.5, 10.5 Hz, 1 H), 3.23 - 
3.38 (m, 1 H), 3.00 (dd, J = 6.3, 13.7 Hz, 1 H), 2.53 (dd, J = 8.2, 13.7 Hz, 1 H), 1.99 - 
2.15 (m, 1 H), 1.78 - 1.86 (m, 1 H), 1.62 - 1.78 (m, 2 H), 1.44 (s, 9 H); 13C NMR (101 
MHz, CDCl3)  167.1, 153.2, 151.3, 133.0, 119.3, 118.4, 79.2, 65.7, 51.5, 48.8, 40.0, 
36.4, 28.5, 21.5. 
 
Compound 3-145 
A solution of alkene 3-144 (1.35 g, 5.0 mmol, 1.0 equiv) in CH2Cl2/MeOH 
(1:1, 100 mL) at -78 °C was degassed with O2 for 5 min, then O3 was 
bubbled through the reaction mixture. Once a blue-grey color was observed O2 was 
bubbled through the reaction mixture for 15 min then Ph3P (2.32 g, 8.5 mmol, 1.5 equiv) 
was added and the reaction mixture was allowed to warm to room temperature. Once the 
reaction mixture obtained room temperature the solvent was removed in vacuo and the 
residue was purified by column chromatography (2:1 hexanes/EtOAc) to afford the title 
N
CO2Me
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compound as a colorless oil (1.29 g, 95%) as a 1:1 mixture of two rotamers. Rf 0.43 (1:1 
hexanes/EtOAc). 
Rotamer 1: 1H NMR (400 MHz, CDCl3)  9.79 - 9.84 (m, 1 H), 3.75 (s, 3 H), 3.67 (dt, J 
= 7.0, 10.6 Hz, 1 H), 3.41 - 3.53 (m, 1 H), 3.07 (dd, J = 3.1, 15.2 Hz, 1 H) 2.99 (dd, 3.1, 
11.7 Hz, 1 H), 2.21 - 2.33 (m, 1 H), 2.16 (td, J = 6.8, 13.6 Hz, 1 H), 1.98 (dt, J = 6.5, 17.4 
Hz, 1 H), 1.81 - 1.92 (m, 1 H), 1.42 (s, 9 H); 13C NMR (101 MHz, CDCl3)  200.1, 
174.0, 154.2, 81.0, 66.2, 52.5, 48.6, 38.1, 28.3, 23.2. 
Rotamer 2: 1H NMR (400 MHz, CDCl3)  9.79 - 9.84 (m, 1 H), 3.74 (sz, 3 H), 3.57 (dt, J 
= 7.0, 10.6 Hz, 1 H), 3.41 - 3.53 (m, 1 H), 2.99 (dd, 3.1, 11.7 Hz, 1 H), 2.77 (dd, J = 1.6, 
15.2 Hz, 1 H), 2.21 - 2.33 (m, 1 H), 2.16 (td, J = 6.8, 13.6 Hz, 1 H), 1.98 (dt, J = 6.5, 17.4 
Hz, 1 H), 1.81 - 1.92 (m, 1 H), 1.41 (s, 9 H); 13C NMR (101 MHz, CDCl3)  199.8, 
173.7, 153.0, 80.3, 65.7, 49.2, 47.9, 37.1, 28.2, 22.6. 
HRMS m/z 271.1413 (calcd for C13H21NO5, 271.1420). 
 
Compound 3-146 
To a solution of aldehyde 3-145 (1.4 g, 5.0 mmol, 1.0 equiv) and 
trimethyl orthoformate (1.7 mL, 15.0 mmol, 3.0 equiv) in MeOH (15 
mL) was added amberlyst acidic resin (28 mg, 2 wt %). After 16 h at 
room temperature the reaction mixture was filtered through celite, the celite pad was 
washed with MeOH and the combined filtrates were concentrated in vacuo to afford the 
title compound as a colorless oil (1.59 g, quant.) as a 2:1 mixture of two rotamers that 
was used without further purification. Rf 0.38 (2:1 hexanes/EtOAc). 
Major Rotamer: 1H NMR (400 MHz, CDCl3)  4.40 (dd, J = 3.9, 6.6 Hz, 1 H), 3.70 - 
3.75 (m, 1 H), 3.69 (s, 3 H), 3.35 - 3.43 (m, 1 H), 3.32 (s, 3 H), 3.29 (s, 3 H), 2.35 - 2.46 
(m, 2 H), 2.17 - 2.25 (m, 1 H), 1.96 - 2.07 (m, 1 H), 1.75 - 1.94 (m, 2 H), 1.39 (s, 9 H); 
13C NMR (101 MHz, CDCl3)  175.2, 153.6, 102.6, 80.2, 65.7, 53.5, 52.6, 52.1, 48.3, 
37.4, 36.3, 28.2, 22.5. 
Minor Rotamer: 1H NMR (400 MHz, CDCl3)  4.45 (dd, J = 3.5, 6.6 Hz, 1 H), 1 3.68 (s, 
3 H), 3.53 - 3.60 (m, 1 H), 3.35 - 3.43 (m, 1 H), 3.32 (s, 3 H), 3.28 (s, 3 H), 2.50 (dd, J = 
3.5, 14.5 Hz, 1 H), 2.25 - 2.33 (m, 1 H), 2.17 - 2.25 (m, 1 H), 1.96 - 2.07 (m, 1 H), 1.75 - 
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1.94 (m, 2 H), 1.43 (s, 9 H); 13C NMR (101 MHz, CDCl3)  174.8, 154.1, 102.9, 79.5, 
66.1, 53.9, 52.5, 52.1, 48.3, 36.9, 36.3, 28.3, 23.1. 
HRMS m/z 316.1767 (calcd for C15H27NO6-H+, 316.1760). 
 
Compound 3-147 
To a solution of ester 3-146 (1.59 g, 5.0 mmol, 1.0 equiv) in CH2Cl2 (25 
mL) was added DIBAL (1.0 M in hexanes, 12.5 mL, 12.5 mmol, 2.5 
equiv) dropwise. After 30 min at room temperature the reaction mixture 
was slowly poured into a ½ saturated solution of Rochelle’s salt (100 mL). After 1 h the 
mixture was diluted with CH2Cl2 (25 mL) and the layers were seperatted. The aqueous 
layer was extracted with Ch2Cl2 (2 x 50 mL) and the organic layers were combined, 
drived over MgSO4, filtered through celite, and concentrated in vacuo to afford the title 
compound as a colorless oil (1.45 g, quant.) as a 10:1 mixture of two rotamers that was 
used without further purification. Rf 0.33 (1:1 hexanes/EtOAc); 1H NMR (400 MHz, 
CDCl3)  5.48 (dd, J = 2.0, 9.8 Hz, 1 H), 4.58 (dd, J = 4.1, 6.8 Hz, 1 H), 3.56 - 3.74 (m, 2 
H), 3.37 - 3.47 (m, 1 H), 3.35 (s, 3 H), 3.33 (s, 3 H), 2.21 - 2.30 (m, 1 H), 2.13 - 2.21 (m, 
1 H), 2.03 (dd, J = 6.6, 14.5 Hz, 1 H), 1.67 - 1.87 (m, 3 H), 1.46 - 1.52 (m, 1 H), 1.44 (s, 
9 H); 13C NMR (101 MHz, CDCl3)  156.0, 102.8, 80.1, 69.4, 65.8, 53.4, 53.3, 48.5, 
35.0, 34.4, 28.4, 21.8; HRMS m/z 290.1960 (calcd for C14H27NO5+H+, 290.1962). 
 
Compound 3-148 
To a solution of alcohol 3-147 (173 mg, 0.60 mmol, 1.0 equiv), iPr2NEt2 
(729 μL, 4.18 mmol, 7 equiv) and DMSO (211 μL, 3.0 mmol, 5.0 equiv) 
in CH2Cl2 (6 mL) was added pyridine•SO3 complex (286 mg, 1.8 mmol, 
3.0 equiv). After 30 min the reaction mixture was diluted with a ½ saturated solution of 
NaHCO3 (5 mL) and CH2Cl2 (10 mL) and the layers were separated. The aqueous layer 
was extracted with CH2Cl2 (2 x 5 mL) and the organic layers were combined, dried over 
MgSO4, filtered through celite and the solvent was removed in vacuo. The residue was 
dissolved in EtOAc (20 mL) and washed with water (2 x 10 mL), brine, dried over 
MgSO4, filtered through celite and the solvent was removed in vacuo to afford the 
aldehyde that was used without further purification. To a mixture of NaH (60 % in 
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mineral oil, 36 mg, 0.9 mmol, 1.5 equiv) in THF (5 mL) was added trimethyl 
phosphonoacetate (95 μL, 0.66 mmol, 1.1 equiv). After 15 min a solution of the above 
prepared aldehyde (172 mg, 0.6 mmol, 1.0 equiv) in THF (5 mL) was added and after 2 h 
the reaction mixture was diluted with ½ saturated NH4Cl (2 mL) and, after 10 min, the 
reaction mixture was diluted with ½ saturated NaHCO3 (10 mL) and EtOAc (10 mL) and 
the layers were separated. The aqueous layer was extracted with EtOAc (3 x 10 mL) and 
the combined organic layers were washed with brine, dried over MgSO4, filtered through 
celite, and concentrated in vacuo. The residue was purified by column chromatography 
(2:1 hexanes/EtOAc) to afford the title compound as a pale yellow oil (211 mg, 58% over 
2 steps) as a mixture of two rotamers. Rf 0.28 (2:1 hexanes/EtOAc).  
Rotamer 1: 1H NMR (400 MHz, CDCl3)  6.95 (d, J = 16.0 Hz, 1 H), 5.69 (d, J = 15.6 
Hz, 1 H), 4.34 - 4.44 (m, 1 H), 3.73 (s, 3 H), 3.61 - 3.68 (m, 1 H), 3.32 - 3.41 (m, 1 H), 
3.24 - 3.32 (m, 6 H), 2.31 - 2.41 (m, 1 H), 2.20 - 2.31 (m, 1 H), 2.12 - 2.20 (m, 1 H), 1.78 
- 1.88 (s, 1 H), 1.61 - 1.78 (m, 2 H), 1.41 (m, 9 H); 13C NMR (101 MHz, CDCl3)  167.0, 
153.8, 152.2, 117.8, 102.2, 80.2, 63.7, 53.3, 52.6, 51.6, 48.4, 39.0, 37.8, 28.3, 21.1. 
Rotamer 2: 1H NMR (400 MHz, CDCl3)  9 7.02 (d, J = 16.0 Hz, 1 H), 5.69 (d, J = 15.6 
Hz, 1 H), 4.34 - 4.44 (m, 1 H), 3.70 (s, 3 H), 3.50 - 3.55 (m, 1 H), 3.32 - 3.41 (m, 1 H), 
3.24 - 3.32 (m, 6 H), 2.31 - 2.41 (m, 1 H), 2.20 - 2.31 (m, 2 H), 1.78 - 1.88 (m, 1 H), 1.61 
- 1.78 (m, 2 H), 1.44 (s, 9 H); 13C NMR (101 MHz, CDCl3)  167.0, 153.2, 151.3, 118.1, 
102.7, 79.3, 64.2, 53.3, 52.9, 51.5, 48.4, 38.3, 37.0, 28.4, 21.6.  
 HRMS m/z 343.1991 (calcd for C17H29NO6, 313.1995). 
 
Compound 3-149 
To a solution of protected amine 3-148 (200 mg, 0.58 mmol, 1.0 equiv) 
and 2,6-lutidine (337 μL, 2.91 mmol, 5.0 equiv) in CH2Cl2 (4 mL) at 0 °C 
was added TMSOTf (421 μL, 2.32 mmol, 4.0 equiv). Following complete 
consumption of the starting material by TLC, a ½ saturated solution of NH4Cl (5 mL) 
was added. Once gas evolution had ceased, a ½ saturated NaHCO3 solution (10 mL) was 
added and the layers were separated. The aqueous layer was extracted with CH2Cl2 (3 x 
10 mL) and the combined organic layers were dried over MgSO4, filtered through celite, 
and concentrated in vacuo. Residual 2,6-lutidine was removed under vacuum to afford 
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the free secondary amine as a pale brown oil (128 mg, 90%) that was used without 
further purification as a 2.3:1 mixture of two rotamers. 
Major Rotamer: 1H NMR (400 MHz, CDCl3)  6.76 (d, J = 15.2 Hz, 1 H), 5.88 (d, J = 
15.6 Hz, 1 H), 4.99 (dd, J = 3.1, 10.2 Hz, 1 H), 3.76 (s, 3 H), 3.55 - 3.73 (m, 3 H), 3.54 
(s, 3 H), 2.52 (s, 1 H), 2.43 (dd, J = 3.1, 13.3 Hz, 1 H), 2.08 - 2.15 (m, 1 H), 1.87 - 1.98 
(m, 2 H), 1.77 - 1.83 (m, 3 H); 13C NMR (101 MHz, CDCl3)  166.0, 148.6, 122.8, 100.3, 
62.8, 57.0, 51.9, 46.7, 38.5, 38.0, 20.8. 
Minor Rotamer: 1H NMR (400 MHz, CDCl3)  6.83 (d, J = 15.6 Hz, 1 H), 6.76 (d, J = 
15.2 Hz, 1 H), 5.88 (d, J = 15.6 Hz, 1 H), 5.75 (d, J = 15.2 Hz, 1 H), 5.20 (dd, J = 1.0, 3.7 
Hz, 1 H), 3.74 (s, 3 H), 3.55 - 3.73 (m, 3 H), 3.40 (s, 3 H), 2.52 (s, 1 H), 2.48 (d, J = 12.9 
Hz, 1 H), 2.08 - 2.15 (m, 1 H), 1.87 - 1.98 (m, 2 H), 1.77 - 1.83 (m, 3 H); 13C NMR (101 
MHz, CDCl3)  166.0, 150.7, 120.1, 100.2, 62.8, 56.4, 51.9, 47.3, 39.4, 37.6, 20.0. 
 
Compound 3-166 
To a solution of 2-nitrobenzaldehyde (3-158, 1.17 g, 7.7 mmol, 1.0 equiv) 
and CBr4 (3.8 g, 11.6 mmol, 1.5 equiv) in CH2Cl2 (100 mL) at 0 °C was 
added PPh3 (6.10 g, 23.2 mmol, 3.0 equiv) and the reaction mixture was allowed to warm 
to room temperature. After 30 min the reaction mixture was filtered through a SiO2/celite 
bilayer pad and the pad was rinsed with CH2Cl2 (100 mL). The filtrates were combined 
and the solvent was removed in vacuo. The residue was purified by column 
chromatography (2:1 hexanes/EtOAc) to afford the title compound as a yellow solid 
(2.10 g, 89%). Rf 0.58 (2:1 hexanes/EtOAc); 1H NMR (400 MHz, CDCl3) d 8.14 (dd, J = 
1.4, 8.4 Hz, 1 H), 7.79 (s, 1 H), 7.66 - 7.72 (m, 1 H), 7.59 - 7.64 (m, 1 H), 7.53 - 7.59 (m, 
1 H); 13C NMR (101 MHz, CDCl3)  146.7, 134.0, 133.5, 131.6, 131.4, 129.4, 124.8, 
93.2. 1H and 13C NMR spectra were in agreement with previously reported data.49 
 
Compound 3-159 
To solution of dibromide 3-166 (306 mg, 1.0 mmol, 1.0 equiv) in EtOH (5 
mL) was added SnCl2•2H2O (903 mg, 4.0 mmol, 4.0 equiv) and the reaction 
mixture was heated to reflux. After 2 h the reaction mixture was cooled to room 
temperature and the solvent was removed in vacuo. The residue was diluted with H2O (10 
NH2
CBr2
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mL) and EtOAc (10 mL) and the layers were separated. The aqueous layer was extracted 
with EtOAc (2 x 10 mL) and the organic layers were combined, washed with brine, dried 
over MgSO4, filtered through celite and the solvent was removed in vacuo. The residue 
was purified by column chromatography (3:1 hexanes/EtOAc) to afford the title 
compound as a orange oil (190 mg, 69%). Rf 0.58 (3:1 hexanes/EtOAc); 1H NMR (400 
MHz, CDCl3)  7.34 (s, 1 H), 7.30 (d, J = 7.4 Hz, 1 H), 7.14 - 7.21 (m, 1 H), 6.76 - 6.83 
(m, 1 H), 6.67 - 6.75 (m, 1 H), 3.71 (br. s., 3 H); 13C NMR (101 MHz, CDCl3)  143.6, 
134.0, 129.7, 129.2, 121.7, 118.4, 115.7, 92.8. 1H and 13C NMR spectra were in 
agreement with previously reported data.49 
 
Compound 3-167 
 To a solution of 2-methylindole (5.25 g, 40 mmol, 2.0 equiv), 
phenyldisulfide (4.36 g, 20 mmol, 1.0 equiv) and DMSO (4.25 mL, 60 
mmol, 3.0 equiv) in methyl carbonate (40 mL) at 40 °C open to atmosphere 
was added and I2 (254 mg, 5 mol %). After 4 hours at 40 °C the reaction mixture was 
cooled to room temperature and diluted with CH2Cl2 (50 mL) and water (50 mL). The 
layers were separated and the aqueous layer was extracted with CH2Cl2 (2 x 25 mL). The 
organic layers were combined, dried over MgSO4, filtered through celite and 
concentrated in vacuo. The residue was purified by flash column chromatography (4:1 
hexanes/EtOAc) to afford the title compound as a pale pink solid (8.2 g, 86%). Rf 0.28 
(4:1 hexanes/EtOAc); 1H NMR (400 MHz, CDCl3)  8.17 (br. s., 1 H), 7.58 (d, J = 7.8 
Hz, 1 H), 7.35 (d, J = 7.8 Hz, 1 H), 7.11 - 7.26 (m, 4 H), 7.02 - 7.11 (m, 3 H), 2.51 (s, 3 
H); 13C NMR (101 MHz, CDCl3)  141.1, 139.3, 135.4, 130.2, 128.6, 125.4, 124.5, 
122.1, 120.6, 118.9, 110.6, 99.2, 12.1; 1H and 13C NMR spectra were in agreement with 
previously reported data.50  
 
Compound 3-161 
 To a solution of 3-167 (3.0 g, 12.5 mmol, 1.0 equiv) in DMF (50 mL) at 0 
°C was added NaH (60% in mineral oil, 602 mg, 15 mmol, 1.2 equiv) and 
the reaction mixture was warmed to room temperature. After 1h the 
reaction mixture was cooled to 0 °C and phenylsulfonyl chloride (1.76 mL, 13.75 mmol, 
N
H
SPh
N
SPh
SO2Ph
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1.1 equiv) was added dropwise. After 2 h the reaction mixture was added to a 1 M HCl 
solution (50 mL) and diluted with EtOAc (100 mL). The aqueous layer was removed and 
the organic layer was washed with water (3 x 25 mL), brine, dried over MgSO4, filtered 
and concentrated in vacuo. The residue was purified by column chromatography ( 8:1 
hexanes/EtOAc) to afford the title compound as an orange syrup (4.07 g, 86%). Rf 0.44 
(5:1 hexanes/EtOAc); 1H NMR (599 MHz, CDCl3)  8.25 (d, J = 8.8 Hz, 1 H), 7.78 - 
7.83 (m, 2 H), 7.55 - 7.59 (m, 1 H), 7.41 - 7.48 (m, 3 H), 7.30 - 7.36 (m, 1 H), 7.20 - 7.24 
(m, 1 H), 7.12 (t, J = 7.6 Hz, 2 H), 7.05 (t, J = 7.3 Hz, 1 H), 6.90 - 6.94 (m, 2 H), 2.74 (s, 
3 H); 13C NMR (101 MHz, CDCl3)  138.7, 135.7, 134.0, 129.4, 129.0, 129.0, 128.9, 
127.5, 126.4, 126.1, 125.2, 125.0, 124.1, 119.6, 119.2, 114.5, 29.7; 1H and 13C NMR 
spectra were in agreement with previously reported data.51 
 
Compound 3-162 
 To a solution of 3-161 (573 mg, 1.46 mmol, 1.0 equiv) and NBS (259 mg, 
1.46 mmol, 1.0 equiv) in CCl4 (10 mL) was added benzoyl peroxide (20 
mg, 0.07 mmol, 5 mol %) and the mixture was heated to 90 °C. After 8 h 
the reaction mixture was cooled to room temperature and filtered through a SiO2/celite 
bilayer pad and the pad was rinsed flushed with EtOAc/hexanes (50 mL). The filtrate was 
concentrated in vacuo to afford the title compound (690 mg, 91%) that was used without 
further purification. Rf 0.36 (5:1 hexanes/EtOAc); 1H NMR (400 MHz, CDCl3)  8.15 (d, 
J = 8.2 Hz, 1 H), 7.96 - 8.02 (m, 2 H), 7.60 (t, J = 7.4 Hz, 1 H), 7.48 (t, J = 7.8 Hz, 3 H), 
7.35 - 7.45 (m, 3 H), 7.20 - 7.25 (m, 1 H), 7.13 - 7.20 (m, 3 H), 7.06 - 7.11 (m, 2 H), 5.29 
(s, 2 H); 13C NMR (101 MHz, CDCl3)  140.2, 134.9, 134.3, 129.8, 129.3, 129.3, 129.0, 
127.5, 127.0, 126.6, 126.1, 126.1, 124.5, 120.7, 115.7, 115.0, 29.7; 1H and 13C NMR 
spectra were in agreement with previously reported data.51 
 
Compound 3-163 
 To a solution of bromide 3-162 (290 mg, 0.614 mmol, 1.0 equiv) and 
P(OMe)3 (87 μL, 0.74 mmol, 1.2 equiv) in CH2Cl2 (5 mL) was added 
ZnBr2 (27 mg, 0.12 mmol, 20 mol %). After 18 h the reaction mixture 
was diluted with CH2Cl2 (10 mL) and 1 M HCl (10 mL), the layers were separated and 
N
SPh
SO2Ph
Br
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the aqueous layer was extracted with CH2Cl2 (2 x 10 mL). The organic layers were 
combined, dried over MgSO4, filtered through celite, concentrated in vacuo and purified 
by column chromatography (4:1 hexanes/EtOAc to 100% EtOAc) to afford the title 
compound as a colorless syrup (230 mg, 75%). Rf 0.49 (100% EtOAc); 1H NMR (400 
MHz, CDCl3)  8.12 (d, J = 8.6 Hz, 1 H), 7.76 (d, J = 7.4 Hz, 2 H), 7.51 - 7.56 (m, 1 H), 
7.46 (d, J = 7.8 Hz, 1 H), 7.39 - 7.44 (m, 2 H), 7.27 - 7.32 (m, 1 H), 7.20 - 7.26 (m, 1 H), 
6.83 (d, J = 3.5 Hz, 1 H), 3.79 (d, J = 22.3 Hz, 2 H), 3.77 (d, J = 10.9 Hz, 8 H); 13C NMR 
(101 MHz, CDCl3)  138.5, 137.0, 133.8, 130.7, 130.7, 129.5, 129.2, 126.3, 124.6, 123.9, 
120.7, 115.0, 112.8, 112.7, 53.1 (d, J = 6.1 Hz, 1 C), 25.3 (d, J = 142.6 Hz, 1 C); LRMS 
m/z 487.1 (calcd for C23H22NO5PS2, 271.1420 
 
Compound 3-164 
 To a mixture of phosphonate 3-163 (1.38 g, 2.83 mmol, 1.0 
equiv) and aldehyde 3-103 (926 mg, 3.40 mmol, 1.0 equiv) at 0 
°C in THF (20 mL) was added LiHMDS (1.0 M in THF, 3.40 mL, 
3.40 mmol, 1.1 equiv) dropwise. After 30 min the reaction 
mixture was diluted with ½ saturated NH4Cl (10 mL) and Et2O (20 mL) and the layers 
were separated. The aqueous layer was extracted with Et2O (2 x 20 mL) and the organic 
layers were combined, washed with brine, dried over MgSO4, filtered through celite and 
concentrated in vacuo. The residue was purified by column chromatography (3:1 
hexanes/EtOAc) to afford the title compound as a bright yellow solid (1.02 g, 57%). Rf 
0.25 (5;1 hexanes/EtOAc); 1H NMR (599 MHz, CDCl3)  8.23 (d, J = 8.2 Hz, 1 H), 7.68 
(d, J = 7.6 Hz, 1 H), 7.53 (t, J = 7.6 Hz, 1 H), 7.36 - 7.41 (m, 2 H), 7.31 - 7.36 (m, 1 H), 
7.23 (d, J = 15.3 Hz, 1 H), 7.17 - 7.20 (m, 1 H), 7.06 - 7.10 (m, 1 H), 7.02 - 7.06 (m, 1 
H), 6.83 (d, J = 7.0 Hz, 1 H), 6.39 (d, J = 15.3 Hz, 1 H), 5.12 (s, 1 H), 3.57 - 3.63 (m, 1 
H), 3.23 (dt, J = 6.9, 10.9 Hz, 1 H), 2.18 - 2.25 (m, 1 H), 2.14 (dt, J = 5.9, 12.2 Hz, 1 H), 
2.04 - 2.11 (m, 1 H), 1.91 (dq, J = 6.1, 12.1 Hz, 1 H); 13C NMR (101 MHz, CDCl3)  
173.3, 140.5, 137.9, 136.4, 136.3, 136.2, 134.0, 131.4, 129.2, 128.9, 126.5, 125.9, 125.5, 
124.5, 120.4, 119.7, 115.2, 112.8, 103.6, 102.5, 100.2, 73.6, 58.3, 38.6, 25.0; HRMS m/z 
632.0162 (calcd for C29H23Cl3N2O5S2, 632.0165. 
 
N
O
O
CCl3
N
SPh
SO2Ph
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Compound 3-165 
To a solution of oxazolidinone 3-164 (300 mg, 0.47 mmol, 1.0 
equiv) in MeOH/MeOAc (1:1, 5 mL) was added sodium metal (12 
mg, 0.5 mmol, 1.0 equiv). After 30 min AcCl (780 μL, 9.0 mmol, 19 
equiv) was added dropwise and the reaction mixture was heated to reflux. Following 
disappearance of the intermediate N-formate by TLC, the reaction mixture was cooled to 
room temperature and the solvent was removed in vacuo. The residue was purified by 
column chromatography (2:1 hexanes/EtOAc to 100% EtOAc) to afford the title 
compound as a white solid (54 mg, 50%) .Rf 0.39 (100% EtOAc); 1H NMR (400 MHz, 
CDCl3)  8.27 (d, J = 8.2 Hz, 1 H), 7.69 - 7.78 (m, 2 H), 7.48 - 7.56 (m, 1 H), 7.30 - 7.41 
(m, 4 H), 7.14 - 7.22 (m, 2 H), 7.01 - 7.14 (m, 3 H), 6.84 - 6.91 (m, 2 H), 6.36 (d, J = 
15.6 Hz, 1 H), 3.72 (s, 3 H), 3.09 - 3.15 (m, 2 H), 2.21 - 2.31 (m, 1 H), 1.93 - 2.03 (m, 1 
H), 1.71 - 1.91 (m, 2 H); 13C NMR (101 MHz, CDCl3)  174.9, 141.2, 140.8, 138.1, 
136.5, 136.4, 133.9, 129.0, 128.8, 126.9, 126.6, 125.7, 125.4, 124.4, 120.3, 118.1, 115.3, 
111.8, 89.8, 70.7, 52.7, 46.4, 36.8, 24.7; HRMS m/z 518.1324 (calcd for C28H26N2O4S2, 
518.1334). 
  
H
N
N
PhS
SO2Ph
MeO2C
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Chapter 4.  Conclusions 
Presented herein has been the culmination of a number of projects which 
disclosed the development of novel strategies and methodologies, and progress towards 
the natural product grandilodine A. These projects, though disparate in nature, are all 
encompassed within the broad field that is synthetic organic chemistry. 
I have demonstrated that siloles may engage productively in Diels–Alder 
chemistry with exceptionally high levels of stereocontrol. These silanorbornene adducts 
have been shown to be valuable substrates as oxidative cleavage of the bridging silicon 
atom reveals a complex cyclohexene-1,4-diol. This complex core is found in numerous 
natural products, including the eudesmanolides; however, further studies were not 
conducted as we deemed the 5-step protocol for the synthesis of the silole to be 
excessively lengthy. Despite its shortcomings, the disclosed study represents the first 
systematic investigation of the Diels–Alder chemistry of siloles in the 85 year history of 
this venerable reaction. 
Following the termination of the silole project, I turned my attention towards 
exploration of the cycloaddition chemistry of donor-acceptor strained ring systems. I, 
along with coworkers, was able to show that alkoxy-activated cyclobutane dicarboxylates 
could successfully undergo annulation events with two and three atom dipoles to form a 
variety of unique bicyclic hetereocycles. Currently, there are no known natural products 
which bear these cis-fused acetal systems but the striking molecular architecture these 
compounds posses may lead to their application as novel scaffolds for biological studies. 
We have also conducted preliminary studies towards functionalization of the 
cycloadducts and are optimistic that they may become valuable synthons in the near 
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future. These newly developed methods greatly expand the current paradigm of 
herteroatom-activated strained ring systems, demonstrating that exceptional levels of 
regio- and stereo-control can be obtained during a variety of annulation events. 
Upon the completion of the cycloaddition projects, I directed efforts towards the 
total synthesis of the recently disclosed natural product grandilodine A. The methods 
which I had developed in the earlier chapters were not tenable for the synthesis of an 
alkaloid of this nature, and thus alternative chemistry was explored. Multiple routes 
towards the total synthesis of grandilodine A were examined, yet I was continually 
stymied by unanticipated intricacies that revealed themselves through my studies. Despite 
the incomplete nature of the work, many lessons were learned that may assist in a 
successful synthesis in the future. 
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Appendix 1 – NMR Spectral Data for Chapter 1 
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1H and 13C NMR of compound 1-19 
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1H and 13C NMR of compound 1-70 
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1H and 13C NMR of compound 1-34 
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1H and 13C NMR of compound 1-20 
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1H and 13C NMR of compound 1-21 
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1H and 13C NMR of compound 1-35 
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1H and 13C NMR of compound 1-36 
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1H and 13C NMR of compound 1-37 
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1H and 13C NMR of compound 1-38 
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1H and 13C NMR of compound 1-39 
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1H and 13C NMR of compound 1-41 
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1H and 13C NMR of compound 1-42 
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1H and 13C NMR of compound 1-43 
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1H and 13C NMR of compound 1-44 
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1H and 13C NMR of compound 1-45 
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1H and 13C NMR of compound 1-46 
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1H and 13C NMR of compound 1-47 
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1H and 13C NMR of compound 1-48a 
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1H and 13C NMR of compound 1-48b 
 
 
 
1H and 13C NMR of compound 1-48c 
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1H and 13C NMR of compound 1-48d 
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1H and 13C NMR of compound 1-48e 
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1H and 13C NMR of compound 1-48g 
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1H and 13C NMR of compound 1-48h 
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1H, 1D nOe, and 13C NMR of compound 1-48i 
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1H and 13C NMR of compound 1-48j 
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1H and 13C NMR of compound 1-48f 
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1H and 13C NMR of compound 1-58 
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1H and 13C NMR of compound 1-59 
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1H and 13C NMR of compound 1-60 
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1H and 13C NMR of compound 1-61 
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1H and 13C NMR of compound 1-62 
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1H, 1D nOe  and 13C NMR of compound 1-68a 
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1H and 13C NMR of compound 1-68b 
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1H and 13C NMR of compound 1-68c 
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1H and 13C NMR of compound 1-68d 
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1H, 1D nOe, and 13C NMR of compound 1-69a 
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1H and 13C NMR of compound 1-69b 
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1H and 13C NMR of compound 1-69c 
 
235 
 
 
 
 
 
1H and 13C NMR of compound 1-70a 
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1H and 13C NMR of compound 1-70b 
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1H and 13C NMR of compound 1-71 
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Appendix 2 – NMR Spectra Data for Chapter 2
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1H, 13C NMR, and 1D nOe of compound 2-65a  
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1H, 13C NMR, and 1D nOe of compound 2-65b 
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1H, 13C NMR, and 1D nOe of compound 2-65c 
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1H, 13C NMR, and 1D nOe of compound 2-65e 
 
245 
 
 
 
 
 
  
246 
 
 
 
1H, 13C NMR, and 1D nOe of compound 2-65g 
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1H, 13C NMR, and 1D nOe of compound 2-65h 
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1H, 13C NMR, and 1D nOe of compound 2-65i 
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1H, 13C NMR, and 1D nOe of compound 2-65k 
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1H, 13C NMR, and 1D nOe of compound 2-65m 
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1H, 13C NMR, and 1D nOe of compound 2-65n 
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1H, 13C NMR, and 1D nOe of compound 2-65o 
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1H, 13C NMR, and 1D nOe of compound 2-65p 
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1H, 13C NMR, and 1D nOe of compound 2-65q 
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1H, 13C NMR, and 1D nOe of compound 2-66a 
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1H, 13C NMR, and 1D nOe of compound 2-66b 
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1H, 13C NMR, and 1D nOe of compound 2-67a 
 
263 
 
 
 
 
 
 
 
264 
 
 
 
1H, 13C NMR, and 1D nOe of compound 2-67b 
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1H, 13C NMR, and 2D nOe of compound 2-81a, cis diastereomer 
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1H and 13C NMR of compound 2-81a, diastereomeric mixture 
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1H, 13C NMR, and 2D nOe of compound 2-81b, cis diastereomer 
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1H, 13C NMR, and 2D nOe of compound 2-81b, trans diastereomer  
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1H, 13C NMR, and 2D nOe of compound 2-81c, cis diastereomer 
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1H, 13C NMR, and 2D nOe of compound 2-81c, trans diastereomer 
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1H, 13C NMR, and 2D nOe of compound 2-81d, cis diastereomer 
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1H, 13C NMR, and 2D nOe of compound 2-81d, trans diastereomer 
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1H, 13C NMR, and 2D nOe of compound 2-81f, cis diasteromer 
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1H, 13C NMR, and 2D nOe of compound 2-81e, trans diastereomer  
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1H and 13C NMR of compound 2-81f, cis diastereomer 
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1H and 13C NMR of compound 2-81f, diastereomeric mixture 
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1H and 13C NMR of compound 2-81g, cis diastereomer 
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1H and 13C NMR of compound 2-81g, trans diastereomer 
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1H and 13C NMR of compound 2-81h, cis diastereomer 
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1H and 13C NMR of compound 2-81h, trans diastereomer 
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1H and 13C NMR of compound 2-81i, cis diastereomer 
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1H and 13C NMR of compound 2-81i, trans diastereomer 
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1H and 13C NMR of compound 2-81j, cis diastereomer 
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1H and 13C NMR compound 2-81j, diastereomeric mixture 
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1H and 13C NMR of compound 2-81n, cis diastereomer 
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1H and 13C NMR of compound 2-81o, cis diastereomer 
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1H, 13C and 1D nOe NMR of compound 2-89a 
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1H, 13C, 1D nOe and 2D HMBCAD NMR of compound 2-89b 
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1H and 13C NMR of compound 2-89c 
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1H, 13C and 1 D nOe NMR of compound 2-89d 
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1H, 13C and 1 D nOe NMR of compound 2-89e 
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1H, 13C, 1D nOe, 2D HMBCAD NMR of compound 2-89f 
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1H, 13C, 1D nOe NMR of compound 2-89g 
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1H, 13C and 1D nOe NMR of compound 2-89h 
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Appendix 3 – NMR Spectral Data for Chapter 3  
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1H and 13C NMR of compound 3-65 
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1H and 13C NMR of compound 3-68 
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1H and 13C NMR of compound 3-69 
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1H and 13C NMR of compound 3-63 
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1H and 13C NMR of compound 3-81 
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1H and 13C NMR of compound 3-82 
 
 
 
 
312 
 
 
 
1H and 13C NMR of compound 3-83 
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1H and 13C NMR of compound 3-84 
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1H and 13C NMR of compound 3-86 
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1H and 13C NMR of compound 3-87 
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1H and 13C NMR of compound 3-88 
 
 
 
 
317 
 
 
 
1H and 13C NMR of compound 3-89 
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1H and 13C NMR of compound 3-90 
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1H and 13C NMR of compound 3-91 
 
 
 
 
320 
 
 
 
1H and 13C NMR of compound 3-92 
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1H and 13C NMR of compound 3-93 
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1H and 13C NMR of compound 3-94 
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1H and 13C NMR of compound 3-106 
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1H and 13C NMR of compound 3-107 
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1H and 13C NMR of compound 3-108 
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1H and 13C NMR of compound 3-109 
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1H and 13C NMR of compound 3-111 
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1H and 13C NMR of compound 3-62 
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1H and 13C NMR of compound 3-112 
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1H and 13C NMR of compound 3-113 
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1H and 13C NMR of compound 3-114 
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1H and 13C NMR of compound 3-115 
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1H and 13C NMR of compound 3-117 
 
 
 
 
334 
 
 
 
1H and 13C NMR of compound 3-118 
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1H and 13C NMR of compound 3-120 
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1H and 13C NMR of compound 3-121 
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1H and 13C NMR of compound 3-122 
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1H of the diastereomeric mixture of compound 3-122 
 
1H of tim containing compound compound 3-126 
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1H and 13C NMR of compound 3-125 
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1H and 13C NMR of compound 3-127 
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1H and 13C NMR of compound 3-131 
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1H and 13C NMR of compound 3-138 
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1H and 13C NMR of compound 3-139 
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1H and 13C NMR of compound 3-141 
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1H and 13C NMR of compound 3-142 
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1H and 13C NMR of compound 3-145 
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1H and 13C NMR of compound 3-146 
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1H and 13C NMR of compound 3-147 
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1H and 13C NMR of compound 3-148 
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1H and 13C NMR of compound 3-149 
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1H and 13C NMR of compound 3-163 
 
 
 
 
352 
 
 
 
1H and 13C NMR of compound 3-164 
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1H and 13C NMR of compound 3-165 
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